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n aneurysm of the aorta is defined as a permanent dilatation of 
the artery, exceeding 1.5 times the normal diameter.1 In clinical 
practice, the definition of an abdominal aortic aneurysm (AAA) is 
set at 3-3.5cm.2,3 The prevalence of AAA  in The Netherlands is 2.1% 
in the population over 55 years of age, and occurs approximately 
6 times more frequent in men.4 A large Veterans Administration 
study (USA) in 1997 demonstrated a prevalence of 4.6% in 73.000 
patients aged 50 to 79 years.5 In specific subgroups, the percentage can be much higher, 
demonstrated by the study of Akkersdijk showing a prevalence of 11.4% in men over 60 
years of age.6 With a growing proportion of elderly people in the population, the incidence 
of aortic aneurysms is expected to increase in the future and could therefore constitute a 
major health risk.7-9
The main risk of this usually asymptomatic disease is rupture and subsequent death. Mortality 
rates have been reported to be as high as 75 - 90% in patients suffering from a ruptured aneu-
rysm.10,11 Therefore, the aim of treatment of the aneurysm is to reduce or preferably eliminate 
this risk of death due to rupture. Since the nature of the disease is one of gradual growth, 
much research has been undertaken to study the effect of lifestyle and medical therapy on 
the growth rate of AAA’s. Cessation of smoking seems to be most effective to diminish the risk 
of AAA rupture.12 The effects of statins, doxycyclin and other drugs to influence AAA growth 
rate, i.e. by altering the activity of inflammation and lytic enzymes look promising but this is 
still experimental.13-17
Treatment
The current consensus is to keep patients with a known AAA under surveillance until the AAA 
diameter reaches 5.5 cm.18 An AAA size smaller than 5.5 cm constitutes only a low risk of rup-
ture: 0.6-1% per year in AAA’s of 4.0 - 5.4 cm.19,20 If the AAA size is 5.5 – 5.9 cm, the annual risk 
of rupture increases to 9.4% in one year.21 As aneurysm size increases further, the rupture rate 
rises dramatically up to 25% in 6 months for aneurysms larger than 8cm.21
Until 1991, the only option for treatment of an AAA was open surgical repair. This procedure has 
excellent long term results but is followed by considerable morbidity and mortality in the post 
operative phase. In 1991, the first clinical experience of endovascular aneurysm repair (EVAR) 
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was reported in literature.22,23 The major advantage of this technique is that the procedure is 
less invasive than open aneurysm repair. The initial outcome after surgery compares favorably 
to open repair with a lower complication and mortality rate.24-26 In the years that followed the 
introduction of EVAR, stent-graft design and materials have improved significantly and the 
success rate of EVAR both in the shorter and longer term have increased. EVAR has now been 
embedded in standard clinical practice in most of the western world and yearly thousands of 
aneurysm patients are treated by endovascular repair. Despite the attractive concept of less 
invasive surgery and the high initial success rate, EVAR remains a relatively new technique 
and durability problems such as kinking, thrombosis, endoleak, stent-graft disintegration and 
stent-graft migration have arisen. Most of these complications were unheard of after open 
aneurysm repair. These adverse events have been analyzed and have lead to the withdrawal of 
earlier types of stent-grafts, adjustments in stent-graft design and development of completely 
new, more durable, devices. 
Although the stent-grafts were submitted to extensive preclinical laboratory and animal test-
ing, newly introduced or redesigned stent-grafts showed varying defects during post-EVAR 
surveillance. These defects are caused by the hostile and demanding biomechanical environ-
ment of the aorta. Repetitive forces of the cardiac and respiratory cycle induce strain to the 
graft material leading to migration and fatigue. Currently, it is impossible to quantify the nature 
and extent of these three-dimensional dynamics of the stent-graft inside the aorta. Therefore, 
preclinical biomechanical modeling is difficult and has shown to have been insufficient in the 
past. This has lead to design shortcomings in stent-grafts that only became apparent after clini-
cal introduction despite extensive but, in retrospect, insufficient pre-clinical testing. Reversed 
engineering of the circumstances to reproduce these types of stent-graft failure have led to 
improved understanding of previously unknown motion of the aorta, like torsion / rotation 
of the thoracic aorta. Increased knowledge of stent-graft dynamics after EVAR is essential to 
improve preclinical testing of new devices and to help detect deficiency of this type of testing 
early after initial clinical introduction of new stent-grafts.
Migration of the graft can result in disconnection between the stent-graft and the “landing 
zone”, the relatively healthy part of the artery in which the stent-graft is positioned before 
bridging the aneurysm. This disconnection may lead to reestablishment of flow and / or 
repressurization of the aneurysm sac. Stent-graft migration has been reported to occur in over 
50% in certain first generation devices.27 Migration can have detrimental effects on patient 





to the aortic wall,31 stent-graft migration is still reported in currently marketed abdominal and 
thoracic devices between 1 and up to 66% and detailed analysis seems to reveal more cases 
of migration.32-50
Material fatigue can lead to stent fracture and / or stent-graft disintegration. Stent fracture 
can be harmless, but can also lead to perforation of the fabric or the aortic wall, with graft 
infection, bleeding or repressurization of the aneurysm as a result.32,46,47 Disintegration of the 
graft, due to detachment of the fabric and the stents can also lead to repressurization of the 
AAA sac.48 These forms of failure can ultimately lead to death of the patient.39 The reported late 
aneurysm related mortality after EVAR is 1-2% per year and is largely explained by migration, 
endoleak and material fatigue.28,30,33,35,37,51-53
Surveillance after EVAR
Surveillance after EVAR aims at early detection of the described adverse events. In contrast 
to open repair, rigorous follow-up is required because long term results of the available 
stent-grafts are unknown and new or redesigned grafts are constantly introduced in clinical 
practice. Current surveillance protocols vary slightly but in general consist of intravascular 
contrast enhanced CT-scan investigation and plain radiography combined with duplex ultra-
sound. To date, intravascular contrast enhanced CT-scan is the clinical gold standard to detect 
stent-graft migration and AAA size.54 The major disadvantages of this surveillance program are 
poor patient compliance, intravascular contrast requirement, logistical burden and healthcare 
cost.30,55,56,57 Another disadvantage is the high cumulative radiation dose that results from 
frequent CT scanning.58 
Patient compliance with the current follow-up regime is poor and this may explain part of 
the incidence of late rupture after EVAR.30,57 A possible explanation for this incompliance is 
the cumbersome amount and intensity of investigations for an asymptomatic disease.57 A 
less intensive surveillance schedule might increase patient compliance. This is an additional 
argument in favor of a more patient friendly alternative to CT surveillance in selected patients. 
The risk of limiting the intensity of surveillance is that adverse effects are identified too late. 
Therefore, it is paramount that alternative surveillance strategies are not only more patient 
friendly but also at least as accurate as current clinical strategies.
Optimal imaging using CT requires intravascular contrast enhancement. The major disad-
vantage of intravascular contrast use is its nephrotoxic side effect. This is especially relevant 
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considering the fact that reported rates of renal function impairment vary from 23% up to 83% 
in patients eligible for EVAR.59-61
Cost effectiveness of EVAR as compared to open aneurysm repair is mainly limited by the cost 
of the stent-graft, post EVAR surveillance and secondary interventions.56 The introduction of a 
safe and accurate lower cost alternative to CT for surveillance in selected cases could therefore 
significantly improve this cost effectiveness balance. 
Alternative to current surveillance modalities
Because surveillance aims at early detection of adverse events, the methods used need to be 
accurate enough to reliably detect abnormalities. The items that need to be identified are:
- Correct position and integrity of the stent-graft
- Exclusion of the AAA sac from the circulation
CT, duplex ultrasound and plain radiography, alone or in various combinations are currently 
used. The correct position and integrity of the stentgraft are currently assessed with CT and 
/ or plain radiography. Both aim at identifying stent fractures, configuration changes and 
(pending) disconnection of components. The accuracy of both methods to determine stent-
graft migration is not known but considered clinically adequate. An important factor in the 
accuracy of CT and plain radiography is the fact that the images have to be analyzed by hand. 
The clinical significance of the impact of human error on the accuracy of this kind of analysis 
is unknown. Furthermore, plain radiography produces a two dimensional image of a three 
dimensional situation. This may lead to projection errors due to the divergence of the X-ray 
beam (parallax). Most clinicians agree that technical problems may arise with reproducibility 
of plain radiographic imaging. CT is, next to the disadvantages of intravenous contrast require-
ment, high radiation dose and cost, a still image reconstructed from a relatively long exposure 
of a dynamic situation and therefore incorporates artefacts of varying degree. 
Plain abdominal radiography is widely used as a method to detect stent-graft migration 62-64 
and has been proposed to replace CT as a more cost effective and patient friendly method. The 
main difference between these modalities is that plain radiography uses the vertebral column 
as the point of reference to determine stent-graft position, whereas CT analysis uses the, more 





Over the last years, the accepted length of the proximal landing zone in EVAR, the aneurysm 
neck, is continuously reported to be shorter.65 Currently a length as short as 5mm is accepted 
in selected patients. With this ever decreasing neck length, the accuracy and precision of 
migration detection becomes increasingly important. 
To ensure exclusion of the AAA sac from the systemic circulation, several strategies can be 
followed. AAA sac diameter or volume can be measured with CT and, in case of growth, addi-
tional diagnostics can be performed to determine and treat the cause of the sac growth. In 
case of significant (over 5mm) sac diameter shrinkage after EVAR, this change can be reliably 
detected and followed by ultrasound. Ultrasound seems inappropriate to accurately detect 
changes smaller than 5mm due to the inter- and intra-observer variability.66 Alternatively, sac 
pressure measurement could be performed to determine trends in pressure changes.67-73 The 
latter method is still under investigation and has considerable pitfalls.74-77 
A significant reduction of aneurysm sac size is reported to occur in 50-73% after EVAR and 
appears to be a strong indicator for succes.78-84 If this reduction is found after EVAR, it can be 
deduced that the pressure in the AAA sac, has been reduced.85 In this case the only remain-
ing issues of interest are stent-graft position and integrity. If a method can be developed to 
accurately determine these items at low cost in terms of logistics and healthcare budget, the 
indications for CT could be reduced and therefore the cost effectiveness and patient friendli-
ness of EVAR could increase. In theory, Roentgen Stereophotogrammetric Analysis (RSA) may 
be the ideal tool to perform the surveillance of stent-graft position and integrity. The tech-
nique is described in further detail below. If RSA can be used for the purpose of surveillance of 
stent-grafts, follow-up intensity after EVAR in patients with a decreased AAA sac size could be 
reduced to ultrasound and RSA imaging without the risk of loss (or possibly even increase) of 
accuracy. This would result in significant reduction of cost, burden to hospital and patient and 
required doses of radiation and intravascular contrast. 
Roentgen stereophotogrammetric analysis
Roentgen stereophotogrammetric analysis is a method that has been used in orthopedic 
surgery for many years.86-88 It enables highly accurate detection of the position of joint pros-
thesis components relative to the bony structures. The technique is based on computer aided 
analysis of calibrated stereo images to determine the relative position of markers in space. The 
markers are placed on the prosthesis and reference markers are attached to the bone. 
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In endovascular surgery, the stent-graft markers that are used to position the graft during 
endovascular aneurysm repair can be used as graft markers. Additional markers need to be 
attached to the aortic wall to function as reference markers and enable detection of change 
of position of the graft. This means an additional procedure has to be performed during EVAR. 
Major assets of RSA are the fact that no intravascular contrast is required, its low cost and low 
burden to hospital logistics and its low radiation dose. Moreover, it may be a more accurate 
method than CT and plain radiography. There are several questions that need to be answered 
before RSA can be introduced into clinical practice. In short, they concern the accuracy and 
feasibility of RSA to detect stent-graft migration and the extent to which these are influenced 
by physiological motion due to the cardiac cycle. Furthermore, the nature and the number of 
aortic reference markers required for accurate analysis needs to be clarified. 
Imaging of stent-graft motion in vivo using FRSA
As previously described, the forces of the cardiac cycle can have a detrimental effect on a 
stent-graft. To analyze these forces and enable accurate laboratory fatigue and biocompat-
ibility modeling, detailed knowledge of stent-graft motion is mandatory. With current imaging 
techniques such as CT, MRI motion analysis is possible using cinematographic reconstruction 
with the help of “ECG-gating”.89-91 These methods have specific disadvantages to the patient in 
terms of intravascular contrast requirement, radiation dose (for CT) and limitation in analysis 
of stainless steel stent-grafts (MRI).  Furthermore, there are technical difficulties in ECG gated 
analysis.
ECG gating is a technique that reconstructs a series of still images acquired over a short period 
of time according to the recorded ECG phase in which the image was acquired. The images are 
all reconstructed in the same plane respective to the position of the patient on the couch. This 
means that the cinematographic loop that is produced with this kind of imaging is actually a 
reconstruction that sequences images that are not acquired consecutively. The image loop is 
therefore a representation of a series of motions, not an exact image. Cardiac arrythmias can 
hinder this kind of image reconstruction. 
The main disadvantage of cine-CT and cine-MRI is that reconstruction of images is limited to 
one single plane at a time. Therefore, quantification of out-of-plane motion is impossible with 
the current techniques. 
In other words, cine-CT and cine-MRI can only quantify two-dimensional motion. The accuracy 
of this type of measurement is not validated. Out of plane motion can only be visualized. 





With the knowledge of RSA available at our institution and the arrival of new, digital bi-plane 
fluoroscopy equipment, we will develop and validate Fluoroscopic Roentgen Stereophoto-
grammetric Analysis, FRSA. FRSA uses the same three-dimensional reconstruction technique as 
RSA, but a different method of calibration is required. Redesigning the available software and 
testing for accuracy will be required before introduction into clinical practice can take place. 
Patient risk of radiation exposure due to imaging in EVAR
As mentioned above, there is considerable exposure of the patient to ionizing radiation due to 
different imaging modalities.58 There is concern with regard to patient safety, since this type 
of radiation can induce malignancy. However, EVAR candidates are afflicted with other forms 
of systemic disease. This co-morbidity results in significant long term mortality.92-95 There is no 
literature on the risk of radiation induced death due to imaging for (surveillance of ) EVAR.
Aims of this research:
- To develop, test for feasibility and validate roentgen stereophotogrammetric analysis to 
assess  stent-graft migration in long-term surveillance studies, as an alternative to plain 
abdominal radiography and CT, the current clinical gold standard.
 
- To develop, validate and clinically introduce fluoroscopic roentgen stereophotogrammetric 
analysis, a noninvasive tool that can be applied to assess real time three-dimensional stent-
graft dynamics due to the cardiac and respiratory cycle. 
Outline
The technique of RSA to determine stent-graft migration and FRSA to study stent-graft dynam-
ics are explained in further detail in CHAPTER 2. CHAPTER 3 and 4 concern the accuracy and 
feasibility of RSA to detect stent-graft migration in a static model and in a model with pulsatile 
motion. The results are compared to CT, the current clinical gold standard. RSA requires an 
aortic reference marker to detect stent-graft migration. A possible aortic reference marker is 
studied in CHAPTER 4 and 5. In CHAPTER 5, the feasibility of RSA in vivo is described. Further-
more, the position and the number of aortic reference markers required for accurate analysis 
needs to be clarified. These issues are discussed in CHAPTERS 5 and 6.
Plain abdominal radiography is widely used as a low cost method to determine stent-graft 
migration. In CHAPTER 7, a study on the accuracy and, therefore, clinical applicability of plain 
abdominal radiography to detect stent-graft migration is described.
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In CHAPTER 8 the feasibility of FRSA is studied in a model and the method is validated for accu-
racy and precision. In CHAPTER 9, the first clinical introduction of this technique is reported.
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oentgen Stereophotogrammetric Analysis (RSA) has a long and success-
ful history in orthopedic surgery. It is used to evaluate joint prostheses for 
signs of aseptic mechanical loosening, the most common cause for revi-
sion surgery in long term follow-up.1-3 A highly accurate measurement 
method is required to detect this detrimental effect at an early stage. 
Early detection allows for early evaluation of new implants, coatings and 
cement in small patient groups before large scale introduction in clinical 
practice.4,5 RSA has a very high accuracy and digitization of the technique with specialized RSA 
software enabled easy, fast and accurate analysis of stereo images. For this reason, RSA has 
evolved to become the gold standard for evaluation of micro-motion of the prosthesis with 
respect to the bone after joint replacement surgery.6-11 
Principles of RSA
The essence of RSA can be compared to stereo vision of human eye sight: two images of an 
object are simultaneously acquired by the eyes. Each image is taken from a different angle. The 
brain compares these images and is able to determine the position of the object in space as 
compared to the human body. “Calibration” of the brain to determine the position of the object 
is done by trial-and-error experience.
RSA also uses two simultaneously acquired, calibrated images to determine the three dimen-
sional position of markers in the human body. During surgery, reference markers are placed 
inside the body. The prosthesis is inserted and the relative position and orientation of the 
prosthesis can be assessed by comparing its position and orientation to that of the reference 
markers. When comparing consecutive RSA images over time, a change of position of the 
prosthesis as compared to the reference markers can be detected. This way, migration of the 
prosthesis can be detected.
RSA uses two still images to perform this reconstruction. It is therefore ideal for follow-up 
after surgery, to determine position changes of prostheses. Obviously, this technique with 
still images cannot be used to assess a dynamic, rapidly changing position that occurs in the 
pulsatile environment of the vascular system. Analysis of a dynamic situation requires rapid 




As discussed previously, distinct prosthesis markers and reference markers are required to 
perform RSA. To apply RSA to the endovascular surgery environment, the stentgraft and the 
aorta have to be marked accordingly. The stentgraft markers used to position the graft dur-
ing placement can be utilized for this purpose. Reference markers need to be attached to the 
aortic wall to serve as reference markers. In CHAPTERS 4, 5 and 6 the issue of aortic reference 
markers will be addressed in more detail.
the rSa set-up
To acquire a stereo image for RSA, two roentgen films or detectors, positioned under the 
patient, are exposed by two synchronized roentgen tubes. A calibration box is positioned 
between the patient and the films to produce a coordinate system and enable measurements 
(Figure 1).
Figure 1. RSA imaging setup. The reference and control markers are in the box under the patient. 





Two synchronized Roentgen tubes
Two standard hospital roentgen tubes are used to acquire the images. The two roentgen tubes 
are positioned approximately 1.60 m above the film and at a 20º angle to the vertical (Figure 
1 and 2). The exposure of the films is synchronized by simply pressing the exposure buttons 
of the two machines at the same time. Because this is done by hand, exact simultaneous 
exposure of the films may not be achieved. This could lead to motion artifacts and result in 
inaccurate measurements. This type of error is especially possible in an endovascular surgery 
setting where the markers are continuously displaced by the pulsatile motion of the blood 
vessels. This issue is further addressed in CHAPTER 4.
Calibration box
Since it is the goal of RSA to perform measurements to determine the three dimensional posi-
tion of markers, the images have to be calibrated. This enables three important steps in the 
image analysis: a) the position of the images (films / detectors) as compared to each other 
has to be determined; b) a laboratory coordinate system has to be added to the image to 
define distance in the image; c) the position of the two roentgen tubes has to be determined as 
compared to the films. After these steps have been performed the position of all components 
of the set-up is known including their relation to each other. These steps will be discussed 
separately below. 
Image calibration is performed with the help of a calibration box positioned between the 
patient and the films (Figure 1). The box is made of carbon fiber sandwich plates. This material 
is chosen because it is insensitive to changes in room temperature and humidity. Furthermore, 
carbon fiber plates are radiolucent. The dimensions of the box are 70 x 46 x 24 cm. The top and 
bottom layers of the box contain tantalum markers to perform the calibration. These markers 
are positioned with a computer controlled device and the position of these markers is known 
within a few micrometers. The bottom layer contains fiducial markers. The top layer of the box 
contains the control markers. The use of the calibration box markers will be elucidated below.
Scatter grids
As the roentgen beam passes through the body, it is partially absorbed by the tissues. The 
X-rays that pass through the body (the primary bundle) generate the image. Some X-rays how-
ever, are neither absorbed nor pass straight through the body but only change direction and 
scatter. These X-rays produce a grey mist in the image and therefore reduce the image quality. 
To reduce this effect, a scatter grid can be used to filter out these scattered X-rays.
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Roentgen tube setting and radiation dose
The roentgen tubes are set to maximize contrast of the metal graft and reference markers. 
Next to RSA, the images can be used for stent fracture detection. Soft and bony tissues are of 
less interest in the image. The radiation dose for a stereo RSA image of an abdominal aortic 
stentgraft is 0.3 mSv, which is roughly one sixth of the yearly natural background radiation. 
This amount of radiation is dwarfed by the radiation dose received for a standard 3-phase 
contrast enhanced CT used for regular follow-up after endovascular aneurysm repair, which is 
approximately 17 mSv.
Digital RSA
After acquisition of the stereo image, the films are digitized and loaded into the RSA software 
(Model Based RSA software, MEDIS Specials BV, Leiden, The Netherlands) on a personal com-
puter. Digitally acquired images are loaded directly into the software.
The software automatically detects the markers and performs the calibration and analysis 
steps. Every step in the marker recognition process can be verified manually in a user friendly 
way. This method has been validated and was described previously in mathematical detail.8-12
Calibration of the set-up
First the fiducial and control markers of the calibration box are detected. With the known posi-
tions of these markers the two images can be virtually repositioned next to each other in the 
same way as they were positioned under the patient. The fiducial markers on the bottom of the 
box are used to define the laboratory coordinate system. Furthermore, these markers are used 
to virtually transform the image from the plane of the film to the lower plane of the box. Now 
that the position of the two films is known relative to each other and the transformation of the 
films has been calculated as well as the laboratory coordinate system for the image pairs, the 
position of the two roentgen foci can be reconstructed. 
The known positions of the control markers (Figure 2 thin arrow, top of the box) can be 
matched to the projections of these markers on the film (Figure 2 thick arrow). The marker 
and its image on the film are, by definition, in one line with the roentgen focus. These lines are 
called projection lines (Figure 2 thick lines). By calculating the point of intersection of different 
projection lines through the control markers and their images, the position of the roentgen 
focus is determined (Figure 2 top right).
Now that the position of the films and the roentgen foci is known as well as their relation to 





Calculation of three-dimensional marker position
After calibration of the set-up, calculation of the position of a marker relative to other markers 
in the body becomes an equation with one unknown value: the position of the foci and the 
films is known, and therefore the position of the marker can be calculated.
To determine the three-dimensional position of a stentgraft marker or reference marker, a 
projection line is calculated through (the now known position of ) the roentgen focus (Figure 
3: F) and the projection of the marker on the film (Figure 3 projection B and C). This is done for 
both projections on the two films (Figure 3 line 1 and 2). By calculating the point of intersection 
of the two lines(Figure 3: A), the three-dimensional coordinates of the marker becomes clear, 
relative to the laboratory coordinate system. In reality, the projection lines do not intersect but 
cross, due to minute measurement errors. Therefore, the marker is positioned in the middle of 
the shortest distance between the two projection lines. This phenomenon of crossing instead 
of intersection is called the crossing line error and is given by the software for each calculated 
three dimensional marker position. It can be used as an internal control for measurement error: 
Figure 2. Reconstruction of the position of the Roentgen foci (F). The control markers (thin arrow, 
top layer of the box) project an image on the film (thick arrow). The point of intersection of the 
projection lines of the control markers (thick lines) defines the Roentgen focus (F). 
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the smaller the crossing line error, the more accurate the calibrated set-up and measurement. 
A typical crossing line error is 0.02 mm. 
Because the calibration is performed with the aid of the box under the patient, each new image 
is calibrated according to its laboratory coordinate system. Positioning of the patient does not 
influence the measurement because the distance between reference marker and graft marker 
is determined according to the coordinate system.
FRSA
Fluoroscopic roentgen stereophotogrammetric analysis (FRSA) is a novel application of RSA 
principles and technique to high definition digital stereo fluoroscopy with a high frame rate 
(images per second). This enables imaging and quantification of marker motion, for instance 
during the cardiac cycle. Until recently, equipment with these specifications was not available. 
In June 2005 a Siemens Axiom Artis dBc imaging system was placed in the Leiden Univer-
sity Medical Center, and we developed and validated a method to accurately quantify three 
Figure 3. Schematic drawing of the RSA technique. Graft marker A gives projections B and C 
on the films. With a known focus position, projection lines 1 and 2 can be reconstructed. The 





dimensional marker motion at a high frame rate.13 This has been impossible up to now, despite 
advanced imaging systems like (ECG-gated) CT and MRI. FRSA could therefore be of great value 
to the knowledge of stentgraft motion and stentgraft improvement.
As explained above, RSA with still images is constrained to longer term follow-up because 
only one image can be produced at a time. In order to quantify marker motion, several images 
need to be acquired per second, comparable to cinematography. These images need to be 
calibrated in a similar way as RSA images.
The FRSA set-up and calibration process is different from regular RSA at several points in the 
process.
the FrSa set-up
The set-up consists of two C-arms with digital flat panel detectors (Siemens Axiom Artis dBc 
imaging system, Siemens, Forcheim, Germany). The C-arms are positioned at a 90º angle, 
producing a lateral and a postero-anterior (PA) image (Figure 4). In contrast to standard RSA, 
the 90º angle is chosen for two reasons: a) practical reasons, since this is a standard setting in 
the machine; b) for maximum accuracy, since on theoretical grounds a 90º angle will result 
Figure 4. Clinical set-up of the bi-plane fluoroscope.
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in a maximum angle of the imaging on the direction of the marker motion (as little out of 
plane motion as possible).  To maximize the field of view, the detectors are placed as close to 
the patient as possible. The set-up acquires high definition digital stereo images of the body 
at a frame rate of 30 bi-directional frames per second. The stereo images are acquired as two 
alternate single images (i.e. 60 single frames per second). The exposure time of each image 
is approximately 4 ms. The pause between the PA and the lateral image is approximately 
12.7 ms.
The image pairs are analyzed using Model-based RSA software (MB-RSA, MEDIS specials, Leiden, 
The Netherlands) to calculate the relative 3-D marker positions.8-11 No image reconstruction is 
required before analyzing the image pairs.
Calibration of the FRSA set-up
To calibrate the set-up, an acrylic block is used with markers at precisely known positions 
(Figure 5). A FRSA (stereo) image of this block is acquired with the set-up. Afterwards, the pro-
cess, as described above, of calculation of the position of markers with the MB-RSA software 
is reversed. This time the position of the markers is known and therefore the position of the 
foci and the detectors can be calculated, as well as their position in relation to each other. The 
patient is positioned in the set-up without changing the C-arm positions. Once the position 
of the foci and the detectors is known, this can be fed into the software and images of the 
patient can be analyzed in the standard way as described for RSA, revealing the positions of 
the markers on the stent-graft. 
Figure 5. Calibration object. Acryllic block, dimensions w x d x h: 8 x 8 x 5 cm. In every corner one 
tantalum marker, diameter 1mm. In the top layer three extra markers, diameter 2mm for ease of 





1. Sundfeldt M, Carlsson LV, Johansson CB, Thomsen P, 
Gretzer C. Aseptic loosening, not only a question of 
wear: a review of different theories. Acta Orthop. 2006 
Apr;77(2):177-97. 
2. Herberts P, Malchau H. Long-term registration has 
improved the quality of hip replacement: a review of the 
Swedish THR Register comparing 160,000 cases. Acta 
Orthop Scand 2000; 71 (2): 111-21. 
3. Robertsson O, Knutson K, Lewold S, Lidgren L. The 
Swedish Knee Arthroplasty Register 1975-1997: an 
update with special emphasis on 41,223 knees operated 
on in 1988-1997. Acta Orthop Scand 2001; 72 (5): 
503-13.
4. Kärrholm J, Borssen B, Lowenhielm G, Snorrason F. Does 
early micromotion of femoral stem prostheses matter? 
4–7-year stereoradiographic follow-up of 84 cemented 
prostheses. J Bone Joint Surg Br. 1994;76:912–917.
5. Ryd L, Albrektsson BE, Carlsson L. F. Dansgard F, Herberts 
P, Lindstrand A, Regner L, and S. Toksvig-Larsen. 
Roentgen stereophotogrammetric analysis as a 
predictor of mechanical loosening of knee prostheses. J 
Bone Joint Surg Br. 1995;77:377–383.
6. Kärrholm J. Roentgen stereophotogrammetry. Review 
of orthopedic applications. Acta Orthop Scand. 
1989;60:491–503. 
7. Kärrholm J, Gill RH, Valstar ER. The history and future of 
radiostereometric analysis. Clin Orthop Relat Res. 2006 
Jul;448:10-21.
8. Valstar ER, Vrooman HA, Toksvig-Larsen S, et al. Digital 
automated RSA compared to manually operated RSA. J 
Biomech. 2000;33:1593–1599.
9. Vrooman HA, Valstar ER, Brand GJ, et al. Fast and 
accurate automated measurements in digitized 
stereophotogrammetric radiographs. J Biomech. 
1998;31:491–498.
10. Valstar ER, de Jong FW, Vrooman HA, et al. Model-based 
Roentgen stereophotogrammetry of orthopaedic 
implants. J Biomech. 2001;34: 715–722.)
11. Kaptein BL, Valstar ER, Stoel BC, Rozing PM, Reiber 
JAC. A new model-based RSA method validated using 
CAD models and models from reversed engineering. J 
Biomech. 2003;36:873-882.
12. Valstar ER. Digital roentgen stereophotogrammetry. 
Development, validation, and clinical application. Thesis, 
Leiden University. Den Haag, The Netherlands: Pasmans 
BV, 2001.
13. Koning OH, Kaptein BL, Garling EH, Hinnen JW, 
Hamming JF, Valstar ER, Bockel JH. Assessment of three-
dimensional stent-graft dynamics by using fluoroscopic 
roentgenographic stereophotogrammetric analysis. J 
Vasc Surg. 2007 Oct;46(4):773-779. Epub 2007 Aug 30. 
References

p a r t
I
Surveillance of stent-graft migration  
after EVAR

C h a p t e r 3
Roentgen Stereophotogrammetric Analysis:  










and J. Hajo van Bockel
J Endovasc Ther 2006;13:468–475
40
Abstract
Purpose: To evaluate in an in vitro model the feasibility and accuracy of Roentgen stereo-
photogrammetric analysis (RSA) versus computed tomography (CT) for the ability to detect 
stent-graft migration.
Methods: An aortic model was constructed from a 22-mm-diameter Plexiglas tube with 6-mm 
polytetrafluoroethylene inlays to mimic the renal arteries. Six tantalum markers were placed 
in the wall of the aortic tube proximal to the renal arteries. Another 6 markers were added 
to a Gianturco stent, which was cast in Plexiglas and placed inside the aorta and fixed to a 
micromanipulator to precisely control displacement of the stent along the longitudinal axis. 
Sixteen migrations were analyzed with RSA software and compared to the micromanipulator. 
Thirty-two migrations were measured by 3 observers from CT images acquired with 16×0.5-mm 
beam collimation and reconstructed with a 0.5-mm slice thickness and a 0.4-mm reconstruc-
tion interval. Measurements were made with Vitrea postprocessing software using a standard 
clinical protocol and central lumen line reconstruction. Results of CT were also compared to 
the micromanipulator. 
Results: The mean RSA measurement error compared to the micromanipulator was 
0.002±0.044 mm, and the maximum error was 0.10 mm. There was no statistically significant 
interobserver variability for CT (p=0.17). The pooled mean (maximum) measurement error of 
CT was 0.14±0.29 (1.00) mm, which was significantly different from the RSA measurement error 
(p<0.0001). 
Conclusion: Detection of endograft migration by RSA is feasible and was significantly more 
accurate than CT in this nonpulsatile in vitro model.  
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ndograft migration is a well recognized complication after endovascular 
aneurysm repair (EVAR) of an abdominal aortic aneurysm (AAA).1,2 Contrast-
enhanced computed tomographic angiography (CTA) is the current gold 
standard to detect endograft migration.3 However, CT has several adverse 
effects, including high radiation dose and the use of nephrotoxic intra-
vascular contrast. With the widespread use of EVAR, CT surveillance also 
places increasingly high logistical and economical burdens on hospitals,4 
considerations that have led many centers to reduce the frequency of CT after EVAR, especially 
if there is evidence of sac shrinkage.5 Less frequent CT scans may be feasible; however, there is 
the risk of unnoticed migration. Clearly, there is a need for another type of imaging modality to 
follow the thousands of patients with aortic endografts.  
Roentgen stereophotogrammetric analysis (RSA) was introduced by Selvik6 in 1974 and became 
the gold standard for assessing micromotion of orthopedic implants7-10; the technique now 
is used widely across northern Europe. RSA is based on calculating the 3-dimensional (3D) 
position of markers from stereo images.9 The technique is relatively simple, requiring only 2 
standard Roentgen tubes, a calibration box with markers, and computer software for the analy-
sis. The major advantages of RSA are the fact that intravascular contrast is not required and the 
radiation dose is only 0.3 mSv. Furthermore, RSA is a low-cost and time efficient method that 
can be performed by a trained technician. 
Georg et al.11 recently described the use of RSA to detect stent-graft migration in a model. 
However, they showed only reproducibility of marker position measurement with RSA in an 
endovascular setting. The accuracy of RSA to detect stent-graft migration is still unknown. To 
evaluate the possible role of RSA in the follow-up after EVAR, we tested the feasibility and 
accuracy of RSA in an in vitro model of endograft migration. 
Methods
aortic Model With Stent-Graft
An aortic model (Figure 1) was constructed from a 22-mm-diameter Plexiglas tube to simulate 
the aorta. The tube had 2 6-mm-diameter polytetrafluoroethylene tubes inserted to mimic the 
renal arteries with intravascular contrast, used for CT analysis. RSA requires the use of markers, 
so 6 1-mm-diameter tantalum markers were placed in the wall of the aortic tube proximal to 
the renal arteries. Another 6 tantalum markers were added to a Gianturco stent (Cook Inc., 
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Figure 1. Model used in the experiments. The micromanipulator can displace the stent in a highly 
controlled manner along the axis of the aorta. Markers are placed on the stent and inside the aorta 
for RSA analysis. Renal arteries (arrow) are mimicked by polytetrafluoroethylene inlays in the wall 
of the aorta for CT analysis.
Figure 2. RSA imaging setup. The reference and control markers are in the box under the patient. 
The radiographic films are placed directly under the box.
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Bjaeverskov, Denmark), which was then cast in Plexiglas, making rotational movement and 
stent distortion impossible. The encased stent was placed inside the aorta and fixed to a micro-
manipulator (Thesa, Veenendaal, The Netherlands) to precisely control displacement of the 
stent along the longitudinal axis of the aorta. The increments of the micromanipulator were 
accurate up to 0.01 mm according to the manufacturer, which was confirmed by laboratory 
testing at our institution. To simulate soft tissue, 22 cm of Plexiglas was placed on top of the 
model during RSA imaging.12
rSa Imaging technique
The RSA setup (Figure 2), identical to that used for orthopedic evaluation,13 consisted of 2 
Roentgen tubes (Philips Rotalix, 90 kV/100 mAs and a Philips Practix 2000, 90 kV/60 mAs; 
Philips Medical Systems Europe, Amsterdam, The Netherlands) positioned 1.5 meters above a 
Figure 3. Schematic drawing of the RSA technique. The projection of the calibration box markers 
on the film is used to reconstruct the position of the Roentgen foci (F). Graft marker A gives 
projections B and C on the films. With a known focus position, projection lines 1 and 2 can be 
reconstructed. The calculation of intersection of 1 and 2 in space gives the position of A.
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pair of 35×43-cm Roentgen cassettes (Kodak, Amsterdam, The Netherlands) at a 20° angle to 
the vertical. To define a 3D laboratory coordinate system, 50 1-mm-diameter tantalum refer-
ence markers were positioned in the lower plane of a calibration box. In order to calculate the 
Roentgen focus position, 24 1-mm tantalum control markers were positioned in the upper 
plane of the box. The films were placed directly under the box (Figure 3). 
First, a reference RSA image was taken by simultaneously exposing the films, and then the 
stent was moved longitudinally in 0.1-mm increments up to 15 mm using the micromanipula-
tor. One migration of 20 mm was also created. After each migration, an RSA image was taken. 
The 16 images were randomly numbered, and the reviewer was blinded as to the distance 
of migration induced. The RSA software determined the distance between the aortic markers 
and the stent markers. It then compared this distance to the reference image to determine the 
extent of migration. This measurement was then compared to the micromanipulator to calcu-
late the measurement error of the technique. Figure 4 shows the RSA software reconstruction 
of the marker and x-ray focus positions in space in relation to the 2 images.
Subsequently, the radiographs were digitized by scanning with a Vidar VXR-12 scanner (Vidar, 
Lund, Sweden) at a 150-dots/inch, 8-bit grayscale resolution. The RSA-CMS software (MEDIS, 
Figure 4. RSA software reconstruction of the position of the 2 Roentgen foci, the stent-graft 
markers, and reference markers in space (crossing lines). These positions were reconstructed from 
the 2 radiographs (black).
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Leiden, The Netherlands) automatically measured the marker coordinates in the digitized 
radiographs from the 3D reconstruction of the marker positions to measure micromotion.8-10 
Cta
The same techniques for acquiring, postprocessing, and analyzing CT data to measure 
endograft position were the same as those used for EVAR surveillance in our clinic The images 
were acquired with a Toshiba Aquilion 16 multidetector CT scanner (Toshiba Medical Systems 
Europe, The Netherlands) set to the following parameters: 80 kV, 200 mAs, 1-second rotation, 
pitch 0.7, and 0.5-mm collimation; images were reconstructed with a 0.5-mm slice thickness and 
a 0.4-mm reconstruction interval. A reference scan was made, and then the stent was moved 
longitudinally in 0.5-mm increments up to 15 mm using the micromanipulator. One migration 
of 20 mm was also created. After each migration, a CT scan was made, for a total of 32 CT scans. 
Because CT involves human action and possible interpretation error, the number of CTs created 
was double that of the RSA setup. The CT images were randomly numbered, and the observers 
were blinded to the amount of migration induced. Using the Vitrea2 postprocessing software 
(Vital Images Inc., Plymouth, MN, USA), the images were reconstructed along the central lumen 
line. The distance was measured from just below the most caudal renal artery to the level where 
the first circumferential view of the stent was obtained. The struts of the stent were used for 
orientation. No special markers were used for CT measurement. To correct for interobserver 
variability, the CT scans were evaluated by 3 medical specialists (2 interventional radiologists 
and a vascular surgeon who were all experienced with this protocol). The distances measured 
in the 32 CT images were compared to the reference image. The migration thus measured was 
compared to the micromanipulator to determine the measurement error of the technique. 
Statistical analysis
Levene’s test for variance was used to detect statistically significant interobserver variability 
between the measurement errors of the 3 CT readers. An F-test was used to compare the 
pooled CT measurement errors to the measurement error of RSA. P<0.05 represented a statisti-
cally significant difference. The tests were performed using SPSS for Windows (version 11.0; 
SPSS Inc., Chicago, IL, USA).
Results
The mean measurement error for RSA compared to the micromanipulator was 0.002±0.044 mm, 
and the maximum error was 0.10 mm. Three observers measured endograft migration (Figure 
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5) in 32 CTA scans. Compared to the micromanipulator (Figure 6), the mean (maximum) errors 
were 0.15±0.26 (0.70) mm for observer A, 0.25±0.36 (1.00) mm for observer B, and 0.02±0.23 
(0.70) mm for observer C. There appeared to be no significant interobserver variability (p=0.17). 
Pooling the CT measurement errors of the 3 observers resulted in a pooled mean (maximum) 
error of 0.14±0.29 (1.00) mm, which was significantly different from the 0.002±0.044-mm RSA 
measurement error (p<0.0001). 
Figure 5. CT image reconstruction with Vitrea2 software. The caudal margin of the renal artery 
is identified (coronal image, largest arrow) on the axial image and the “ruler” is set to 0 mm. 
Afterward, the axial image is used to determine the first image with a circumferential view of the 










The use of RSA to evaluate endograft migration is promising for several reasons. Perhaps the 
most important advantage of RSA is that it does not require intravascular contrast to accurately 
determine stent-graft position, which is an asset in a patient population with a significant 
incidence of renal dysfunction. Plain CT without contrast enhancement may be used for stent-
graft migration assessment, but it is likely that this reduces the accuracy of identifying the renal 
arteries consistently in consecutive scans.
Comparing radiation doses, RSA results in a radiation dose of only 0.3 mSv. In contrast, the 
radiation dose of CT is much higher, ~17 mSv for a complete triple-phase scan: 6.8 mSv for the 
unenhanced phase and 6.8 mSv for the early contrast-enhanced phase to measure stent-graft 
position. The RSA images can also be used to identify other adverse effects, such as possible 
stent fractures, so that RSA could replace the plain abdominal radiographs that are part of 
current routine follow-up in most centers. 
RSA is a simple technique to use and does not require a large investment in special equipment. 
The imaging as well as the computerized postprocessing and migration measurement can be 
Figure 6. Box plot of the measurement errors of RSA and CT (observers A, B, and C) compared to 
the micromanipulator. The median, 10th, 25th, 75th, and 90th percentiles are given in mm.
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performed by a trained technician instead of a dedicated medical specialist, which makes the 
investigation far less expensive in terms of logistical burden and healthcare cost. It could thus 
increase the cost effectiveness of EVAR by reducing the need for serial CTs.
Furthermore, there is the high accuracy of RSA. To our knowledge, no data exist in the literature 
about the accuracy of CT measurement of stent-graft migration. We used thin 0.5-mm slices 
for CT and 3D image reconstruction, which resulted in a significantly less accurate migration 
measurement by CT than by RSA. Thicker CT slices, as are the current practice in follow-up 
protocols, will undoubtedly result in larger errors of measurement by CT. 
Another possible advantage of RSA is that it uses a single 90-ms exposure for the entire field of 
interest, which is minimally affected by the cardiac cycle and produces a high-definition image 
with high spatial resolution. Pulsatile changes in the aorta–stent-graft complex14,15 will result 
in minimal measurement error due to this short acquisition time. 
In terms of image postprocessing, RSA uses digital image processing that will distinguish the 
points of reference automatically with the help of a computer. To the contrary, CT requires 
observer-assigned reference points for measurement, which are sensitive to human variance. 
RSA reference points are constant, inherent metal markers, so accuracy of measurement is 
higher due to this consistent position. 
Finally, there is the measurement of CT itself that can be performed in different ways, varying 
from workstation “image counting” multiplied by slice thickness to advanced postprocessing 
software, as used in our study. RSA is a consistent method using one well-established protocol 
for measuring the distance between reference points. In RSA analysis, the relative positions of 
markers do not change in the absence of migration. Any change in relative position indicates 
movement between the markers. Patient position is not critical, as the calibration box will 
facilitate the calculation of marker coordinates each time an RSA image is taken.
A potentially significant disadvantage of RSA compared to CT with intravascular contrast is the 
fact that at least one marker is required in the aortic wall as a reference point. Theoretically, one 
marker is sufficient to accurately measure axial migration. This marker would have to be placed 
as an additional procedure, preferably during EVAR. After secure fixation, migration of a reference 
marker is unlikely, as there is no significant dislocating force acting on it. The markers used to 
identify the endograft could be incorporated during manufacture of the stent-graft without many 
modifications. Certain endografts already have welding points that might function as markers. 
In theory, remodeling of the aorta could lead to erroneous detection of migration. However, the 
amount of error will be minimal as the reference markers will be placed directly proximal to the 
stent-graft and renal arteries. The distance between the aortic markers and the stent-graft markers 
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will therefore be small, and slight changes in the aortic wall in this area will subsequently have mini-
mal significance. The amount and design of the endovascular marker(s) needed for this application 
is subject to further study at our institution. We are confident that this issue can be resolved. 
Currently, plain abdominal radiography may be used to detect endograft migration as an 
alternative to CT. In this investigation, the lumbar spine is used as a reference. Based on the 
protocol published by Murphy et al.,16 a 2-mm margin of error has been reported by Hodgson 
et al.17 in an experimental static model that  eliminated any pulsatile axial movement of the 
aorta relative to the spine. Flora et al.18 measured a pulsatile movement up to 1 mm in just 4 
patients,18 while Vos et al.14 reported craniocaudal movement of up to 1.99 mm in 7 patients,14 
indicating that a wider range of movement is likely. The measurement error in a static situation 
versus the pulsatile motion of the aorta–stent-graft complex could significantly impair the 
accuracy of stent-graft migration assessment with plain radiography. 
Other possible errors in the analysis of plain abdominal radiographs are changes in the verte-
bral column, e.g., due to osteoporosis or fractures, and possibly changes in neck angulation 
due to AAA shrinkage. RSA uses reference markers in the aorta and is therefore, in theory, not 
susceptible to pulsatile movement or changes in, or relative to, the vertebral column. Georg 
et al.11 described the use of the transverse process of a vertebral body as a reference point to 
measure stent-graft migration. We believe that this will provide a significant source of error 
due to the pulsatile movement of the aorta.
When considering our model, it is obvious that all motion artifacts were eliminated in this 
static setup. To assess the impact of pulsatile motion on the accuracy of RSA, further studies are 
necessary. Axial movement of the aorta-endograft complex, as well as rotational movement, 
will probably have insignificant impact on RSA accuracy; endovascular reference markers are 
placed directly proximal to the endoprosthesis, which eliminates any significant movement 
between the two. With the use of endovascular reference markers, the vertebral column is 
no longer required as a reference, and all the abovementioned confounders regarding this 
structure and its relation to the endoprosthesis can be avoided. 
Conclusion
Detection of stent-graft migration by RSA was feasible and significantly more accurate than CT in 
this nonpulsatile in vitro study. RSA combines high accuracy with low cost in terms of radiation, 
healthcare cost, and logistics. The absence of intravascular contrast is an additional asset of this 
method. Further studies are necessary to investigate the application of RSA markers in endovas-
cular surgery and to investigate the influence of pulsatile motion on the accuracy of RSA. 
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Abstract
Purpose: To evaluate the feasibility and accuracy of Roentgen stereophotogrammetric analy-
sis (RSA) versus computed tomography (CT) for detecting stent-graft migration in an in vitro 
pulsatile circulation model and to study the feasibility of a nitinol endovascular clip (NEC) as an 
aortic wall reference marker for RSA.
Methods: An aortic model with stent-graft was constructed and connected to an artificial 
circulation with a physiological flow and pressure profile. Tantalum markers and NECs were 
used as aortic reference markers for RSA analysis. Stent-graft migrations were measured during 
pulsatile circulation with RSA and CT. CT images acquired with 64×0.5-mm beam collimation 
were analyzed with Vitrea postprocessing software using a standard clinical protocol and 
central lumen line reconstruction. RSA in the model with the circulation switched off was used 
as the reference standard to determine stent-graft migration. The measurement errors of RSA 
and CT were determined during pulsatile circulation. 
Results: The mean measurement error ± standard deviation (maximum) of RSA during pulsa-
tile circulation using the tantalum markers was –0.5±0.16 (0.7) mm. Using the NEC, the mean 
(maximum) measurement error was –0.4±0.25 (1.1) mm. The mean (maximum) measurement 
error of CT was –1.1±1.17 (2.8) mm.
Conclusion: RSA is an accurate and feasible tool to measure stent-graft migration in a pulsatile 
environment. Migration measurement with RSA was more accurate than CT in this experimen-
tal setup. The nitinol clip tested in this study is potentially feasible as an aortic reference marker 











tent-graft migration is a potential complication after endovascular aneu-
rysm repair (EVAR) of an abdominal aortic aneurysm (AAA) .1-3 Periodic 
surveillance is necessary to detect migration and other complications.4,5 
The current gold standard for follow-up after EVAR is contrast-enhanced 
computed tomography (CT).6 However, this modality requires intravascular 
contrast, a high radiation dosage, and significant logistical consequences 
and costs, making EVAR less cost effective.7 For these reasons, the use of 
CT for routine surveillance after EVAR is less attractive. Reducing the frequency of CT imaging 
in EVAR surveillance may be possible, especially if there is evidence of sac shrinkage.8 However, 
stent-graft migration may go unnoticed as a result of this reduced imaging frequency. 
Roentgen stereophotogrammetric analysis (RSA) may be a valuable alternative to identify 
stent-graft migration.9 This technique is a well established and highly accurate tool to detect 
3-dimensional micromotion of orthopedic implants in relation to tantalum reference mark-
ers in the bone.9-13 The potential benefits of RSA are low costs, low radiation dose, and no 
intravenous contrast enhancement. In addition to these potential benefits of RSA, its highly 
accurate method of measurement could be of great advantage in detecting migration in the 
early period after introduction of new endografts.
Furthermore, RSA data acquisition and analysis is simple and fast and can be performed by a 
trained technician. Since RSA images are stereo plain abdominal radiographic images, they can 
also be used to detect stent fractures. In a static model for stent-graft migration, RSA was found 
to be more accurate than CT.9 
A disadvantage of RSA is that aortic wall reference markers are required to assess the relative 
motion of the stent compared to the aorta.9 The pulsatile change of the aortic diameter results 
in movement of both the aortic markers and stent-graft markers during the cardiac cycle, 
which could induce a measurement error in RSA.
In this study, we evaluated the effect of pulsatile motion on the accuracy of RSA and CT in stent-
graft migration measurement in an in vitro model for endograft migration with physiological 
flow and pressure profiles. Furthermore, we tested the feasibility of a nitinol endovascular clip 
(NEC) as an aortic reference marker for RSA.
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Methods
pulsatile aortic Model With Stent-Graft
A pulsatile flow model was developed to simulate migration of a stent-graft in the pulsating 
aorta. A human cadaver spine was obtained from the anatomical department and used accord-
ing to the standard consent procedures of our Institutional Review Board. A fresh specimen of a 
pig thoracic aorta was attached to the cadaver spine, replacing the cadaveric aorta. The spine, 
including the surrounding soft tissues, was conserved in a solution of formaldehyde, ethanol, 
glycerin, and phenol (Figure 1). Since accurate CT analysis requires a reference point (usually 
a renal artery), a side branch was anastomosed to the aorta at the level of the cadaver’s renal 
artery. The model was placed in a Plexiglas box, topped off with water to simulate soft tissue. 
The perfusate of this artificial circulation was starch solution with the same viscosity as blood. 
To enable CT analysis, the perfusate was enhanced with intravascular contrast [iomeprol 
816.5 mg/mL (Iomeron 400); Altana Pharma, Hoofddorp, The Netherlands) to a level of 250 
Hounsfield units, which is similar to the attenuation in a normal abdominal CT scan. The 
Figure 1. The porcine aorta fixed to the human cadaveric spine. A side branch was attached to the 









contrast was washed out by changing the perfusate after each CT acquisition, so RSA imaging 
was not disturbed by the contrast medium.
To generate pulsatility, the model was connected to an artificial circulation set at 70 beats per 
minute with a 75 mL/s flow rate, which produced a physiological flow and pressure profile 
(Figure 2 and 3).14 The pulsatility resulted in a luminal diameter change from 20.0 to 21.5 mm, 
as recorded in M-mode ultrasound with a 7.5-MHz linear array probe (ProSound SSD-5500; 
ALOKA, Tokyo, Japan). This diameter change was induced to simulate aortic diameter changes 
measured in vivo.16-18
A Gianturco stent (Cook, Bjaeverskov, Denmark) was placed inside the aorta (Figure 4). A stent 
rather than a stent-graft was used to model migration since radiological imaging techniques 
use the stents of the stent-graft for analysis. Furthermore, deleting the fabric from the model 
facilitated the induction of migration. The stent could be “migrated” along the aorta by pulling 
Figure 2. Experimental setup. The model (M) is placed on the CT table. Imaging can be switched 
between RSA and CT without disturbing the model. The physiological flow and pulsatility is 
generated with an artificial circulation (P). The RSA setup is positioned next to the CT gantry (CT). 
Two crossing X-ray beams from the 2 Roentgen foci (R) expose the films under the calibration box (B).
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Figure 3. Schematic representation of the model, which consists of the aortic model with stent-
graft (A), an artificial heart driver (B), a valve (C), an open reservoir (D), a ball valve (E), left ventricle 
(F), a blood pressure cuff (G), a flow transducer (H), and an air chamber (I). Fluid pressures were 
measured at the entrance of the aortic model.
Figure 4. 3D maximum intensity projection of the CT image of the model. Short arrow lower left: 
tantalum marker; short arrow upper left: nitinol clip; long arrow lower right: renal artery. Cranial 









on monofilament fishing wire (Spro, Vianen, The Netherlands), which was attached to each 
side of the stent. To prevent unintended migration, the fishing wire was fixed to the box during 
the measurements.
For RSA analysis, markers were added at the cranial and caudal corners of the stent (i.e., stent-
graft markers), and reference markers were attached to the aorta (i.e., aortic markers). Two sets 
of aortic markers were tested: (1) 3 clusters of 1-mm-diameter tantalum markers glued to the 
aortic adventitia with Histoacryl (B. Braun Aesculap, Tuttlingen, Germany), representing the 
standard clinical RSA situation used in orthopedics (Figure 4), and (2) 3 Anson Refix nitinol 
endovascular clips (NEC; Figure 5) (Lombard Medical, Didcot, UK) placed in the aortic wall by 
an endovascular technique to mimic the clinical situation (Figure 4).
Three stent-graft positions were analyzed with RSA and CT: the initial or reference position and 
2 migrations. The stent-graft was migrated caudally under visual control provided by an image 
intensifier (Philips BV300 plus; Philips Medical Systems Europe, The Netherlands). 
rSa Imaging technique
Two manually synchronized, standard, mobile Roentgen tubes (Philips Practix 2000; Philips 
Medical Systems Europe) were set to 110 kV/8.5 mAs, resulting in an exposure time of 78 ms for 
all RSA images. A calibration box was positioned between the model and the radiographic films 
to define a 3D laboratory coordinate system and to determine the position of the Roentgen foci 
(Figure 6 and 7).9 Defining the 3D laboratory coordinate system in each RSA image eliminates 
any influence of model (or patient) positioning on the outcome of RSA measurements (Figure 
8). After digitizing the films, image postprocessing was performed on a personal computer with 
the help of RSA-CMS software11-13,15 (MEDIS, Leiden, The Netherlands).9 The RSA images were 
randomly numbered, and the reviewer was blinded to the degree of induced migration. Using 
this technique, it was possible to calculate the distance between 2 groups of markers. Migration 
was determined by comparing an initial reference RSA image to the follow-up RSA image. 
Figure 5. Nitinol endovascular clip.
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Since RSA is proven to be highly accurate in a static environment,9-13 RSA of the model with-
out pulsatile circulation was used as the reference standard to determine actual stent-graft 
migration,9 using the tantalum aortic reference markers for the analysis. Five RSA images of 
the reference position and 3 images of each stent-graft position after migration were acquired. 
These results would later be compared to RSA and CT analysis with pulsatile circulation in the 
model to determine the measurement error of the 2 techniques. The migration was assessed 
using cross-table analysis, comparing each of the 5 reference images to all 3 follow-up images, 
producing 15 measurements per migration. 
To determine the influence of pulsatility on RSA migration measurement, 11 RSA images were 
acquired of each stent-graft position at a random point in the pulsatile circulation cycle. Migra-
tion was determined by cross-table analysis, comparing each of the 11 reference images to 
all 11 follow-up images, resulting in 121 measurements per migration or 121 possible clinical 
combinations of RSA images. The measurements were performed using tantalum markers 
as well as NECs. The measured migration with RSA was compared to the actual migration to 
determine the measurement error of RSA with both types of aortic reference markers. 
Figure 6. RSA imaging setup. The box under the patient contains markers that are used to define the 









Figure 7. Schematic drawing of the RSA technique. The projection of the calibration box markers 
on the film is used to reconstruct the position of the Roentgen foci (F). Graft marker A gives 
projections B and C on the films. With known focus position, projection lines 1 and 2 can be 
reconstructed; calculating the intersection of 1 and 2 in space gives the position of A.
Figure 8. RSA software reconstruction of the position of the 2 Roentgen foci and the stent-graft 
markers and reference markers in space (crossing lines). These positions were reconstructed from 
the 2 radiographic images (black).  
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Computed tomography
To compare the results of RSA to those of CT, the accuracy of CT measurement with 3D image 
reconstruction was determined using the same technique for postprocessing and analysis to 
measure stent-graft position as the one used for CT surveillance in our clinic. The CT images 
were acquired with a Toshiba Aquilion 64 CT scanner (Toshiba Medical Systems, Otawara, 
Japan), which was set to 120 kV, 250 mA, 400-ms rotation, pitch factor 0.84, 0.5-mm beam 
collimation, and 64 detector rows during pulsatile flow in the model. The images were recon-
structed with a 0.5-mm thickness and 0.4-mm reconstruction interval. 
A reference CT scan was made of the initial stent-graft position. After each migration, a 
follow-up CT scan was produced. The CT images were randomly numbered, and the observ-
ers were blinded to the amount of migration induced. Using Vitrea2 postprocessing software 
(Vital Images Inc., Plymouth, MN, USA), the amount of migration was measured on 3D curved 
multiplanar reconstructions along the aortic central lumen line to evaluate the aorta in 2 per-
pendicular longitudinal directions as well as the perpendicular axial direction. Using automatic 
calipers, the distance was measured between the lower margin of the renal artery (reference 
point) and the stent at the level where the first circumferential view of the stent was observed 
(in perpendicular axial direction). The struts of the stent were used for orientation; no special 
markers were used for CT measurement. 
The CT scans were evaluated by 5 observers: 4 interventional radiologists and a vascular sur-
geon, all experienced users of this technique. Migration was determined by comparing the 
distance measured by the same observer in the follow-up CT images to the distance in the 
reference CT. The resulting migration was compared to the actual migration to determine the 
measurement error of CT. 
Statistical analysis
Data are presented as the mean ± standard deviation (SD) and maximum. Levene’s test for 
variance was used to detect statistically significant interobserver variability between the mea-
surement errors of the 5 CT readers. The tests were performed using SPSS for Windows (version 
11.0; SPSS Inc., Chicago, IL, USA).
Results
The actual migration of the stent-graft as determined by RSA without pulsatile circulation was 
7.0±0.02 mm for the first migration (n=15) and 13.9±0.03 mm for the second migration (n=15). 









mm measured by RSA using the tantalum aortic reference markers, which gave a mean (maxi-
mum) measurement error of –0.5±0.08 (0.7) mm. For the second migration measured during 
pulsatile flow (n=121), the mean measured distance was 13.4±0.21 mm, for a mean (maximum) 
measurement error of –0.5±0.21 (0.7) mm. The pooled error of all migration measurements 
by RSA in the pulsatile situation using tantalum aortic markers (n=242) was –0.5±0.16 mm 
(maximum error 0.7 mm). (Figure 9)
Using the NECs as aortic reference markers, the mean distance of the first migration (n=121) 
measured by RSA was 6.7±0.19 mm [–0.3±0.19 (0.7) mm mean (maximum) measurement 
error]. The mean distance of the second migration (n=121) was 13.3±0.24 mm [—0.6±0.24 (1.1) 
mm mean (maximum) measurement error]. The pooled measurement error of all migration 
measurements by RSA in the pulsatile situation using NECs as reference markers (n=242) was 
–0.4±0.25 mm (maximum error 1.1 mm). (Figure 9)
Stent-graft migration was measured with CT under pulsatile flow in the model using the renal 
artery as a reference. The mean distance of the first migration (n=5) was 6.2±1.22 mm, for 
a mean (maximum) measurement error of –0.8±1.37 (2.7) mm versus the actual migration. 
The mean distance of the second migration (n=5) was 12.5±0.88 mm, which gives a mean 
(maximum) measurement error of–1.4±0.98 (2.8) mm. The pooled measurement error of all 
migration measurements by CT (n=10) was –1.1±1.17 mm (maximum error 2.8 mm; Figure 9). 
There appeared to be no significant interobserver variability (p=0.27).
Figure 9. Box plot of the measurement errors of RSA with tantalum aortic markers (RSA), RSA 
with nitinol endovascular clips as aortic markers (RSA-nitinol), and CT using the renal artery as a 
reference (CT) compared to the measurement with RSA in a static situation. Median (line), 25th and 
75th percentiles (boxes), and range (whiskers) are plotted.
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Discussion
This study shows that roentgen stereophotogrammetric analysis is an accurate tool for the 
measurement of stent-graft migration despite pulsatile motion of the stent-graft and the aor-
tic markers. RSA, with either tantalum or NEC aortic markers, was more accurate than CT with 
3D image reconstruction in determining stent-graft migration in our model with physiological 
pulsatile flow.
The accuracy of CT and RSA in detecting stent-graft migration has been previously assessed in 
a static plastic model.9 The measurement error of RSA was 0.002±0.044 mm versus 0.14±0.29 
mm for CT with 3D image reconstruction. When comparing these results to the present study, 
pulsatile movement caused by a simulated cardiac cycle apparently reduces the accuracy of RSA 
and CT to a measurement error of –0.5±0.16 mm and 1.1±1.17 mm, respectively. Furthermore, 
in the present study, RSA in the situation with pulsatile motion was less consistent in migration 
measurement (SD=0.16 mm) compared with RSA in the static situation (SD=0.02/0.03 mm). 
This may be explained by the limited temporal resolution in imaging. While the RSA images 
are acquired, the stent and the aorta will have moved slightly, including the renal arteries, the 
stent-graft markers, and the aortic markers in the wall of the aorta. This results in an image 
blurring of markers that may lead to less accurate measurement (Figure 10A,B). Furthermore, 
the stereo RSA images are taken with manually synchronized X-ray tubes; a delay between the 
2 roentgen tubes may cause an additional measurement error because of a slight change in 
marker position between the stereo images (Figure 10C). Nevertheless, this study shows that 
RSA measurement errors remain extremely small despite pulsatile movement.
The pulsatile movement also occurs during CT acquisition and could partially explain the 
decrease in accuracy compared to the static experiments as previously described. In the clini-
cal situation, vessel distention (1- to 2-mm diameter change) and craniocaudal (up to 1.5 mm) 
and rotational (up to 0.59 mm) movements have been described.16-19 For both the RSA and 
CT techniques, image acquisition was performed at random time points during the pulsatile 
cycle. These pulsatile movements may have influenced the accuracy of stent-graft position 
measurements for both techniques. Electrocardiographically-gated CT has the potential to 
significantly reduce the measurement error caused by the cyclic motion of the aorta and stent-
graft. However, the disadvantages of CT for follow-up after EVAR, such as the high cost and 
radiation dose, contrast, and logistical burden, remain or may even increase.
An increasing distance between the aortic and stent-graft markers due to migration caused a 
slight increase in the error of measurement in our study, which is in accord with orthopedic RSA 









the aortic markers need to be positioned as close to the stent-graft as possible. Despite the 
reduction of accuracy after the 13.9-mm migration reported in our study, RSA is still more accu-
rate than CT. A reason for this finding may be the combination of a higher spatial resolution 
and a shorter acquisition time of an RSA image compared to CT. For these reasons, using a CT 
scan with less than 64 detectors could further increase the measurement error of CT.
In the present study, we tested an NEC available for use in endovascular surgery for feasibility 
of use as an aortic marker. The measurement of stent-graft migration using this clip was also 
accurate but less precise than the standard tantalum markers. This could be explained by the 
fact that tantalum markers are spherical and have a smaller diameter (Figure 3), which may 
Figure 10. Sources of measurement error in RSA for markers in pulsatile motion versus (A) the 
static situation: marker a gives projection p on both films F after exposure by X-ray foci R1 and 
R2. (B) Movement of the marker a to a’ during image acquisition will blur p, resulting in less 
accurate measurement. (C) Delay between the exposures of the 2 films F will produce 2 different 
projections, p and p’, resulting in less accurate measurement. 
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be more accurately detected. Despite this decreased accuracy, RSA with NEC aortic markers 
remained more accurate than CT. Automatic detection of the NECs by the RSA software was 
not possible due to their non-spherical shape. Manual identification of the center of the marker 
could be performed without difficulty using the RSA software, from which the position of the 
marker could be determined. Marker detection is done at a different phase in the processing 
of RSA images than the migration measurement, and the reviewer was blinded to the amount 
of migration. Therefore, manual detection of the clip could not interfere with the outcome 
of measurement. Despite this potential source of error, the RSA measurements using the 
NEC were accurate. Therefore, the NEC could potentially be used as an aortic marker for RSA 
measurement in patients. The NEC requires further testing for its clinical suitability as an RSA 
marker, which is the subject of further study at our institution. 
When considering the model, it is apparent that this is not an in vivo situation. Exact reproduc-
tion and modeling of cyclic aortic motion remains difficult. Further testing is needed to evalu-
ate the RSA technique and the endovascular clip before patient studies can be undertaken.
Conclusion
RSA is an accurate and feasible tool to measure stent-graft migration in a pulsatile environ-
ment. Migration measurement with RSA is more accurate than with 3D image reconstruction 
of CT scans. Because RSA has several other advantages over CT, it may be a valuable tool for 
EVAR surveillance. The nitinol clip tested in this study has the potential to be an aortic refer-
ence marker in patients.
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Objective:  To study detection and quantify stentgraft migration with RSA in-vivo as compared 
with CT and to evaluate the application and detection of a nitinol endovascular clip as an aorta 
reference marker for RSA.
Design: experimental animal model.
Materials and Methods: A model of a stentgraft was positioned in the thoracic aorta of two 
pigs. Tantalum aortic reference markers were attached to the adventitia for CT and RSA analy-
sis. Nitinol endovascular clips (NEC) were inserted in the aortic wall for RSA analysis. Stentgraft 
migrations were measured with CT and RSA. CT images acquired with 64×0.5-mm beam col-
limation were analyzed with Vitrea postprocessing software using a standard clinical protocol 
and central lumen line reconstruction. RSA images were analyzed using standard Medis RSA 
software.
Results: The standard deviation of the measurements by RSA using tantalum markers was 
0.33mm. The standard deviation of the measurements by CT with 3D reconstruction was 
0.47mm. Placement of the clips was performed without difficulty or adverse effects but 
radiopacity of the clips was insufficient to allow detection with the RSA software.
Conclusion: RSA to measure stent-graft migration in vivo is feasible and very precise. Preci-
sion of RSA was superior to CT with 3D image reconstruction if a well defined aortic reference 
marker was applied for CT analysis. Placement of an aortic reference marker may facilitate CT 
surveillance for migration after EVAR. RSA has several other advantages over CT. Therefore, it 
may be a valuable tool for EVAR surveillance. The nitinol clip tested in this study as an aortic 












tentgraft migration is a potentially lethal failure after endovascular aneu-
rysm repair (EVAR) 1. Migration incidence increases over time and still occurs 
despite modifications of design in the latest generation of stentgrafts.2-5 In 
a patient cohort study by Sun, comparing measurement in axial CTA images 
to 3D image reconstructions, stentgraft migration appeared to occur in all 
patients, even if supplied with strong hooks and barbs, proving that more 
accurate detection methods indeed show more stentgraft migration. 4 In 
case of aneurysm diameter reduction after EVAR, the main points of interest in surveillance are 
detection of stentgraft migration and stentgraft disintegration at the earliest stage.
In previous studies of experimental models, detection of stentgraft migration using Roentgen 
Stereophotogrammetric Analysis (RSA) has been described.6-8 RSA proved to be very accurate 
and stentgraft migration could be detected with RSA with a mean error of 0.5mm.7 RSA imag-
ing also enables stentgraft structure evaluation.6,7 
Compared to CT with 3D image reconstruction, advantages of RSA over CT are that RSA is 
a low cost test, with a radiation exposure that is only a fraction of that of CT, while intravas-
cular contrast is not required.6 Furthermore, RSA compared favorably to CT with 3D image 
reconstruction in detecting migration in experimental studies. 6,7  However, RSA has not been 
tested in vivo for evaluation of stentgraft migration. The influences of human size soft tissue 
surroundings and respiratory and cardiac action on the results of RSA have not been modeled 
and are an essential step in preclinical evaluation of the technique.
A disadvantage of RSA is that a reference marker is required in the aortic wall. Inserting this 
marker constitutes an additional procedure during the EVAR operation. A nitinol endovascular 
clip (NEC), designed as an endovascular stapler, has been proposed to serve this purpose, and 
this device has been tested successfully in an experimental model. 7
The present study analyses the detection of stentgraft migration with RSA in in-vivo animal 
experiments. Furthermore, we tested the application and detection of a NEC as an aorta refer-
ence marker for RSA.
Materials and METHODS 
animal model with stentgraft
Two 100 Kg female pigs were used. The Institutional Review Board for animal experimentation 
approved the study and the animals were cared for in compliance with the national guidelines 
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for animal experiments. After general anesthesia, the pulse rate was kept at approximately 90 
per minute. Thoraco-laparotomy was performed exposing the thoracic and infrarenal aorta. 
Heparine was continuously administered. A Dacron 8mm conduit (Gelsoft Plus, Vascutek, 
Inchinnan, UK) was attached to the infrarenal aorta as a conduit for vascular access.
A Gianturco stent (Cook, Bjaeverskov, Denmark) was placed inside the thoracic aorta (Figure 1) via 
endovascular technique. The thoracic aorta was chosen for placement as it has the largest available 
aortic diameter, resembling the human situation as much as possible. The stent could be displaced, 
“migrated” along the aorta by pulling on monofilament fishing wire (Spro, Vianen, The Netherlands), 
attached to each stent side. The cranial end of the wire was passed through the left carotid artery, 
the caudal end was passed through the conduit on the infrarenal aorta. For RSA analysis, markers 
had been added at the cranial and caudal corners of the stent prior to placement (stentgraft mark-
ers). In a clinical situation, markers used to position the EVAR device can be used for this purpose.
CT analysis of stentgraft migration requires a point of reference. There is no major vascular 
branch in the descending aorta available as a reference for measurement like the renal artery 
in human clinical practice. Therefore, a 1mm tantalum spherical marker was glued to the 
adventitia of the aorta with Histoacryl® (B.Braun Aesculap, Tuttlingen, Germany). 
Figure 1. 3D maximum intensity projection of the CT image of the thoracic aorta. Small arrow 










Also for RSA analysis, reference markers were attached to the aorta, the aorta markers. We 
tested two sets of aorta markers: a cluster of 8 tantalum markers (with a diameter of 1 mm), 
glued to the adventitia with Histoacryl®, representing the standard clinical RSA situation as 
used to detect micromotion after joint replacement surgery (Figure 1); and three Anson Refix® 
Nitinol endovascular clips (Lombard Medical, Didcot, United Kingdom) (Figure 1 and 2) placed 
in the aortic wall by endovascular technique, to represent a clinical endovascular application.
In the first animal, two stentgraft positions were analyzed: the initial or reference position and 
one migration. In the second animal, five stentgraft positions were analyzed: the initial or refer-
ence position and four migrations.
For each stent-graft position CT and RSA imaging was performed. The stent-graft was migrated 
caudally under visual control with an image intensifier (Philips BV300 plus, Philips Medical 
Systems Europe, The Netherlands).
The animals were sacrificed after the experiments and autopsy was performed to study the 
position of the clips and local adverse effects of the clip placement.
rSa imaging technique
Roentgen Stereophotogrammetric Analysis (RSA) is comparable to stereo vision of human eye 
sight. By comparing two calibrated simultaneous images taken at a different angle, the position 
of an object in space can be determined. It is based on calculating 3-dimensional coordinates 
of radiopaque markers in the body using a stereo image of these markers. 6,9 A calibration box 
is positioned between the patient and the X-ray films, to define a 3-D laboratory coordinate 
system.6 We used two manually synchronized standard mobile Roentgen tubes (Philips Practix 
2000, Philips Medical Systems Europe, The Netherlands). The exposure settings used were: 125 
kV/15mAs, resulting in an exposure time of 160msec for all RSA images.
Figure 2. Nitinol endovascular clip.
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The image postprocessing was done on a personal computer with the help of special RSA 
software9-11 (Model Based RSA software, MEDIS Specials BV, Leiden, The Netherlands) after 
digitizing the films.6 The RSA images were randomly numbered and the reviewer was blinded 
for the distance of migration induced.
Using RSA, it is possible to calculate the distance between two (groups of ) markers inside the 
body. Migration is determined by comparing an initial, reference RSA image to the follow up 
RSA image. The technique was described in more detail in previous studies.6,7
In RSA analysis, the relative positions of markers do not change in absence of migration. Any 
change in relative position indicates movement between the markers. Positioning of the 
animal, or the patient in clinical practice, is not critical as the calibration box will facilitate the 
calculation of marker coordinates each time an RSA image is taken. 
Pulsatile motion of the aorta may influence measurement, as each RSA image is acquired at a 
random point in the cardiac cycle. To study the in-vivo situation and the influence of pulsatile 
motion on migration measurement by RSA, 5 RSA images were acquired of the reference posi-
tion and 9 images of each stentgraft position after migration. The RSA images were acquired 
at a random point in the cycle of pulsatile circulation. Migration was assessed using cross-table 
analysis, comparing each of the 5 reference images to all 9 follow-up images. This resulted in 45 
measurements per migration, resembling the 45 possible clinical combinations of RSA images. 
The measurements were performed using tantalum markers as well as NEC-s. The Nitinol endo-
vascular clips were evaluated for feasibility as an aorta reference marker and for applicability.
To summarize the RSA results, we pooled the data to determine the variance of the method. 
This was done by calculating the average migration per group of 45 measurements. After-
wards, this value was subtracted from every single measurement in the same group, thereby 
calculating a variance from the mean value. This enabled calculation of the standard deviation 
and range of deviation of all RSA measurements (n=225).
Computer tomography (Ct)
CT analysis of stentgraft migration was performed using the same technique for post-process-
ing and analysis to measure stentgraft position is used for CT follow up in our clinical setting. 
Instead of using the orifice of the renal artery as a point of reference, we used a tantalum 
marker fixed to the adventitia of the thoracic aorta.
The CT images were acquired with a 64 detector row CT scanner, Toshiba Aquilion (Toshiba 










pitch factor 0.83, 0.5-mm beam collimation. The images were reconstructed with a 0.5-mm 
thickness and 0.4-mm reconstruction interval. 
The CT images were enhanced with Iomeprol 816.5 mg/ml intravascular contrast (Iomeron 
400, Altana Pharma, Hoofddorp, The Netherlands) to obtain an enhancement level of 250 
Hounsfield units in the aorta for each CT image acquisition.
A reference CT scan was made of the initial stentgraft position. After each stentgraft migra-
tion, imaging was repeated. The CT images were randomly numbered and the observers were 
blinded for the amount of migration induced. 
Using Vitrea2 post-processing software (Vital Images Inc., Plymouth, MN, USA), stentgraft 
migration was measured on 3D curved multiplanar reconstructions along the aortic central 
lumen line to evaluate the aorta in 2 perpendicular longitudinal directions as well as the 
perpendicular axial direction. Using automatic calipers, the distance was measured between 
the tantalum aorta reference marker and the stent at the level where the first circumferential 
view of the stent was observed (in perpendicular axial direction). The stent struts were used 
for orientation. 
CT requires interpretation by an observer, and subsequently involves possible human error 
and inter-observer variability. To correct for inter-observer variability, CT scans were evaluated 
by five medical specialists; four radiologists and a vascular surgeon, all experienced users of 
this technique. Migration was determined by comparing the distance between the aortic refer-
ence marker and the stentgraft in the follow up CT to the distance in the reference CT image, 
as measured by the same observer. 
To summarize the CT results, we pooled the data to determine the variance of the modality. This 
was done by calculating the average migration per group of 5 measurements. Afterwards, this 
value was subtracted from every single measurement in the group of five, thereby calculating 
a variance from the mean value. This enabled calculation of the standard deviation and range 
of deviation of all CT measurements (n=25).
Results
Nitinol endovascular clip 
The application of the NEC was performed without difficulty or complications in both animals. 
The clips could be positioned and repositioned without failure of device and introducer. Visibil-
ity of the NEC with the image intensifier was good. Autopsy revealed no local adverse effects, 
76
specifically no evidence of haematoma or perforation other than the intended perforation of 
the aortic wall by the anchors of the NEC (Figure 3).
However, the NEC had insufficient radiopacity to enable analysis of the stereo images with RSA 
in large animals of 100 kg. Therefore, the marker position could not be determined accurately 
using the software. 
rSa measurements
RSA measurement of stentgraft migration with the tantalum aorta reference markers was 
possible in all cases. The results of the RSA measurements of stentgraft migration are shown 
in Figure 4. The standard deviation of the measurements by RSA was 0.33mm (range -1.35 
Figure 3. Specimen of the thoracic aorta. The wall of the aorta is (intentionally) perforated by the 










– 1.64mm) as compared to the mean value of the corresponding group of migrations (n=225). 
There were five outliers with a deviation from the mean of >1 mm (2.2%).
Ct measurements 
The results of the CT measurements of stentgraft migration using a tantalum aorta marker as 
a point of reference are shown in Figure 4. The standard deviation of the measurements by CT 
with 3D reconstruction was 0.47mm ( -1.38 – 0.92mm) as compared to the mean value of the 
corresponding group of migrations (n=25). There were two outliers with a deviation from the 
mean >1 mm (8%).
Discussion
Roentgen stereophotogrammetric analysis of stentgraft migration is feasible and very precise 
in this in vivo animal model. This study confirms favorable results in previous in-vitro work. 
Despite soft tissue surroundings and the pulsatile change that occurred due to cardiac action, 
the variation in measurement is very low (SD = 0.36mm). Unfortunately, the nitinol endovascu-
lar clip did not have sufficient radiopacity to allow detection by RSA software.
Five outliers with a deviation of more than 1 mm from the mean were identified in 225 
measurements (2%). We analyzed the outliers and found that these were due to the fact that 
the software had problems in identifying the markers on the cranial side of the stent due 
position symmetry of the markers. The circular position (see figure 1) diminishes the ability 
Figure 4 
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Figure 4. Results of the measurements with RSA and CT with 3D image reconstructions using a 
tantalum marker as a reference point (see figure 1). X-axis: P1M1=Pig 1, Migration 1; P2M1=Pig 2, 
Migration1; etc. Y-axis :migration (mm) mean, 25th and 75th percentiles and range, including all 
outliers.
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of the software to recognize the 9 identical markers based on the stereo image, in which they 
projected in one row. An asymmetrical distribution of markers on the stent will solve this prob-
lem. The currently marketed stentgrafts either have this asymmetrical distribution (e.g. Zenith, 
Cook) or have less and therefore easier distinguishable markers (e.i. Excluder, Gore and Talent, 
Medtronic). Furthermore, automated pattern recognition of the stent could enable RSA data 
analysis regardless of marker position. This is subject to further study at our institution.
The reproducibility of CT with 3D image reconstruction (SD=0.47) was slightly less than RSA. 
This compared favorably to a previous study comparing 3D-CT to RSA in a pulsatile in vitro 
model.7 In this model, a renal artery was used as a reference. As expected, it appears that the 
accuracy of the CT measurements increases by using a better defined reference point like a 
tantalum marker as compared with the less defined renal artery. Thus, adding a marker to the 
aortic wall as a reference point for CT analysis facilitates highly accurate migration detection 
with CT analysis using 3D image reconstruction, and this result is achieved without the use of 
intravascular contrast. 3D image reconstruction is a powerful tool to detect stentgraft migration 
and has shown better results in migration detection than reviewing axial images only, as is cur-
rent practice in many centers world wide.4 Furthermore, the cost of routine post-EVAR surveil-
lance using CT will remain high, although radiation dose could possibly be diminished to that of 
a low dose CT image. Because of these considerations, we believe that RSA could be preferable 
over CT for routine surveillance in patients with a decreased aneurysm size after EVAR. 
When considering our animal model, this experiment represents a step closer to clinical applica-
bility. The study clearly shows feasibility of RSA under physiological in-vivo conditions. However, 
the consistency of the aorta of the pig is different from an atherosclerotic aneurysm neck. This 
may have impact on NEC placement in the bare aortic wall. During placement, the visibility 
of the marker using the image intensifier was good. As stated, the NEC could not be detected 
by the RSA software due to insufficient radiopacity of these markers in moderate low contrast 
resolution projection imaging techniques. Because a stereo image is produced for RSA, scatter 










radiation may further decrease image contrast and visibility of the marker. In order to enable RSA 
analysis using the NEC as a reference marker, the radiopacity of the marker should be enhanced. 
This could be achieved by adding radiopaque metal to the clip, for instance a small gold or plati-
num ring (Figure 5). Recent preliminary studies at our institution into this issue are encouraging. 
Digital flat panel Roentgen detectors instead of analogue films will also enhance marker visibility. 
The design and safety of the marker are subject to further study at our institution.
Conclusion
RSA to measure stent-graft migration in vivo is feasible and very precise. Precision of RSA was 
superior to CT with 3D image reconstruction if a well defined aortic reference marker was 
applied for CT analysis. Placement of an aortic reference marker facilitates CT surveillance for 
migration after EVAR. Because RSA has several other advantages over CT, it may be a valuable 
tool for EVAR surveillance. The nitinol clip, tested in this study as an aortic reference marker, 
needs to be modified to increase radiopacity to enable RSA analysis. 
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Purpose: To assess the accuracy of detection of stent-graft migration with RSA using one 
single aortic reference marker instead of a cluster of several markers, as is currently standard 
in clinical RSA.
Methods: A model of a stentgraft was positioned in an aortic model that was connected to an 
artificial circulation with a physiological flow and pressure profile. A similar model of a stent-
graft was positioned in the thoracic aorta of two pigs. Stent-graft migration was simulated in 
these in-vitro and in-vivo models. The amount of migration was determined using standard 
RSA with multiple aortic reference markers as well as with RSA using only one aortic refer-
ence marker (1-ref-RSA). RSA measurements with the circulation switched off were used as the 
reference standard to determine stent-graft migration in the in-vitro model. The measurement 
error of 1-ref-RSA was determined during pulsatile circulation in the in-vitro model. In-vivo, 
the results of RSA stent-graft migration measurement using a single reference marker and a 
standard cluster of reference markers were compared.
Results: The mean measurement error ± SD of standard RSA during pulsatile circulation in-vitro 
was -0.5 ± 0.16mm. Using 1-ref-RSA, the mean measurement error in-vitro was -0.73 ± 0.12mm. 
In-vivo, the standard deviation of all measurements by standard RSA was 0.33mm as compared 
to the mean value of the corresponding group of migration measurements. 1-ref-RSA had a 
pooled mean error of 0.17 ± 0.65mm as compared to standard RSA in-vivo.
Conclusion: Roentgen Stereophotogrammetric analysis with a single aortic reference marker 










tentgraft migration still occurs in spite of major improvement in stentgraft 
design over the past decade. Migration constitutes a potentially lethal 
complication after endovascular aneurysm repair (EVAR).1-5 The current 
gold standard for detection of this phenomenon is contrast enhanced CT 
imaging.6 However, contrast enhanced CT has several disadvantages of 
which nephrotoxic contrast, high radiation dose and logistical burden are 
most important. Furthermore, the high cost of this investigation renders 
EVAR less cost effective.7 If the aneurysm size decreases during follow-up with ultrasound, 
migration and stentgraft integrity are the key points of interest in EVAR surveillance. 
Roentgen stereophotogrammetric analysis (RSA) is a method that measures prosthesis 
migration relative to reference markers in the body (Figure 1). 8-11 RSA has proven to be highly 
accurate in clinical detection of prosthesis micro-motion after joint replacement surgery.12,13 
It also demonstrated to be feasible and highly accurate in several stent-graft migration studies 
in-vitro and in-vivo.8,9,14 Furthermore, RSA is cheap, relatively simple and can also be used to 
detect stent fractures. Consequently, it has the potential to become the new gold standard for 
stentgraft migration detection. 
RSA requires markers to perform position measurements and detect migration during follow 
up.8-11 The most important disadvantage of RSA is that a reference marker is required that is 
attached to the aortic wall.8,9,14 This marker is used to determine position change, or migration, 
of the graft and will have to be inserted during the EVAR procedure. An enhanced version of 
the Anson Refix® Nitinol endovascular clip (Lombard Medical, Didcot, United Kingdom), an 
endovascular stapler device to secure a stent-graft to the aortic wall, might be used for this 
purpose.9,14 The design of the marker is currently under investigation at our institution.9,14 
An important question that has remained unanswered is how many markers are needed for 
accurate detection of axial stent-graft migration. At least three non linear placed markers are 
required in surveillance after joint replacement surgery.10 Using only one marker minimizes the 
additional risk and cost of the procedure. However, reducing the number of reference markers 
may diminish the accuracy of RSA measurement of axial migration of a stent-graft.
To assess the accuracy of detection of stent-graft migration with RSA using one single aortic 
reference marker instead of a cluster of reference markers as is currently standard in clinical RSA, 
we performed in-vivo and in-vitro experiments comparing these different reference points.
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Methods
pulsatile aortic Model With Stent-Graft
A pulsatile flow model was developed to simulate migration of a stent-graft in the pulsating 
aorta.9,15 A human cadaver spine was obtained from the anatomical department and used 
according to the standard consent procedures of our Institutional Review Board. A fresh speci-
men of a pig thoracic aorta was attached to the cadaver spine, replacing the cadaveric aorta. 
The spine, including the surrounding soft tissues, was conserved in a solution of formaldehyde, 
ethanol, glycerin, and phenol (Figure 2).9 The model was placed in an Acrylic box, topped off 
with water to simulate soft tissue.
Figure 1. Schematic drawing of the RSA technique. Two standard hospital X-ray tubes (F) are 
used, in combination with two standard X-ray films or flat panel detectors placed directly under a 
calibration box that is positioned under the patient. The projection of the calibration box markers 
on the film is used to reconstruct the position of the Roentgen foci (F) and their relation to the 
two X-ray films. Graft marker A gives projections B and C on the films. With known focus position, 
projection lines 1 and 2 can be reconstructed; Calculating the intersection of lines 1 and 2 in space 








The perfusate of this artificial circulation was starch solution with the same viscosity as blood. 
To generate pulsatility, the model was connected to an artificial circulation set at 70 beats per 
minute with a 75 mL/s flow rate, which produced a physiological flow and pressure profile.9,15 
The pulsatility resulted in a luminal diameter change from 20.0 to 21.5 mm, as recorded in 
M-mode ultrasound with a 7.5-MHz linear array probe (ProSound SSD-5500; ALOKA, Tokyo, 
Japan). This diameter change was induced to simulate aortic diameter changes measured in 
vivo.16-18
A Gianturco stent (Cook, Bjaeverskov, Denmark) was placed inside the aorta by endovascular 
technique. A stent rather than a stent-graft was used to model migration since radiological 
imaging techniques use the stents of the stent-graft for analysis. Furthermore, deleting the 
fabric from the model facilitated the induction of migration. The stent could be “migrated” 
along the aorta by pulling on monofilament fishing wire (Spro, Vianen, The Netherlands), which 
was attached to each side of the stent. To prevent unintended migration, the fishing wire was 
fixed to the box during the measurements.
For RSA analysis, markers were added at the cranial and caudal corners of the stent (i.e., stent-
graft markers), and reference markers were attached to the aorta (i.e., aortic markers). The aortic 
markers consisted of three clusters of 1mm diameter tantalum markers glued to the aortic 
adventitia with Histoacryl (B. Braun Aesculap, Tuttlingen, Germany). These markers are also 
used in standard clinical RSA in joint replacement surgery (Figure 2). The aortic marker closest 
to the stent in the initial position / image was used for RSA analysis with one single reference 
marker (1-ref-RSA).
Figure 2. Model of the fresh pig aorta fixed to a human cadaver spine, complete with soft tissue. 
Three clusters of aortic reference markers are attached to the adventitia (arrows).
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Three stent-graft positions were analyzed with RSA: the initial or reference position and 2 
migrations. The stent-graft was migrated caudally under visual control provided by an image 
intensifier (Philips BV300 plus; Philips Medical Systems Europe, The Netherlands). 
Since RSA is proven to be highly accurate in a static environment, RSA of the model without 
pulsatile circulation was used as the reference standard to determine actual stent-graft migra-
tion. 8-11 Five RSA images of the reference position and 3 images of each stent-graft position 
after migration were acquired. These results could later be compared to standard RSA and 
1-ref-RSA with pulsatile circulation in the model, to determine the measurement error of the 
2 techniques. The migration was assessed using cross-table analysis, comparing each of the 5 
reference images to all 3 follow-up images, producing 15 measurements per migration.9 
To determine the influence of pulsatility on RSA and 1-ref-RSA migration measurement, 11 
RSA images were acquired of each stent-graft position at a random point in the pulsatile cycle. 
Migration was determined by cross-table analysis, comparing each of the 11 reference images 
to all 11 follow-up images, resulting in 121 measurements per migration or 121 possible clinical 
combinations of RSA images per migration. These images were assessed using all aortic refer-
ence markers (“standard” RSA) as well as one single reference marker (1-ref-RSA).
animal Model With Stent-Graft
Two 100 Kg female pigs were used. The Institutional Review Board for animal experimentation 
approved the study and the animals were cared for in compliance with the national guidelines 
for animal experiments. After general anesthesia, the pulse rate was kept at approximately 90 
per minute. Thoraco-laparotomy was performed exposing the thoracic and infrarenal aorta. 
Heparine was continuously administered. A Dacron 8mm tube graft (Gelsoft Plus, Vascutek, 
Inchinnan, UK) was attached to the infrarenal aorta as a conduit for vascular access.14
A Gianturco stent as described above was placed inside the thoracic aorta via endovascular 
technique. The thoracic aorta was chosen for placement as it has the largest available aortic 
diameter, resembling the human situation as much as possible. Migration was induced under 
visual control as described above, the fishing wire was positioned as a “body floss” through 
the left carotid artery and the conduit. Eight tantalum reference markers (with a diameter of 
1 mm) were glued to the adventitia of the thoracic aorta using Histoacryl® (B.Braun Aesculap, 
Tuttlingen, Germany), the aortic markers. The aortic marker closest to the stent in the initial 








In the first animal, two stentgraft positions were analyzed: the initial or reference position and 
one migration. In the second animal, five stentgraft positions were analyzed: the initial or refer-
ence position and four migrations. 
For each stent-graft position RSA imaging was performed.14 To simulate the in-vivo human 
situation and the influence of pulsatile motion on migration measurement by RSA and 1-ref-
RSA, 5 RSA images were acquired of the reference position and 9 images of each stentgraft 
position after migration. The RSA images were acquired at a random point in the cycle of 
pulsatile circulation. Migration was assessed using cross-table analysis, comparing each of the 
5 reference images to all 9 follow-up images. This resulted in 45 measurements per migration, 
resembling the 45 possible clinical combinations of RSA images. These images were assessed 
using all aortic reference markers (“standard” RSA) as well as only one reference marker (1-ref-
RSA). To summarize the standard-RSA results, we pooled the data to determine the variance of 
the method. This was done by calculating the mean migration per group of 45 measurements. 
Afterwards, this value was subtracted from every single measurement in the same group, 
thereby calculating the variance of the standard-RSA measurement. This enabled calculation 
of the standard deviation and range of deviation of all standard-RSA measurements (n=225). 
The measurement error of 1-ref-RSA was determined by comparing each 1-ref-RSA observa-
tion to the corresponding mean value of migration measured by standard-RSA.
rSa imaging technique
We used two manually synchronized standard mobile Roentgen tubes to acquire the RSA 
images (Philips Practix 2000, Philips Medical Systems Europe, The Netherlands) (Figure 1). The 
exposure settings used were: 110 kV / 8.5 mAs, resulting in an exposure time of 78 ms for the 
in-vitro model and 125 kV / 15mAs, resulting in an exposure time of 160 ms for the animal 
studies.9,14 
After digitizing the films, image postprocessing was done on a personal computer with the 
help of special RSA software (Model Based RSA software, MEDIS Specials BV, Leiden, The Neth-
erlands). 8-11,14 The RSA images were randomly numbered and the reviewer was blinded for the 
distance of migration induced.
Using RSA, it is possible to calculate the distance between two (groups of ) markers inside the 
body. Migration is determined by comparing an initial, reference RSA image to the follow up 
RSA image. The technique was previously described in more detail. 8-11
In RSA analysis, the relative positions of markers do not change in absence of migration. Any 
change in relative position indicates movement between the markers. Positioning of the 
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model, animal, or the patient, is not critical as the calibration box will facilitate the calculation 
of marker coordinates each time an RSA image is taken. 
Results
In-vitro
The actual migration of the stent in the model as determined by standard RSA in a non pulsatile 
situation was 7.00 ± 0.02mm (n=15) for the first migration; the second migration was 13.90 ± 
0.03mm (n=15).9 
In the pulsatile situation standard RSA registered a migration of 6.50 ± 0.08mm for the first, and 
13.4 ± 0.21mm for the second migration (n=121), the pooled measurement error was -0.50 ± 
0.16mm.9
According to 1-ref-RSA, the first migration in the pulsatile situation was 6.17 ± 0.08mm 
(n=121). For the second migration 1-ref-RSA determined a mean migration of 13.28 ± 0.08mm 
(n=121). The pooled measurement error of all migration measurements by 1-ref-RSA was -0.73 
± 0.12mm. A box plot of the measurements is shown in Figure 3. 
Figure 3. Boxplot of RSA migration detection in an in-vitro pulsatile model. X-axis: Standard of 
reference is RSA in the model without pulsatile circulation (RSA (non pulsatile)). RSA represents 
measurement error with three clusters of aortic reference markers. 1-ref-RSA represents 










Standard RSA measured a migration of 8.15 ± 0.39mm for the migration in the first pig, migra-
tion 1-4 in the second pig were 6.59 ± 0.23mm, 10.74 ± 0.36mm, 15.03 ± 0.26mm and 16.62 
± 0.35mm, respectively. The standard deviation of all measurements by RSA was 0.33mm as 
compared to the mean value of the corresponding group of migrations (n=225).14 
The results of 1-ref-RSA were 9.09 ± 0.68mm for the migration in the first pig and 6.42 ± 0.84mm, 
9.95 ± 0.31mm, 14.73 ± 0.15mm and 16.51 ± 0.17mm for the migrations in the second pig, 
respectively. 1-ref-RSA had a pooled mean error of 0.17 ± 0.65mm as compared to standard 
RSA. 
Discussion
For the detection of stentgraft migration, the accuracy of RSA using only one single refer-
ence marker is slightly less accurate compared to standard, multiple reference markers. The 
in-vitro and in-vivo measurement errors of standard RSA as well as of RSA using one single 
reference marker appear to be well below 1mm, a difference that is clinically very acceptable 
and compares favorably with other techniques to determination stentgraft migration.8,9,14,20 
Reduction of the number of reference markers to only one single aortic reference marker for 
RSA surveillance of stent-graft migration appears to be feasible. 
RSA requires a reference marker to measure a change in position. This reference marker is best 
attached to the aortic wall, close to the stent-graft.9,19 As discussed previously, a bony refer-
ence marker like the lumbar spine, or an artificial marker attached to the spine, is not useful 
because of the significant cyclic motion of the aorta-stent-graft complex relative to the lumbar 
spine.8,17,18,21 This cyclic motion will induce a cyclic error in measurement when bony reference 
markers are used, adding to the measurement error of RSA itself. Furthermore, it is difficult 
to accurately reproduce bony reference markers in a clinical setting. The stentgraft markers 
that are used to position the graft during surgical placement can be used for RSA-detection of 
the graft. However, it is important to be able to identify the different markers either through 
asymmetric placement on the graft or by specific marker characteristics. If this is not the case, 
symmetrical marker configurations will result in measurement errors due to erroneous identi-
fication and consequent position calculation of the marker by the software. 
In orthopedic surgery, a cluster of at least three non linear placed tantalum markers are used 
to detect prosthesis micro-motion. Using this configuration enables accurate quantification 
of micro-motion in three dimensions, including rotational micro-motion. Using less than 
three markers eliminates the possibility of rotational motion measurement. Other forms of 
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motion are detectible using only one reference marker. The issue of interest in surveillance 
after EVAR is to detect stentgraft migration along the vessel wall. Rotation inside the vessel 
is of less importance for long term follow-up, and migration outside the vessel has not been 
reported. Therefore, on theoretical grounds, one single marker to detect axial migration could 
be sufficient. Our data show that the accuracy of RSA using a single reference marker is not 
significantly hampered for clinical use. Therefore, it appears that one single aortic reference 
marker is sufficient for stent-graft migration surveillance after endovascular aneurysm repair. 
Design, safety and positioning of the aortic reference marker are subject to further study at 
our institution.9,14
Conclusion
Roentgen Stereophotogrammetric analysis with a single aortic reference marker enables very 
accurate detection of stent-graft migration. 
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Purpose: To determine the accuracy and precision of plain abdominal radiography (AXR) as a 
method to detect stent-graft migration and thereby define its clinical applicability.
Methods: Stent-graft migration was simulated in a static model of an aorta with stent-graft. 
Migration was measured by five different observers in AXR images with image acquisition and 
analysis according to a standardized protocol with correction for geometric distortion. The 
results were compared to Roentgen stereophotogrammetric analysis as the standard of refer-
ence. This way, accuracy and precision could be determined in-vitro. Next, the five observers 
determined stent-graft migration in two consecutive AXR images of four patients after endo-
vascular aneurysm repair (EVAR). The results of the five observers were compared to determine 
the precision of the method in-vivo. 
Results: In-vitro, migration as measured with RSA was 9.97 mm for the first and 27.75 mm for 
the second migration. The mean migration determined with AXR was 8.6 ± 2.5 mm (range 
0.4 – 20.6 mm, n=57) and 23.7 ± 2.2 mm (range 14.7 – 27.4 mm, n=57), respectively. The mean 
pooled error of AXR as compared to RSA was 3.0 ± 2.4 mm (range 0.01-13.1 mm, n=114). Of all 
AXR measurements, 16% had an error larger than 5mm. In-vivo, the pooled mean variation was 
3.0mm ± 4.5mm (n=76). The maximum difference between measurements in one patient was 
33.0 mm. There was no significant inter-observer variability in the in-vitro and in-vivo groups.
Conclusion: The accuracy and precision of plain radiography for detection of stent-graft migra-
tion after EVAR is insufficient for clinical use, especially when early and accurate identification 
of minimal migration is required like in patients with short aneurysm necks. .
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lain abdominal radiography (AXR) is widely used as a practical and reli-
able tool for routine surveillance after endovascular aneurysm repair 
(EVAR).1-3 AXR is fast and requires only limited hospital resources in terms 
of personnel and equipment. Other advantages of AXR are that it does 
not require nephrotoxic contrast enhancement and has a low radiation 
dose per investigation. Therefore, it compares favorably to CT as a tool for 
surveillance after EVAR. 
AXR reveals information about stent-graft position and integrity, enabling detection of stent-
graft migration, kinking/deformity, limb dislocation, hook and stent fracture, anchor-stent 
separation, and progressive dilatation of the native vessels.1 Hodgson et al. demonstrated 
that an accuracy of 2 mm could be achieved to detect stent-graft migration in a static model 
using standardized AXR and an algorithm to correct for geometrical distortion due to varying 
positioning of the Roentgen tube.2 They did not describe the effect of inter-observer variation 
on the measurement, nor the precision of repeated measurements with AXR. These aspects of 
AXR remain unclear, even though AXR has found such widespread acceptance for an important 
aspect of surveillance after EVAR. 
In AXR, the spine is used as the point of reference to detect stentgraft migration, by compar-
ing the position of the stent-graft relative to the lumbar spine in sequential examinations.2 
However, the spine is not always a stable landmark over time. Moreover, cranio-caudal stent-
graft motion during the cardiac cycle has been described up to 3 mm in a small number of 
patients, making a wider range of motion likely.4-6 Because of this pulsatile motion of the 
graft, the use of bony points of reference seems to be hazardous in terms of measurement 
accuracy. Furthermore, the minimum acceptable aneurysm neck length continues to decrease 
with increased experience and new generation stent-grafts, approaching 5mm.7 This requires 
increased accuracy of our tools for migration surveillance.  
In this study, we determined the accuracy and precision of AXR as a method to detect in-vitro 
and in-vivo stent-graft migration to further define its clinical applicability. 
METHODS
Plain Radiography (AXR) versus RSA in-vitro
For the in-vitro condition we used a static model to acquire AXR images according to a stan-
dard clinical protocol and compared the measurements to RSA, the standard of reference for 
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this experiment. Roentgen stereophotogrammetric analysis (RSA) is a method that uses stereo 
roentgen images to determine the 3D position of markers relative to each other. RSA has been 
used for many years to detect micro-motion of orthopedic prosthesis with sub-millimeter 
accuracy.8-10 In recent literature, it has also been proposed as a highly accurate tool for migra-
tion surveillance after EVAR.11-12 An accuracy of 0.002 ± 0.044mm was demonstrated in a static 
model of stent-graft migration.11 Because RSA acquires a calibrated stereo plain radiographic 
image, it has the same possibilities and advantages as AXR. RSA combines these advantages 
with a very high accuracy for micro-motion measurement.11-12 RSA was regarded as the stan-
dard of reference in the static situation because of its proven high accuracy. This comparison 
of AXR to a highly accurate standard of reference is a measure for the accuracy of AXR, the 
measurement error. 
A static model was developed to simulate stent-graft migration. The model consisted of a 
fresh thoracic pig aorta, fixed to a cadaver human spine complete with soft tissue. The spine 
was obtained from the anatomical department and used according to the standard consent 
procedures of our Institutional Review Board. It was conserved in a solution of formaldehyde, 
ethanol, glycerin, and phenol (Figure 1). The model was placed in an acrylic box, topped off 
with water to simulate soft tissue. 
A Gianturco stent (Cook, Bjaeverskov, Denmark) was placed inside the aorta. A stent rather than 
a stent-graft was used to model migration since radiological imaging techniques use the stents 
of the stent-graft for analysis. Furthermore, deleting the fabric from the model facilitated the 
induction of migration. Three stent-graft positions were analyzed with RSA and AXR: the initial 
or reference position and 2 migrations, induced by pulling on a thin wire attached to the stent.
For RSA analysis, markers were added at the cranial and caudal corners of the stent (i.e., 
stent-graft markers), and reference markers were attached to the aorta (i.e., aortic markers), as 
published previously.12 RSA imaging and measurement was performed as published previ-
ously.9,11-12
For plain radiography, the same setup was used to determine migration as is current practice 
in our clinical setting for EVAR surveillance, as described by Murphy et al.3 From every posi-
tion one anterior- posterior and three left lateral radiographs were produced using a Bucky 
set-up by Oldelft (Triathlon DR, Oldelft Veenendaal, The Netherlands) with the tube positioned 
1 meter above one 35 x 43 cm digital flat panel detector (CXDI-50G, Canon, Amstelveen, the 
Netherlands). As described by Hodgson et al.2, the exact position of a stentgraft inside the body 
is impossible to determine from the outside of the patient in a clinical situation. Therefore, 
lateral photos cannot always be taken through the exact center of the top of the stentgraft. To 
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mimic a clinical setting, and reproducing the experiment performed by Hodgson et al 2, three 
different lateral radiographs were acquired, one with the center of the X-ray beam aimed at the 
center of the stent and one aimed 7.5 cm cranial and 7.5 cm caudal to this point. 
The position of the stent was determined by measuring the distance between two reference 
points. We used the center of one end of the stent as the stent reference. Similarly, the vertebral 
reference was the center of the vertebral endplate closest to the stent reference point on the 
initial photo. It is preferable to choose the centers of the stent and vertebra as reference points 
instead of the edges, because the centers are less affected by variation in angulation, distortion 
or vertebral osteophytes at the border of the vertebra.2 
The AXR images were randomly numbered and measured by 5 different observers. Two observ-
ers performed five measurements per image; three observers performed three measurements 
per image. All observers were blinded for the amount of migration. This way, a total of 19 mea-
surements were performed on three images per position (cranial, center and caudal image). 
This lead to 57 measurements per migration, and therefore a total of 114 measurements of 
the two induced migrations. Geometric distortion was corrected according to the suggestions 
by Hodgson et al.2 Migration was determined by calculating the difference in distance from 
the vertebral endplate to the stent, as measured in the reference radiographs and follow up 
images.2
Figure 1. Model of an aorta with stent-graft. Fresh pig aorta fixed to a human spine complete with 
soft tissue. Spherical markers are attached to the adventitia as reference markers for RSA.
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Plain Radiography (AXR) in-vivo
Next, we measured the variability of AXR measurements of stent-graft migration in patients 
who had undergone EVAR. The standard deviation and the maximum variation between all 
observations per migration are a measure for the precision of the technique. To determine the 
precision of AXR in a clinical setting, migration was measured in four randomly chosen patients 
who underwent EVAR. 
The AXR image pairs (AP and lateral) were acquired at two different points in time: one refer-
ence image directly post-operative and a randomly chosen follow-up image. The AXR image 
pairs were acquired according to the protocol as described by Murphy et al.3, with a standard 
Bucky imaging set-up (Philips Medio 50 CP, Philips Medical Systems Europe, the Netherlands) 
positioned 1 meter above a 35 x 43 cm film (Kodak, Amsterdam, the Netherlands). The exposure 
was regulated automatically at approximately 75 kV. The AXR measurements of the stent-graft 
position were performed in the same way as described for the in-vitro experiment following 
the Hodgson protocol, determining the vertical distance between the vertebral endplate and 
the center of one end of the top stent of the stent-graft.2 . As in the in-vitro experiments, two 
observers performed five measurements per image; three observers performed three mea-
surements per image. This way, 19 measurements were performed in four patients, leading 
to a total of 76 measurements in-vivo. To determine the pooled mean deviation and standard 
deviation of AXR, we compared each AXR measurement to the mean of the AXR measure-
ments of the same patient to determine the variation compared to the mean measurement. 
Subsequently, we pooled these data. 
Statistics
Levene’s test for variance was used to detect statistically significant interobserver variability 
between the measurement errors of the observers. P<0.05 represented a statistically significant 
difference. Standard deviation and maximum variation of the measurements were determined 
for each migration. The tests were performed in cooperation with the Medical Statistics depart-
ment of the LUMC using SPSS for Windows (version 11.0; SPSS Inc., Chicago, IL, USA).
Results
plain radiography (aXr) versus rSa in-vitro
RSA analysis revealed a stent-graft migration of 9.97 mm for the first migration, and 27.75 
mm for the second migration. The mean migration determined with AXR with correction for 
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geometric distortion was 8.6 ± 2.5 mm (range 0.4 – 20.6 mm, n=57) and 23.7 ± 2.2 mm (range 
14.7 – 27.4 mm, n=57), respectively. No significant difference was found between the observ-
ers using Levene’s test for variance (P=0.466). The pooled mean error of AXR as compared to 
RSA in a static in-vitro condition was 3.0 ± 2.4 mm (range 0.01-13.1 mm, n=114). Of all 114 AXR 
measurements, 16% had an error larger than 5mm in this model without pulsatile stent-graft 
motion (Figure 2).
plain radiography (aXr) in-vivo
Migration of the stent-graft as measured by AXR with correction for geometric distortion is 
shown in Figure 3. The pooled mean variation of AXR was 3.0mm ± 4.5mm (range 0.0 - 22.4 mm) 
(n=76).  The maximum difference between measurements in one patient was 33.0 mm. No sig-
nificant difference was found between the observers using Levene’s test for variance (P=0.284). 
Discussion
This study demonstrates that plain abdominal radiography has poor accuracy and precision 
to measure stent-graft migration despite adherence to a strict imaging and measurement 
protocol.
A mean error of 3.0 ± 2.4 mm was found in a model without pulsatile motion. This displays a low 
accuracy and precision. This is emphasized by the finding that 16% of the measurement errors 
were larger than 5mm. In the developments in design of stent-grafts and growing experience 
Figure 2. AXR measurement error of 5 different observers using a static model and RSA as 
standard of reference. In 16% the error was larger than 5mm. No significant difference was found 
between the observers.
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of endovascular specialists, the accepted neck length of aneurysms is constantly decreasing, 
approaching 5mm.7 Stent-graft migration of only several millimeters could already be very 
significant in these cases. The cyclic cranio-caudal motion of the stentgraft relative to the 
spine, the point of reference for AXR, has been reported to be up to 5,8mm. 4-6,11,13  Combining 
the measurement error found in this study with the understanding of this cyclic motion, an 
aneurysm neck length of 5-10 mm seems to be too short for surveillance of stent-graft migra-
tion by AXR alone.
In the in-vivo measurements, the accuracy and precision could have been reduced due to the 
pulsatile motion of the graft relative to the spine. This could possibly explain the disappointing 
precision of AXR found in-vivo. The variation of 3.0mm was large, especially when considering 
the very high standard deviation of this result: 4.5mm. This standard deviation would yield a 
95% confidence interval of stentgraft migration measurement with AXR of 9mm. When stent-
graft migration of 5mm is considered significant, AXR is simply not precise enough to reliably 
determine presence or absence of this complication.
The current gold standard to detect stent-graft migration after EVAR is contrast enhanced 
multi-detector CT with sub-millimeter beam collimation and 3D image reconstruction.14 This 
method has the advantage of enabling detection of possible endoleaks and aneurysm sac 
growth or shrinkage, apart from measuring stent-graft position. However, these advantages 
come at a price in terms of cost and logistical burden. The contrast requirement and, to a lesser 
Figure 3. Results of migration measurements using AXR in patients after EVAR by 5 different 
observers, no significant difference was found between the observers. 
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extent, radiation dose can be a considerable disadvantage. Furthermore, 3D image reconstruc-
tion is not available in every hospital, nor is a multi-detector CT. CT without contrast enhance-
ment, small acquisition slice thickness or 3D image reconstruction will undoubtedly produce 
less accurate results14, however the accuracy of such measurements has not been quantified. 
Roentgen stereophotogrammetric analysis has been described as a possible tool to meet the 
requirements of high accuracy of stentgraft position measurement without the disadvantages 
of CT.11,12 Unfortunately, RSA is still not suitable for widespread clinical introduction.
When considering the accuracy and precision of AXR, combined with a minimum length of the 
proximal neck zone to secure aneurysm exclusion, the results of our study imply that AXR is 
unreliable for surveillance of patients with an aneurysm neck of less than 15 – 20mm. For safety 
reasons, an aneurysm neck length of 30mm seems to be more appropriate when AXR is used 
for migration surveillance. In clinical practice, the vast majority of cases have an aneurysm 
neck length of less than 30mm, and the average length in reported series is deminishing.15-17 
Therefore, most of the patients after EVAR are unsuitable for this method of migration surveil-
lance alone. 
Limitations
This study is a combination of an in-vitro and an in-vivo study. The model is by nature of its 
design limited because of the absence of normal physiological behavior due to cardiac and 
respiratory motion. Furthermore, only a limited amount of soft tissue was simulated by means 
of water, an isodense substance. However, the accuracy and precision of AXR measurements 
will most likely further decrease if the above mentioned factors would have been present in 
the model. 
We measured a limited number of four patients for the in-vivo part of the study. These results 
already show a considerable variation between measurements, without showing significant 
inter-observer variation. Considering the finding that the range of measurements as found 
in each patient was at least 5mm (Figure 2), a larger sample of patients and images will not 
contribute significantly to the data. 
Conclusion
The accuracy and precision of plain radiography for detection of stent-graft migration after 
EVAR is insufficient for clinical use, especially when early and accurate identification of minimal 
migration is required like in patients with short aneurysm necks. 
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Abstract
Objective: To validate the use of Fluoroscopic Roentgen Stereophotogrammetric Analysis 
(FRSA) for its feasibility and accuracy to measure 3-D dynamic motion of stentgrafts.
Methods: A digital bi-plane fluoroscopy set-up was calibrated (Siemens Axiom Artis dBc®). 
Stereo images were acquired of a static aortic model with a stentgraft in different axial posi-
tions, imposed by a micromanipulator. The 3-D measurement error of FRSA was determined 
by comparing FRSA measurements to the micromanipulator. An aortic model with stent-graft 
was constructed and connected to an artificial circulation with a physiological flow and pres-
sure profile. Markers were added to the spine (tantalum spherical markers, diameter 1mm) and 
stent (welding tin, diameter 1mm). 3-D measurement precision was determined by measuring 
the position of a single (stable) spine marker during 2 pulsatile cycles. Finally, 3-D stent marker 
motion was analyzed with a frame rate of 30 images per second, including 3-D marker position 
(change), diameter change, and center of circle position change.
Results: The mean error of FRSA measurement of displacement was 0.003mm (SD=0.019mm, 
max. error 0.058mm). A very high precision of position measurement was found (SD=0.009-
0.015mm). During pulsatile motion, the position (changes) of the markers could be assessed in 
X, Y and Z direction, as well as stent diameter change and center of circle position change.
Conclusion: FRSA has proven to be a method with very high accuracy and temporal resolution 
to measure three dimensional stentgraft motion in a pulsatile environment. This technique 
has the potential to contribute significantly to the knowledge of stentgraft behavior after 













ndovascular repair (EVAR) of an abdominal aortic aneurysm (AAA) is a widely 
used therapeutic alternative to open repair. A known problem with this 
technique is that the stentgraft can fail due to device defects caused by the 
continuous and significant forces of pulsatile blood flow. These failures have 
potential detrimental effects on patient health and safety.1,2 An important 
problem of understanding failures is that it is difficult to study and measure 
aorta and stentgraft dynamics after EVAR, and clinical data are therefore 
limited. For the development, improvement and evaluation of new and current stentgrafts, it 
is of significant interest to understand aorta and stentgraft dynamics in vivo. Modeling of these 
blood flow related dynamics is very difficult. Subsequently, bench-testing of repetitive motion 
of stentgrafts is often inadequate and can lead to faulty stentgraft design. 
Currently, cinegraphic CT and MRI can be used to measure aorta and stentgraft motion during 
the cardiac cycle.3-5 An important limitation of these imaging modalities is that motion can 
only be measured in one plane. Three dimensional motion of specific points of a stentgraft 
cannot be quantified. Furthermore, the spatial resolution of these techniques is limited.5 
Roentgen stereophotogrammetric analysis (RSA) is a tool to assess marker positions using ste-
reo roentgen images.6,7 This technique has proven to be highly accurate, and is used to measure 
prosthesis migration in the relative static environment of follow-up after joint replacement 
surgery.8-11 Recently, RSA was introduced as an accurate tool to measure stentgraft migration 
during post-EVAR surveillance.12,13 RSA can not be used to measure stentgraft motion during 
the cardiac cycle, since it uses one single stereo image acquired with two regular “single-shot” 
X-ray machines. It is therefore impossible to acquire a rapid sequence of calibrated images.
With the development of digital bi-plane fluoroscopic imaging systems, accurate measure-
ment of three dimensional stentgraft motion during the cardiac cycle can become possible 
by combining stereo fluoroscopy with the RSA technique. This could enable in-vivo motion 
analysis of stentgrafts during the cardiac cycle. We validated the use of this combination of 
techniques: Fluoroscopic Roentgen Stereophotogrammetric Analysis, or FRSA, for its feasibility 
and accuracy to measure 3-D dynamic motion of stentgrafts.
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Methods
the concept of FrSa
Roentgen stereophotogrammetric analysis (RSA) is performed by calculating the point of inter-
section of two projection lines of a marker in space, using calibrated stereo Roentgen imaging 
(Figure 1). 6-13 FRSA uses high resolution digital stereo fluoroscopic images that are calibrated 
according to the same principles as RSA to calculate marker positions. Fast image acquisition 
and high frame rate theoretically enable accurate measurement of stentgraft motion in high 
spatial and temporal resolution.
FrSa set-up
We used a Siemens Axiom Artis dBc imaging system (Siemens Nederland NV Medical Solutions, 
The Hague, The Netherlands) (Figure 2), which consists of two C-arms with digital flat panel 
Roentgen detectors. The focus to detector distance was set at 95 cm. The two C-arms were 
positioned at a 90 degree angle, to produce a posterior-anterior image and a lateral image. The 
images were acquired and stored in 1024 x 1024 pixels, 14 bits grey scale resolution (Figure 3). 
The frame rate was 30 bi-directional images per second. Each stereo image is acquired as two 










Figure 1. Schematic drawing of FRSA technique. The positions of the Roentgen foci (R1 and R2), 
the detectors (D1 and D2) and their relative position are known by calibration of the set-up. Graft 
markers give projections P and P’ on the detectors. With a calibrated set-up, projection lines can be 











Figure 2. Clinical set-up of the bi-plane fluoroscope
Figure 3. Image of the software with reconstruction of the stentgraft in space. The two images of 
a stereo image pair, a lateral and a postero-anterior image are visible. Right lower corner shows a 
detected stent marker.
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separate alternating images, resulting in 60 alternating images per second. The exposure time of 
each image was 4 ms. The time between the posterior-anterior image and lateral image was 12.7 
ms. For each analysis reported in this study, a 1.5 second run (45 stereo images) was acquired.
The image pairs were analyzed using Model-based RSA software (MB-RSA, MEDIS specials, 
Leiden, The Netherlands) to calculate the relative 3-D marker positions.8-11 No image recon-
struction is required before analyzing the image pairs.
FrSa set-up calibration
To calibrate the set-up, a single focus run of a specially designed acrylic (PMMA, Vink Kunststof-
fen, Didam, The Netherlands) calibration box was acquired with each of the two C-arms.14 From 
each run, a randomly chosen image was analyzed using the calibration algorithm as published 
previously.14 This algorithm provides the calibration parameters to correct for image scale and 
geometric distortion, as well as the position of the Roentgen focus relative to the image for 
each C-arm. The relative position and orientation between the two C-arm images is necessary 
to calculate the 3-D marker positions using RSA analysis. This was achieved using a calibration 
object with 11 markers in known positions (Figure 4). The two images of the object were aligned 
to reconstruct the marker positions in space, reversing the calculation used to reconstruct an 
RSA image (Figure 1). This gave the position and orientation between the C-arms.
 Further analysis of the experimental images as described below could now be performed 
within this calibrated set-up.
Figure 4. Calibration object. Plexiglas block, dimensions w x d x h: 8 x 8 x 5 cm. In every corner one 
tantalum marker, diameter 1mm (red and yellow). In the top layer three extra markers, diameter 











A static model of an aorta with stentgraft, with markers in known positions, was placed in the 
set-up (Figure 5). The same model was used as described previously.12 The stentgraft could be 
translated accurately in the aorta lumen with a micromanipulator. The stentgraft was moved in 
axial direction inside the aorta over a distance of 1, 1.5 and 3mm, using the micromanipulator. 
The increments of the micromanipulator were accurate up to 0.01 mm according to the manu-
facturer, and confirmed by laboratory testing at our institution. The translation of the stent 
resulted in a 3D displacement of the markers. Three random stereo images were taken from an 
acquisition run of each position. Five marker positions were determined using FRSA. This was 
done to test for accuracy of measurement of the relative change in position of the markers by 
comparing the change in X, Y and Z coordinates and calculating the length of the resulting vec-
tor of displacement. Mean, standard deviation, minimum and maximum of the translations of 
the markers were measured and the results were compared to the micromanipulator settings, 
used as the standard of reference. This way, the measurement error of FRSA was determined 
for all measurements (n=45). These data were pooled to describe the mean error, standard 
deviation and maximum measurement error of marker position change as measured by FRSA.
pulsatile model experiments
For measurements under flow conditions, we developed a model to simulate a pulsating aorta 
with a stent-graft. To resemble human aorta characteristics, a fresh specimen of a porcine 
thoracic aorta was used, as published previously.13 The porcine aorta was fixed to a human 
cadaver spine, replacing the cadaver aorta. The spine was complete with soft tissue (Figure 6). 
As an internal control for the experiments, the spine was marked with nine tantalum markers. 
Figure 5. Static model of an aorta (tube) with stentgraft (visible inside tube). Micromanipulator is 
on the left side.
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The aorta was filled with a starch solution with the same viscosity as blood. Inside the aorta, a 
Gianturco stent (Cook, Bjaeverskov, Denmark) was placed. The stent was marked with small drops 
of welding tin with a diameter of 1mm; the stent graft markers included nine at the cranial side 
and three at the caudal side. We used a stent rather than a stentgraft to study marker motion, since 
FRSA uses the stents of the stentgraft for analysis, identical to other radiological imaging tech-
niques. The model was placed in a Plexiglas box, topped of with water to simulate soft tissue. 
To test the feasibility to measure marker motion in a clinical situation, a study of a pulsating 
aorta was performed. The porcine – human aorta model was connected to an artificial circula-
tion with a physiologic flow and pressure profile, as published previously.13,15 This induced 
pulsatile marker motion of the aorta and stentgraft markers in X,Y and Z direction. With a pulse 
rate set at 80 per minute, a bi-plane fluoroscopy run of 1.5 sec resulted in imaging 2 pulsatile 
cycles. 3-D marker positions of the stent markers and the control markers in the spine were 
determined in every stereo image. 
The tantalum spine markers were used to determine measurement precision. For each stereo 
image, the coordinates of a randomly chosen spine marker were determined (n=45). The X, Y and 
Z coordinates of the markers were compared to the average of the 45 measured positions and the 
standard deviation, minimum and maximum deviation were determined. This is a measure for 
the precision of the position estimation of a marker in consecutive stereo images using FRSA.
Finally, 3-dimensional stent marker motion was analyzed. The marker positions were deter-
mined for each sequential frame. The resulting series of marker positions was analyzed for 
Figure 6. Pulsatile flow model. A fresh specimen of a porcine aorta was positioned ventral to a 
preserved human spine, complete with soft tissue. The porcine aorta replaced the human aorta. 










marker motion. Furthermore, a circle was estimated through the nine cranial markers in every 
stereo image. The resulting series of circles were analyzed for change of diameter (i.e. the 
stentgraft and inner vessel diameter) and motion of the circle center, as a measure for the three 
dimensional motion of the aorta – stentgraft complex. Analysis was performed with Matlab 
r2006B (The MathWorks, Natick, USA). 
Results
Using the calibration box, the set-up was tested for image distortion. No image distortion was 
found.
Validation studies
The mean, standard deviation, minimum and maximum of the relative changes in position 
of the markers in the static stentgraft model are presented in Table 1. After pooling the mea-
surement errors of FRSA, as compared to the micromanipulator, the mean error of 3D marker 
motion measurement by FRSA was 0.003mm, SD 0.019mm, maximum error 0.058mm (n=45).
The precision of 3D marker position measurement by FRSA was determined by analysis of 
the position of one of the spine markers in 45 consecutive frames. The results are presented 
in Table 2. The precision is expressed by the standard deviation of the measured laboratory 
coordinates (0.009-0.015mm). 
Table 1. 3D Changes in position (mm) of 5 markers measured by FRSA in 3 image frames (n=15 per 
displacement) compared to actual displacements as imposed by the micromanipulator which was 
applied as the “gold standard’. 
Imposed Translation







ts Mean 1.007 1.497 3.004
St Dev 0.015 0.022 0.023
Min 0.979 1.442 2.967
Max 1.025 1.513 3.030
Table 2. Precision of position measurement of one spine marker in the 45 image frames (n=45).
X (mm) Y (mm) Z (mm)
St Dev 0.015 0.009 0.012
Min dev -0.032 -0.020 -0.023
Max dev 0.027 0.017 0.027
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Measurement of stentgraft dynamics
Finally, the pulsatile dynamics of the stentgraft were analyzed using the calibrated and vali-
dated set-up. 
There appeared to be a cyclic motion of the stentgraft. This motion occurred in all directions. 
Figure 7a shows a schematic drawing of the stent configuration. Figure 7b shows the position 
(changes) of the stentgraft markers during the 2 pulsatile cycles (1.5 second acquisition run, 
45 images). Figure 7c shows the position (changes) of a single marker during the same period. 
Figure 7d shows a break down of this marker motion in X, Y and Z direction. 
invasive technique enables quantifying clinical assessment
of three-dimensional motion of a stent graft in vivo at a
high frame rate. This method is extremely important be-
cause the effects of pulsatile flow and stent graft design on
motion of the various stent graft parts can be measured in
real time, in detail. Until now, this was impossible. FRSA
may provide information that is crucial for further improve-
ments in stent-graft design.
The use of CT and MRI for assessment of stent-graft
motion has b en reported, but these techniques are limit d
tothemeasurementofmotioninasingleplane.3-5Further-
more, the accuracy and reproducibility of these measure-
ments have not been validated. This limitation to single-
plane analysis prevents analysis of the complex motion
patterns that occur differently in the various stent grafts
during the cardiac cycle, including axial, transverse, and
rotational components.3-5,16 This technical limitation of
CT and MRI is caused by the fact that there currently is no
technique available to follow a specific point (marker) of
the graft in time through the fo r-dime sional image data
Fig 7. Three-dimensional motion of the stent-graft markers. (a) Drawing of the stent configuration. (b) Overview of
the motion of 12 stent-graft markers: 9 at the cranial side and 3 at the caudal side. (c) Three-dimensional motion of a
single stent-graft marker plotted in the x, y, and z directions. (d) Motion analysis of a stent-graft marker; breakdown in
motion is shown in the x, y, and z directions. The x-axis depicts the images (1-45), and the y-axis depicts the position
relative to the laboratory coordinate system (millimeters).
JOURNAL OF VASCULAR SURGERY
















































































e e u n
invasive technique enables quantifying clinical assessment
of three-dimensional motion of a stent graft in vivo at a
high frame rate. This method is extremely important be-
cause the effects of pulsatile flow and stent graft design on
motion of the various stent graft parts can be measured in
real time, in detail. Until now, this was impossible. FRSA
may provide information that is crucial for further improve-
ments in stent-graft design.
The use of CT and MRI for assessment of stent-graft
motion has been reported, but these techniques are limited
tothemeasurementofmotioninasingleplane.3-5Further-
more, the accuracy and reproducibility of these measure-
ments have not been validated. This limitation to single-
plane analysis prevents analysis of the complex motion
patterns that occur differently in the various stent grafts
during the cardiac cycle, including axial, transverse, and
rotational components.3-5,16 This technical limitation of
CT and MRI is caused by the fact that there currently is no
technique available to follow a specific point (marker) of
the graft in time through the four-dimensional image data
Fig 7. Three-dimensional motion of the stent-graft markers. (a) Drawing of the stent configuration. (b) Overview of
the motion of 12 stent-graft markers: 9 at the cranial side and 3 at the caudal side. (c) Three-dimensional motion of a
single stent-graft marker plotted in the x, y, and z directions. (d) Motion analysis of a stent-graft marker; breakdown in
motion is shown in the x, y, and z directions. The x-axis depicts the images (1-45), and the y-axis depicts the position
relative to the laboratory coordinate system (millimeters).
JOURNAL OF VASCULAR SURGERY
Volume 46, Number 4 Koning et al 777
i vasive tec i e e a les a tifyi g cli ical assess e t
f t ree- i e si al ti f a ste t graft i viv at a
ig fra e rate. is et is extre ely i p rta t e-
ca se t e effects f p lsatile fl a ste t graft esig
ti f t e vari s ste t graft parts ca e eas re i
real ti e, i etail. til , t is as i p ssi le. S
ay pr vi e i f r ati t at is cr cial f r f rt er i pr ve-
e ts i ste t-graft esig .
e se f a I f r assess e t f ste t-graft
ti as ee rep rte , t t ese tec i es are li it
t t e eas re e t f ti i asi glepla e.3-5 rt er-
re, t e acc racy a repr ci ility f t ese eas re-
e ts ave t ee vali ate . is li itati t si gle-
pla e a alysis preve ts a alysis f t e c plex ti
patter s t at cc r iffere tly i t e vari s ste t grafts
ri g t e car iac cycle, i cl i g axial, tra sverse, a
r tati al c p e ts.3-5,16 is tec ical li itati  f
a I is ca se y t e fact t at t ere c rre tly is
tec i e availa le t f ll a specific p i t ( arker) f
t e graft i ti e t r g t e f u - i e si al i age ata
ig 7. hree-di ensional otion of the stent-graft arkers. (a) ra ing of the stent configuration. (b) vervie of
the otion of 12 stent-graft arkers: 9 at the cranial side and 3 at the caudal side. (c) hree-di ensional otion of a
single stent-graft arker plotted in the x, y, and z directions. (d) otion analysis of a stent-graft arker; breakdo n in
otion is sho n in the x, y, and z directions. he x-axis depicts the i ages (1-45), and the y-axis depicts the position
relative to the laboratory coordinate syste ( illi eters).
J R AL F VAS LAR S R ERY
Volu e 46, u ber 4 o i g et al
i si t i l s tif i li i l ss ss t
f t r - i si l ti f st t r ft i i t
i fr r t . is t is tr l i rt t -
s t ff ts f ls til st t r ft si
ti f t ri s st t r ft rts s r i
r l ti , i t i . til , t is s i ssi l .
r i i f r ti t t is r i l f r f rt r i r -
ts i s t- r ft si .
s f I f r ss ss t f st t- r ft
ti s e r rt , t t s t i s r li it
t t  s r t f ti i  si l  l . -  rt r-
r , t r r r i ilit f t s s r -
ts t li t . is li it ti t si l -
l l sis r ts l sis f t l ti
tt r s t t r iff r tl i t ri s st t r fts
ri t r i l , i l i i l, r s rs ,
r t ti l ts. - ,  is t i l li it ti  f
I is s t f t t t t r rr tl is
t i il l t f ll s i i t ( r r) f
t r ft i ti t r t f r- i si l i t
i . r - i si al ti f t st t- raft ar rs. ( ) ra i f t st t c rati . ( ) r i f
t ti f st t- raft ar rs: at t cra ial si a at t ca al si . (c) r - i si al ti f a
si l st t- raft ar r l tt i t , , a ir cti s. ( ) ti a al sis f a st t- raft ar r; r a i
ti is s i t , , a ir cti s. -a is icts t i a s ( - ), a t -a is icts t siti
r lati t t la rat r c r i at s st ( illi t rs).
J
l e , er i et l
invasive technique enables quantifying clinical assessment
of three-dimensional motion of a stent graft in vivo at a
high frame rate. This method is extremely important be-
cause the effects of pulsatile flow and stent graft design on
motion of the various stent graft parts can be measured in
real time, in detail. Until now, this was impossible. FRSA
may provide information that is crucial for further improve-
ments in stent-graft design.
The use of CT and MRI for assessment of stent-graft
motion has been reported, but these techniques are limited
tothemeasurementofmotioninasingleplane.3-5Further-
more, the accuracy and reproducibility of these measure-
ments have not been validated. This limitation to single-
plane analysis prevents analysis of the complex motion
patterns that occur differently in the various stent grafts
during the cardiac cycle, including axial, transverse, and
rotational components.3-5,16 This technical limitation of
CT and MRI is caused by the fact that there currently is no
technique available to follow a specific point (marker) of
the graft in time through the four-dimensional image data
Fig 7. Three-dimensional motion of the stent-graf markers. (a) Drawing of the stent configuration. (b) Overview of
the motion of 12 st nt-gr ft markers: 9 at the cranial side and 3 at the caudal side. (c) Three-dimensional m t on of a
single stent-graft ma ker plotted in the x, y, and z directions. (d) Motion analysis of a stent-graft marker; breakdown in
motion is shown in the x, y, and z directions. The x-axis depicts the images (1-45), and the y-axis depicts the position
relative to the laboratory coordinate system (millimeters).
JOURNAL OF VASCULAR SURGERY
Volume 46, Number 4 Koning et al 777
Figure 7. 3-D m tion of the stentgraft marker . a) rawing of stent onfiguration. b) verview 
of the mot on of twelve ste tgraft markers, nine t the cra ial s de nd three t the caudal side. 
c) 3D motion of a single stentgraft marker plotted in X, Y and Z direction. d) motion analysis of a 
stentgraft marker. break down in motio  in X, Y and Z direction. X-axis epicts the images (1-45), 










Figure 8 shows the circle that was estimated through the cranial markers of the stentgraft. The 
cyclic diameter change of the circle is shown in Figure 9. The circle center motion is displayed 
in Figure 10, showing cyclic motion of the stent in all directions. 
Discussion
Fluoroscopic Roentgen Stereophotogrammetric Analysis (FRSA) enables highly accurate 
measurement of three dimensional motion of markers on a stentgraft in a pulsatile in-vitro 
model. Axial, lateral and rotational motion can be measured with a mean error of less than 
0.01 millimeter, in every direction (error: 0.003mm, SD 0.019 ). The precision of 3D marker 
position measurement by FRSA is very high, expressed by the small standard deviation of the 
measurement of the X, Y and Z coordinates of the markers (0.009-0.015mm).  This non-invasive 
technique enables quantifying clinical assessment of 3D-motion of a stentgraft in vivo at a 
high frame rate. This method is extremely important because the effects of pulsatile flow 
and stentgraft design on motion of the various stentgraft parts can be measured real time, in 
detail. Until now, this was impossible. FRSA may provide information that is crucial for further 
improvements in stentgraft design.
The use of CT and MRI for assessment of stentgraft motion has been reported, but these 
techniques are limited to the measurement of motion in a single plane.3-5 Furthermore, the 
accuracy and reproducibility of these measurements have not been validated. This limitation 
to single plane analysis prevents analysis of complex motion patterns that occur differently in 
the various stentgrafts during the cardiac cycle, and include axial, transverse and rotational 
components.3-5,16 This technical limitation of CT and MRI is caused by the fact that there cur-
rently is no technique available to follow a specific point (marker) of the graft in time through 
the 4D image data set. Moreover, application of MRI is limited by the fact that certain stentgrafts 
cause significant artifacts in MRI images.
Single focus fluoroscopic measurement of marker motion has been used to assess joint kine-
matics in orthopedic applications, using single plane images. This method is accurate parallel 
to the image plane (reported measurement error 0,1-0,17mm), but out of plane measurement 
error is relatively large (0,7-1,9mm).14,17 Furthermore, this technique requires a fixed configura-
tion of, at least 3, markers to enable reconstruction of the position of the implant. This fixed 
configuration cannot be achieved in the dynamic structure of current stentgrafts, making 
single focus fluoroscopy inappropriate for application in EVAR evaluation.
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In this study, we used two sets of markers. One was the tantalum marker, a highly radiopaque, 
spherical marker, resulting in the best possible measurement in orthopedic RSA. This kind of 
marker could be added to the stentgraft by the manufacturer. The other marker we used was a 
drop of welding tin. These already occur in certain stentgrafts that are currently in wide clinical 
use. Markers that are used for positioning of the graft during EVAR can also be used for this 
procedure. Alternatively, automated pattern recognition of the stentgraft could be used to 
facilitate measurements without the need for markers. These aspects of FRSA are subject to 
further evaluation at our institution. In contrast to RSA, used to detect graft migration during 
follow-up 12,13, no additional markers are needed in the wall of the aorta to perform these 
dynamic measurements. The spine markers used in our study were solely used for this experi-
ment to determine measurement precision and as an internal control. They were not used to 
determine the actual stent motion. The latter is done by independently reconstructing the 
position of each stent marker in space in the sequential images acquired by the calibrated set 
up, and calculating the marker displacement between these consecutive images.  
Limitations
A model was used to study pulsatile change in an aorta with a stentgraft. Patient studies have 
to be undertaken to assess the quality of the images and visibility of the markers of a stentgraft 
in vivo, surrounded by soft tissue. However, when considering the image quality of clinical 
















































































































































































































cardiovascular studies acquired by the Siemens set-up, and the validation of FRSA as demon-
strated in this study, we are certain that analysis of patient images is feasible, and therefore 
analysis of stentgraft motion in-vivo can be performed. 
Different commercially available stentgrafts bare different markers. In this study only one 
graft design was tested.  Based of our experience with RSA, including pilot testing of imaging 
and detectability of markers on different commercially available stentgrafts, we believe that 
motion analysis of different commercially available grafts is feasible. This issue is subject to 
further study at our institution.
practical applications
Further, detailed, knowledge of stentgraft motion during the cardiac cycle is required to better 
understand in-vivo behavior of stentgrafts after EVAR. New stentgrafts can be evaluated, as 
well as existing grafts. With this knowledge, virtual mechanical modeling becomes possible 
and assessment of the failure modus of the stentgraft, such as failure due to metal fatigue is 
facilitated. Based on clinically acquired, detailed knowledge of stentgraft motion, forces acting 
on the stentgraft during the cardiac cycle can be calculated more accurately. With this knowl-
edge, it is possible to evaluate pre-clinical bench testing of stentgrafts and verify its adequacy. 
Bench testing itself will be improved according to in-vivo measured clinical data. Knowledge 
of in-vivo stentgraft motion should be an important adjunct in phase I clinical evaluation of 
Figure 9  















Figure 9. Change in radius of the circle in mm (Y-axis), as fitted through the 45 images (X-axis).
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stentgrafts. Withdrawal of a graft from the market due to mechanical defects that arise after 
widespread introduction could be prevented with better bench testing and early detection of 
unexpected graft motion. 
The radiation dose of FRSA was determined in a separate, unpublished experiment by our 
clinical physicists. The radiation dose is approximately 0.1 mSv for a 3 second study, which 
corresponds to 4 cardiac cycles at a heart rate of 80 bpm. This compares very favorable to the 
17 mSv dose of triple phase CT scan used for EVAR follow up.
Conclusion
In this study, FRSA has proven to be a method with very high accuracy and temporal resolution 
to measure three dimensional stentgraft motion in a pulsatile environment. This technique 
has the potential to contribute significantly to the knowledge of stentgraft behavior after 
endovascular aneurysm repair and improvements in stentgraft design. The technique is ready 
for clinical testing. 
 - 1 - 
Figure 10 




Circle center position X (mm)




Circle center position Y (mm)




Circle center position Z (mm)
 
 
Figure 10. Change of position of the circle center. X-axis depicts the images (1-45), Y-axis depicts 











We would like to acknowledge the help of the following persons:
M.J. Schalij, MD, Interventional Cardiologist, Department of Cardiology, LUMC, for his assistance 
with the image acquisition.
M. Boonekamp, Department of Fine Mechanics, LUMC, for his assistance in building the models 
and the calibration object.
J. Geleijns, MSc, PhD and P.W. de Bruin, MSc, PhD, Clinical Physics, Department of Radiology, for 
their work on radiation dose measurement of FRSA.
122
1. Bockler D, von Tengg-Kobligk H, Schumacher H, Ockert 
S, Schwarzbach M, Allenberg JR. Late surgical conversion 
after thoracic endograft failure due to fracture of 
the longitudinal support wire. J Endovasc Ther. 2005 
Feb;12(1):98-102.
2. Jacobs TS, Won J, Gravereaux EC, Faries PL, Morrissey 
N, Teodorescu VJ, et al. Mechanical failure of prosthetic 
human implants: a 10-year experience with aortic stent 
graft devices. J Vasc Surg. 2003 Jan;37(1):16-26.
3.  Verhagen, HJ, Teutelink A, Olree M, Rutten A, de Vos 
AM, Raaijmakers R, et al. Dynamic CTA for cutting edge 
AAA imaging: Insights into aortic distensibility and 
movement with possible consequences for endograft 
sizing and stentdesign J Endovasc Ther. 2005;12:I-45.
4. Teutelink A, Rutten A, Muhs BE, Olree M, van 
Herwaarden JA, de Vos AM, et al. Pilot study of dynamic 
cine CT angiography for the evaluation of abdominal 
aortic aneurysms: implications for endograft treatment. 
J Endovasc Ther. 2006 Apr;13(2):139-44.
5. Vos AW, Wisselink W, Marcus JT, Vahl AC, Manoliu RA, 
Rauwerda JA. Cine MRI assessment of aortic aneurysm 
dynamics before and after endovascular repair.J 
Endovasc Ther 2003;10:433-9.
6. Selvik G. Roentgen stereophotogrammetry. A method 
for the study of the kinematics of the skeletal system. 
Acta Orthop Scand Suppl. 1989;232:1-51.
7.  Karrholm J. Roentgen stereophotogrammetry. Review 
of orthopedic applications. 
Acta Orthop Scand. 1989;60:491-503.
8. Valstar ER, Vrooman HA, Toksvig-Larsen S, Ryd L, Nelissen 
RG. Digital automated RSA compared to manually 
operated RSA. J Biomech. 2000;33:1593-1599.
9. Vrooman HA, Valstar ER, Brand GJ, Admiraal DR, 
Rozing PM, Reiber JH. Fast and accurate automated 
measurements in digitized stereophotogrammetric 
radiographs. J Biomech. 1998;31:491-498.
10. Valstar ER, de Jong FW, Vrooman HA, Rozing PM, Reiber 
JH. Model-based Roentgen stereophotogrammetry of 
orthopaedic implants. J Biomech. 2001;34:715-722.
11. Kaptein BL, Valstar ER, Stoel BC, Rozing PM, Reiber 
JAC. A new model-based RSA method validated using 
CAD models and models from reversed engineering. J 
Biomech. 2003;36:873-882.
12. Koning OH, Oudegeest OR, Valstar ER, Garling 
EH, van der Linden E, Hinnen JW, et al. Roentgen 
Stereophotogrammetric Analysis: an accurate tool to 
assess endovascular stentgraft migration. J Endovasc 
Ther. 2006;13:468-475 
13.  Koning OH, Garling EH, Hinnen JW, Kroft LJ, van der 
Linden E, Hamming JF, et al. Accurate detection of 
stentgraft migration in a pulsatile aorta using Roentgen 
Stereophotogrammetric Analysis. J Endovasc Ther. 
2007;14(1):30-8.
14. Garling EH, Kaptein BL, Geleijns K, Nelissen RG, Valstar 
ER. Marker Configuration Model-Based Roentgen 
Fluoroscopic Analysis. J Biomech. 2005;38(4):893-901.
15. Hinnen, JW, Visser MJ, Van Bockel JH. Aneurysm 
sac pressure monitoring: effect of technique on 
interpretation of measurements. Eur J Vasc Endovasc Surg 
2005; 29:233-8
16. Flora HS, Woodhouse N, Robson S, Adiseshiah M. 
Micromovements at the aortic aneurysm neck measured 
during open surgery with close-range photogrammetry: 
implications for aortic endografts. J Endovasc Ther. 
2001;8:511-520.
17. Ioppolo J, Borlin N, Bragdon C, Li M, Price R, Wood D, et 
al. Validation of a low-dose hybrid RSA and fluoroscopy 
technique: Determination of accuracy, bias and 
precision. J Biomech. 2007;40(3):686-92.
References
C h a p t e r 9
Fluoroscopic roentgen 
stereophotogrammetric analysis (FRSA) to 
study 3-D stent-graft dynamics in patients: a 
pilot study
Olivier H. J. Koning
Bart L. Kaptein






and J. Hajo van Bockel
J Vasc Surg 2009; in press
124
Abstract
Objective: To study the feasibility and analyze the first results of Fluoroscopic Roentgen Ste-
reophotogrammetric Analysis (FRSA) quantifing real time three-dimensional dynamic motion 
of stent-grafts (SG) in patients after endovascular aortic aneurysm repair (EVAR).
Methods: A digital bi-plane fluoroscopy set-up was calibrated (Siemens Axiom Artis dBc®). 
Stereo images were acquired of a patient after thoracic EVAR and of a patient after abdominal 
EVAR. Images were analyzed using a customized version of commercially available software for 
Roentgen stereophotogrammetric analysis (MB-RSA, MEDIS specials BV). SG motion was mea-
sured during the cardiac cycle with respiratory arrest. In addition, SG motion due to respiratory 
action was measured in the patient after abdominal EVAR.
Results: SG motion could be quantified in all 3 dimensions at 30 (stereo) frames per second 
in both patients without difficulty. For the thoracic SG, the maximum translational motions 
of the center of mass of the top stent in X-, Y-, and Z- direction (TM XYZ) were 2.3mm, 2.5mm, 
1.9mm respectively. The diameter changed (DC) between 27.9mm and 28.7mm. Motion in 
axial direction (AX) was 2.9mm. Rotational motion around the longitudinal axis of the top stent 
(RM) was 3.5°. For the abdominal SG, the TM XYZ were 1.2mm, 1.0mm, 1.5mm respectively. DC: 
22.8mm-23.5mm. AX: 1.6mm. RM: 1.1°. During respiratory action TM XYZ were 5.8mm, 1.5mm, 
2.4mm respectively. 
Conclusion: FRSA is the first validated clinically feasible tool to quantify real time three-dimen-
sional stent-graft dynamics after EVAR. Because quantification of three-dimensional motion 
was not available until now, FRSA can provide crucial information of the continuous forces 
that are exerted in all directions on stent-grafts. Thus, it will provide essential information for 
further improvements in stent-graft design.
II
FRSA







ndovascular repair (EVAR) is widely accepted as a reliable technique for treat-
ment of selected abdominal and thoracic aortic aneurysms. Stent-graft failure 
can occur due to the physically demanding environment in which the device 
is placed. The repetitive strain that is induced by the cardiac and respiratory 
cycle can result in device failure such as stent fractures, fabric perforation and 
migration. These failures are a threat to patient health and safety.1-3 Detailed 
knowledge of stent-graft dynamics after EVAR is indispensable to minimize 
the risk of graft failure by continuously improving stent-graft design and testing. 
Stent-graft dynamics appear to be complex and three-dimensional. Axial, transverse and 
rotational motion of the aorta, as well as dilatation have been reported to occur during the 
cardiac cycle.4-8
Currently, it is impossible to precisely quantify stent-graft dynamics with current clinically 
used imaging techniques.  The two main modalities used to study stent-graft dynamics during 
the cardiac cycle are cinematographic (cine-) CT and MRI.4-6 These techniques have several 
disadvantages and technical limitations. The most important of these is the fact that the recon-
structions are limited to a single, two-dimensional plane.9
Recently, an experimental study was published on the use of fluoroscopic roentgen stereo-
photogrammetric analysis (FRSA) to quantify real time three-dimensional dynamics of stent-
grafts during the cardiac cycle.10 FRSA is a combination of a  commercially available digital 
bi-plane fluoroscopic imaging system and the well known and validated method of roentgen 
stereophotogrammetric analysis, used to measure micromotion in-vivo. 11-18 FRSA uses cali-
brated, high resolution digital stereo images to assess the position of (metallic) markers using 
specialized software. The images are acquired at 30 stereo frames per second. The technique is 
completely non-invasive, does not require intravascular contrast and has a radiation exposure 
of approximately only 0.1 mSv for a 3 second study, which corresponds to 4 cardiac cycles at a 
heart rate of 80 bpm. 10 
In this study, we have evaluated the feasibility and obtained the first results of Fluoroscopic 
Roentgen Stereophotogrammetric Analysis (FRSA) to quantify real time three-dimensional 




We used a Siemens Axiom Artis dBc imaging system (Siemens AG, Erlangen, Germany) (Fig-
ure 1), which consists of two C-arms with digital flat panel Roentgen detectors. The focus to 
detector distance was set at 95 cm. The two C-arms were positioned at a 90 degree angle, to 
produce a posterior-anterior image and a lateral image. The images were acquired and stored 
in 1024 x 1024 pixels, 14 bits grey scale resolution (Figure 2 and 3). The frame rate was 30 
bi-directional images per second. Each stereo image was acquired as two separate alternating 
images, resulting in 60 alternating images per second. The set-up was calibrated to determine 
the exact relative position of the two Roentgen foci and the two detectors. The procedure was 
performed as described previously, using a calibration box with markers in known postions.10 
For each analysis reported in this study, a 1.5 second run (45 stereo images) was analyzed. 
Figure 1. FRSA set-up consisting of two C-arms with digital flat panal Roentgen detectors 
(Siemens Axiom Artis dBc imaging system, Siemens AG, Erlangen, Germany).
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The image pairs were analyzed using Model-based RSA software (ModelBased-RSA, version 
3.2, MEDIS specials, Leiden, The Netherlands) to calculate the relative 3-D marker positions.10-16 
No image reconstruction is required before analyzing the image pairs.
patients
Two patients were randomly selected for this pilot study. Both had undergone EVAR within a 
week before evaluation. The first patient was a 57 year old male with a symptomatic type-B 
     
Figure 2. Lateral and Posterior-Anterior fluoroscopic images of the thoracic stent. The spherical 
shaped welding points and fabric markers are visible on the top stent.
     
Figure 3. Lateral and Posterior-Anterior fluoroscopic images of the abdominal stent. The spherical 
shaped welding points and fabric markers are visible on the top stent.
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aortic dissection.. A proximal component of a Zenith TX2® thoracic stent-graft device (Cook, 
Bjaeverskov, Denmark) was implanted, intentionally covering the ostium of the left subclavian 
artery. The graft had a diameter of 34mm. The blood pressure during imaging was 160/97 
mmHg with a pulse rate of 100 per minute, which corresponds to 2.5 cardiac cycles during the 
1.5 second image acquisition run. The imaging of the stent-graft dynamics during the cardiac 
cycle was performed during respiratory arrest.
The second patient was a 75 year old male with an abdominal aortic aneurysm. He was treated 
with a Zenith® stent-graft (Cook, Bjaeverskov, Denmark). The proximal graft diameter was 
28mm. The patient had a blood pressure during imaging of 129/69 mmHg and a pulse rate of 
80 per minute, which corresponds to 2 cardiac cycles during the 1.5 second image acquisition 
run. The imaging of the stent-graft dynamics during the cardiac cycle was performed during 
respiratory arrest. As an additional study, stent-graft displacement as a result of respiratory 
action was measured in a separate image run. 
The study was approved by our institution’s ethics review committee.
analysis of stent-graft dynamics
The welding points of the hooks to the top stent of the stent-graft were used as markers for 
3D motion analysis, as well as the gold markers designating the upper edge of the fabric of 
the graft (Figure 4). The marker positions were determined in each sequential frame. The 
resulting series of marker positions was analyzed for marker motion. The changing position 
of the center of mass of the stent markers was used to quantify three-dimensional motion of 
the aorta – stent-graft complex during the cardiac cycle. Furthermore, a cylindrical shape was 
fitted through the cranial markers in every stereo image (12 markers for the thoracic stent and 
11 markers for the abdominal stent). The changing diameter of the cylinders was used as a 
measure for the pulsatility of the stent. Finally, rotation and translation of the stent around and 
along the longitudinal stent axis were assessed. Analysis was performed using routines that 
were implemented in Matlab r2006B (The MathWorks, Natick, USA). 
The origin of the coordinate system was placed in the center of the markers in the first image 
frame. The positive X-axis was oriented in caudal direction, the positive Y-axis in lateral direc-
tion towards the right side of the patient, and the Z-axis in dorsal direction. 
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analysis of stent-graft dynamics
Thoracic stent-graft
Three-dimensional cyclic motion of the stent-graft was observed. Figure 2 shows the lateral and 
posterior-anterior images of a stereo image of the graft. Figure 4 shows a three-dimensional 
Figure 4. Overview of the stereo reconstruction of the thoracic stent-graft device.  
Center: 3D reconstruction of the stereo image and the Roentgen foci of the bi-plane set-up. The 
crossing lines reflect the position of the stent-graft markers. 
Left: Close-up of the 3D reconstructed markers, the red markers are reconstructed from the 
welding points of the hooks to the top-stent, and the green markers represent the gold markers at 
the upper edge of the fabric.  
Upper right: Close-up of the image with the detected markers, the red markers designate the 
welding points; the yellow markers designate the gold markers. 
Lower right: Close-up of a single welding point of the hook to the stent-graft. These welding points 














































Figure 6. Detail of the typical track of a thoracic stent marker.
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representation of the stent markers as reconstructed by the FRSA software. Figure 5 shows the 
position change of the stent markers and the gold fabric markers during the image acquisition 
run. Figure 6 shows the dynamics of a single, randomly chosen, marker during the cardiac 
cycle. Figure 7 shows a break down of all marker motions in X, Y and Z direction, relative to their 
positions at t=0.3, which is the start of the systole. 
The dynamics of the center of mass of all markers are displayed in Figure 8, showing cyclic 
motion of the stent in all directions. The thoracic stent-graft showed a motion pattern of stent 
dilatation and a center of mass motion of the top stent in caudal-ventral-right hand side direc-
tion relative to the patient, followed by an over-compensation in opposite lateral and cranial 
direction and a gradual return to the starting position with reduction of diameter of the graft. 
This means that, at the start of the systole, the stent-graft moves toward the heart. This is prob-
ably due to contraction of the left ventricle. The maximum translational motions of the center 
of mass of the stent in X-, Y-, and Z- direction were 2.3mm, 2.5mm and 1.9mm respectively. A 
cylinder was fitted through the cranial markers of the stent-graft. The average distance from 
the markers to this cylinder was 0.14mm. The cyclic diameter change of the cylinder, between 
27.9mm and 28.7mm, is also shown in Figure 8. The rotational motion of the top stent was 3.5° 
around its longitudinal axis. The stent motion along its long axis was 2.9mm per cycle.


























Figure 7. Motion of all thoracic stent markers relative to their first positions; break down in X, Y and 




Three-dimensional cyclic motion of the stent-graft was observed. Figure 3 shows the lateral 
and posterior-anterior images of a stereo image of the graft. Figure 9 shows the cyclic change 
of position of the center of mass of the top-stent. The maximum translational motions of the 
center of mass of the stent in X-, Y-, and Z-direction were 1.2mm, 1.0mm and 1.5mm respectively. 
The average distance from the markers to the cylinder that was fitted through the markers was 
0.26mm. The diameter change of the cylinder was between 22.8mm and 23.5mm (Figure 9). 
The rotational motion of the top stent was 1.1° around its longitudinal axis. The stent motion 
along its long axis was 1.6mm per cycle.
As a result of respiratory action, the maximum translational motions of the top stent in X-, Y-, 
and Z-direction were 5.8mm, 1.5mm and 2.4mm respectively. 
Discussion
This study clearly demonstrates that fluoroscopic Roentgen stereophotogrammetric analysis 
(FRSA) is a clinically feasible, non-invasive tool to quantify real time 3-D stent-graft dynamics 
after EVAR in detail. For the first time, quantification of 3-D motion including rotational dynam-
ics is possible. 






































Figure 8. Thoracic stent motion (X, Y, Z motion of the center of mass of the top-stent and the 
change in diameter of the cylinder fitted through the stent markers).
II
FRSA





Previous experimental validation studies have shown that the fast stereo image acquisition 
and high frame rate of FRSA enable accurate and precise quantification of stent-graft motion 
in high spatial and temporal resolution, with a mean measurement error of 0.003 ± 0.019 mil-
limeter.10 
Image acquisition itself is painless, of short duration, does not require intravascular contrast 
and with a radiation exposure of 0.1mSv the patient burden is very low.
The clinical data found in this study are limited in size. Therefore, it is of little interest to exten-
sively discuss the nature and implications of the stent-graft motion found in these two patients. 
However, to point out the possible implications of our findings, it is interesting to review part 
of the presented data. The thoracic stent-graft showed a three-dimensional motion pattern of 
stent dilatation and a center of mass motion.  If the dynamics of this thoracic stent-graft are 
assessed in a single reconstruction plane, as is the case with cine-CT or cine-MRI, the initial seg-
ment of the aorta as viewed in the first reconstructed image would be out of the reconstruction 
plane almost all the time. Only at the end of the diastole will it return to the initial position in 
the image reconstruction plane. As a result of this out of plane motion, dynamics of conically 
shaped stent-grafts or change of stent-graft angulation during cyclic motion can result in false 
measurements of shape or diameter change Therefore, FRSA is much more powerful than 






































Figure 9. Abdominal stent motion (X, Y, Z motion of the center of mass of the top-stent and the 
change in diameter of the cylinder fitted through the stent markers).
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current cinematographic imaging using cine-CT and cine-MRI as it enables quantification of 
the true changes of three-dimensional stent-graft position and configuration.
We found a significant motion of the abdominal stent-graft due to respiratory action of almost 
6mm in caudal direction. When using plain abdominal radiography to detect long-term stent-
graft migration, the dynamics due to respiratory action could result in under- or over-reporting 
of migration in individual cases. This is due to the change of position of the stent-graft as 
compared to the reference point, the vertebral column. 
The results demonstrate that standard markers used for positioning of the graft during EVAR 
can easily be used for FRSA, as well as welding points of the hooks to the top stent. As an alter-
native to marker detection, automated pattern recognition of the stent-graft could be used 
to facilitate measurements without the need for markers. These aspects of FRSA are subject 
to further evaluation at our institutions. In contrast to standard Roentgen stereophotogram-
metric analysis used to detect graft migration during long term follow-up with comparison 
of multiple investigations over time 12,17,18, additional markers in the wall of the aorta are not 
required to perform these dynamic measurements. 
Contrary to cine-CT and cine-MRI, there are no limitations to FRSA in terms of direction of 
motion, type of motion or type of metal of the stent-graft, duration of image acquisition 
or ECG changes. Furthermore, no intravascular contrast is required. Motion analysis with 
cine-CT and cine-MRI is limited to a single (2-Dimensional) plane due to the reconstruction 
of the images.9 Out-of-plane motion can not be quantified and complex three-dimensional 
motion can only be interpreted semi-quantitatively by analyzing different image planes. 
Moreover, rotational motion can not be quantified at all. In addition, the spatial resolution 
of these techniques is limited 6 and their accuracy and reproducibility have not been vali-
dated. Because FRSA uses direct three-dimensional reconstruction of the images, the listed 
limitations do not apply to this technique. Another disadvantage of cine- CT and -MRI is 
that both require intravascular contrast. Difficulties with ECG reconstruction, as is required 
with these techniques, can occur in patients without sinus rhythm. The resulting CT or MRI 
image is a compilation of several cardiac cycles, resulting in a “time average” dynamic image, 
rather than an actual “real time” view of the stent-graft motion. Contrary to cine-CT and 
-MRI, FRSA does not require ECG reconstruction because it uses real time images to quantify 
three-dimensional motion. Therefore, there are no technical time constraints or difficulties 
with ECG abnormalities with this technique. Finally, there are inherent technique specific 
disadvantages such as a high radiation dose in cine-CT and the limitations in imaging stain-
less steel stent-grafts in cine-MRI.
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There are still many unknown aspects of stent-graft motion in-vivo. The cardiac and respiratory 
cycle, in conjunction with tissue properties of the aortic wall and surrounding tissues, result in 
repetitive strain on the stent-graft. This strain has lead to stent-graft failure resulting in devas-
tating complications, despite intensive testing before clinical introduction. 1,2 The main reason 
for this kind of device failure is that preclinical testing depends on modeling of motion and 
forces acting on the stent-graft. Unexpected types of stent-graft motion, including stent-graft 
torsion, have revealed unanticipated forces acting on the stent-graft. These forces could obvi-
ously not have been modeled beforehand and therefore device failure was not anticipated. 
Detailed knowledge of stent-graft motion after EVAR is vital to stent-graft development and 
improvement. Only with this knowledge it is possible to optimize modeling of graft safety 
testing and improve design e.g. by improved biocompatibility and (computer aided) fatigue 
modeling and bench testing. FRSA enables this kind of detailed real time imaging. Further-
more, modeling can be adjusted with the information obtained with FRSA after implantation 
in patients. 
One could argue that assessment of the dynamics of a new stent-graft should be mandatory in 
the period of first clinical introduction to possibly detect unexpected motion in an early phase 
to determine if adequate bench testing has been performed and predict possible failure by 
fatigue modeling according to clinical motion data. 
Currently, the only limitations of FRSA are that the field of view is limited by the detector size 
and that specifically identifiable markers are required to detect stent-graft position in consecu-
tive images. We could visualize up to 8 stents of the thoracic or abdominal graft in one view 
(Figure 2 and 3) with the standard size digital detectors used for cardiac imaging. Larger detec-
tors are commercially available and could enable imaging of the full length of longer grafts.
We plan to expand FRSA imaging and motion analysis to different stent-grafts and larger 
cohorts, as well as repeated imaging over time to study changes in motion pattern. The rela-
tive position change of the different stents of the stent-graft can also be measured. This way, 
angulation change and stent-graft torsion can be determined.
Conclusion
FRSA is the first clinically feasible tool to quantify real time three-dimensional stent-graft 
dynamics after EVAR. Because quantification of three-dimensional motion was not available 
until now, FRSA can provide crucial information of the continuous forces that are exerted in all 
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Objective: To assess cumulative patient dose and to calculate associated radiation risks for 
patients undergoing abdominal endovascular aortic aneurysm repair (EVAR).
Design of study: A traditional protocol and a reduced dose scenario for medical imaging in 
EVAR planning, repair and surveillance was assumed and patient dose was assessed. The excess 
relative radiation risk was calculated using a model for age-, gender- and site-specific solid 
cancer mortality. Life tables were used to calculate risk related parameters for patients that 
underwent EVAR at 55, 65, 75 and 85 years of age. In addition to radiation risk, mortality rates 
that are typical for the EVAR population were taken into account, knowingly the probability of 
30-day mortality and the mortality rate from AAA-related causes in general during follow-up.
Results: Effective dose for EVAR planning was 18 (8) mSv; for EVAR repair 10 (10) mSv; and 
during the first, second and subsequent years of surveillance 87.5 (35) mSv/y, 35 (17.5) mSv/y 
and 17.5 (17.5) mSv/y. The number of radiation induced deaths per 1000 EVAR patients was 
12 (10), 8 (6), 4 (3) and 1 (1) for patients treated at ages 55, 65, 75 and 85 years (respectively 
traditional protocol and between brackets reduced dose scenario). The corresponding number 
of abdominal aortic aneurysm (AAA) related deaths per 1000 EVAR patients was: 126, 91, 67 
and 47, respectively (for both the traditional protocol and the reduced dose scenario). The 
average radiation induced reduction of life expectancy was 40 (30), 21 (15), 8 (5) and 2 (1) days 
for patients treated at ages 55, 65, 75 and 85 years; corresponding AAA related reduction of 
life expectancy was 739 (740), 387 (387), 197 (197) and 82 (82) days (respectively traditional 
protocol and between brackets reduced dose scenario).
Conclusion: Radiation exposure accumulates rapidly for patients undergoing surveillance 
after abdominal EVAR. However, associated radiation risks are modest, even for the traditional 
surveillance protocol that is associated with a relatively high patient dose. Radiation risks are 
much smaller compared to AAA-related risks.
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-ray imaging for image guided treatment, preoperative planning 
and postoperative surveillance is frequently used in vascular surgery. 
It is well known that X-ray imaging is associated with a certain risk 
for induction of malignant lesions, particularly if the radiation dose 
becomes relatively high. Proper radiation protection is required for 
such practices. Justification and optimization of practices are the two 
main principles in radiation protection. Specific guidance for proper 
radiation protection in medical applications is provided in a publication of the International 
Commission on Radiological Protection (ICRP) ‘Radiological Protection In Medicine’ 1. Justifica-
tion of radiation exposure for patients undergoing abdominal endovascular aortic aneurysm 
repair (EVAR) implies that EVAR, and its associated preoperative planning and postoperative 
surveillance, should as a rule improve patient care and that radiation induced side effects are 
minimized. In other words, radiation exposure for patients undergoing EVAR should do more 
good than harm to the individual patient. Optimization implies that the level of radiation 
protection is the best achievable under the prevailing circumstances, maximizing the margin 
of benefit over radiation induced harm.
Pre- and peroperative radiation exposure for patients undergoing EVAR is already relatively 
high and may accumulate further during postoperative surveillance depending on the type 
and frequency of postoperative testing, particularly when complications occur which are 
endovascularly treated. This raised concern about radiation doses and particularly about the 
potential radiation induced carcinogenic effect in the long term 2.
The x-ray imaging modalities that are used for patients undergoing EVAR are radiography, 
fluoroscopy and computed tomography (CT). For these imaging techniques, assessment of 
radiation exposure of patients is rather straightforward, and can be based on the output of x-ray 
imaging equipment. An adequate measure of the output is generally provided on the operator 
console after the examination, either as a dose-area product (fluoroscopy, radiography) or com-
puted tomography dose index (CT scanner). Radiation risk assessment is required for balancing 
benefits against harm. In addition to the late mortality risk resulting from exposure to ionizing 
radiation, other acute and late mortality risks have to be taken into account for proper risk 
assessment of the complete EVAR procedure. These include the procedure related mortality 
risk and risks of death from aneurysm, other cardiovascular and non-vascular causes 3.
In this study two imaging strategies for EVAR were taken as a starting point, one strategy cor-
responding with traditional practices (traditional protocol) and one with more recent practices 
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(reduced dose protocol). The associated radiation exposures was assessed for both practices. 
Next, comprehensive radiation risk assessment was performed taking into account mortality 
rates that are typical for the EVAR population. To achieve this, a demographic methodology 
based on life tables was developed. These data were used to quantify the cumulative patient 
radiation dose and associated mortality risk for patients after abdominal endovascular aortic 
aneurysm repair (EVAR) in relation to all cause mortality risk for these patients.
Methods
Clinical practice 
A  traditional protocol for x-ray imaging of patients undergoing EVAR was defined based on 
a guideline of the European Collaborators on Stent-graft Techniques for Abdominal Aortic 
Aneurysm Repair (EUROSTAR) protocol 4;5. A reduced dose protocol was derived from observed 
clinical practices. Surveillance with duplex ultrasound may be performed in EVAR patients but 
was not considered in this study since it does not add to the radiation exposure and radiation 
risk evaluation.
radiation exposure 
Radiation exposure from pre-operative and peroperative angiography depends strongly on the 
used equipment, local practices, experience of the operator and complexity of the procedure. 
For this study the exposure was estimated as 10 mSv effective dose per procedure 6. Organ 
doses resulting from fluoroscopy corresponding to an effective dose of 10 mSv were assessed 
using PCXMC Monte Carlo software (STUK, Radiation and Nuclear Safety Authority, Finland). 
Assessment of radiation exposure from CT scans, i.e. organ doses and effective dose, was 
estimated from the clinical CT acquisition protocols as implemented in one hospital (ImPACT 
CT Patient Dose Calculator; 7). Radiation exposure resulting from four radiographs of the abdo-
men was calculated from measurements of the dose area product using an anthropomorphic 
phantom representing a standard adult (Rando Male Phantom, The Phantom Laboratory, 
Salem, NY, USA) followed by organ dose and effective dose calculations with PCXMC Monte 
Carlo software. Doses were assessed for organs for which information on age and gender 
dependent excess relative radiation risk is provided in BEIR VII 8, i.e.  bone marrow, stomach, 









Risk assessment was performed for males and females at four clinically relevant ages, i.e. 
patients undergoing abdominal EVAR at the ages of 55, 65, 75 and 85 years old; the age of 75 
is approximately the average age of patients treated for abdominal aortic aneurysms 9. The 
BEIR VII excess relative risk (ERR) model was used for radiation risk assessment 8. In the BEIR 
VII model, organ specific solid cancer mortality is expressed relative to the background risk of 
solid tumor mortality; taking into account both gender and age. Data on the background risk 
of solid tumor mortality depending on organ, gender and attained age were derived from ICRP 
Publication 103 (Euro-American cancer mortality rates by age and site) 10. Next, according to 
the BEIR VII model, an overall ERR function depending on organ dose, gender, age at exposure, 
and attained age was calculated for male and female patients with EVAR at the ages of 55, 65, 
75 and 85 years old. Incurred organ dose was also incorporated in the risk model as a function 
of attained age, this was required because patients who undergo EVAR are exposed at different 
ages. In addition to radiation risk, mortality rates that are typical for the EVAR population were 
taken into account, i.e. the probability of 30-day mortality (0.007 at the ages 55 and 65; 0.016 
at the age of 75; and 0.022 at the age of 85) and the mortality rate from AAA-related causes in 
general during follow-up (6 per 15 000 patient months) 3.
Life tables are used in demography for measuring and modeling population processes and 
they allow for calculation of death rate, life expectancy and reduction of life expectancy. The 
radiation induced, age, gender, and dose dependent overall mortality for the European popula-
tion (Eurostat database 11), was incorporated in life tables together with EVAR related mortality 




Traditional clinical practice included one pre-operative contrast enhanced CT scan in the arte-
rial phase and a pre-operative angiogram, followed by fluoroscopy guided EVAR. Post operative 
evaluation after EVAR was performed directly after the procedure, and followed by surveillance 
1, 3, 6, 12, 18, 24, and 36 months after EVAR; after 36 months surveillance was performed yearly. 
Common clinical practice is currently associated with reduced application of medical imag-
ing, it includes one pre-operative contrast enhanced CT scan in the arterial phase, followed 
by fluoroscopy guided EVAR. Post operative evaluation after EVAR is performed directly after 
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the procedure, and followed by yearly surveillance. The post operative evaluation and surveil-
lance sessions included radiography (four projections (AP, LAT, 30°LPO, 30°RPO)) and CT (two 
contrast enhanced scans, one arterial phase and one delayed phase scan).
radiation exposure 
Radiation exposure per procedure is presented in Table 1. Organ doses and effective dose are 
listed for pre-operative CT, pre-operative fluoroscopy, operative fluoroscopy, post operative 
and surveillance CT, and post operative and surveillance abdominal radiographs. Relatively 
high organ doses were assessed for bone marrow, stomach, colon, liver, uterus, ovaries, and 
bladder. From the radiation exposure per procedure and the observed practices, appropriate 
organ doses and effective dose were assigned to the year before EVAR; to the year in which 
EVAR was performed, and the years of post operative evaluation and surveillance (Table 2). 
Due to the intensive use of x-ray imaging the effective dose accumulates rapidly to hundreds 
of millisieverts for patients treated with EVAR; this is illustrated in Figure 1 by the cumulative 
effective dose.
Table 1. Radiation exposure per procedure, expressed as organ dose (mGy) and effective dose 
(mSv)
Pre-operative Pre-operative Operative Post operative evaluation and
CT Fluoroscopy Fluoroscopy Surveillance
1 year before 
EVAR






(mGy) (mGy) (mGy) (mGy) (mGy)
Bone marrow (mGy) 6.1 16.7 16.7 12.2 0.7
Stomach (mGy) 17.0 5.6 5.6 34.0 2.3
Colon (mGy) 11.0 21.8 21.8 22.0 4.7
Liver (mGy) 15.0 3.1 3.1 30.0 1.8
Lung (mGy) 2.0 0.2 0.2 4.0 0.0
Breast (mGy) 0.5 0.0 0.0 1.0 0.0
Prostate (mGy) 1.0 0.6 0.6 2.0 0.2
Uterus (mGy) 16.0 27.6 27.6 32.0 3.2
Ovary (mGy) 14.4 31.7 31.7 28.8 3.2
Bladder (mGy) 14.0 9.2 9.2 28.0 3.2
Other solid cancers 
(mGy) 8.0 10.0 10.0 16.0 1.5
Thyroid (mGy) 0.0 0.0 0.0 0.1 0.0
Effective dose (mSv) 8.0 mSv 10.0 mSv 10.0 mSv 16.0 mSv 1.5 mSv
A
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Demographic and risk related parameters were derived from the life tables for patients aged 
55, 65, 75 and 85 years at EVAR. This information is presented in Table 3. The number of natural 
deaths (per 1000 EVAR patients) increases with increasing age. The reason is that at higher 
ages the overall (natural) mortality increases rapidly, and both radiation induced deaths and 
AAA related deaths decrease with increasing age; this decrease is more prominent for radiation 
induced deaths. The number of radiation induced deaths is much smaller than the number of 
AAA related deaths. 
The reduction of life expectancy associated with radiation exposure was for the traditional and 
reduced dose protocols (between brackets) respectively 40 (30), 21 (15), 8 (5) and 2 (1) days for 
patients treated with EVAR at 55, 65, 75 and 85 years of age. These figures are much smaller 
compared to the AAA related reduction of life expectancy of 739 (740), 387 (387), 197 (197) and 
82 (82) days respectively. Reason for this is that compared to the more acute, disease related, 
risks that are typical for the EVAR population, radiation induced mortality requires a relatively 
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Fig. Cumulative effective dose (mSv) resulting from abdominal endovascular aortic aneurysm repair 
(EVAR) planning, repair and surveillance relative to the year of abdominal EVAR. Dots represent a 
traditional protocol (relatively high dose); triangles represent a protocol with a reduced frequency for 
imaging during surveillance (relatively low dose).
Figure 1. Cumul ive effective dose (mSv) resulting from abd minal endovascular aortic aneurysm 
repair (EVAR) planning, repair and surveillance relative to the year of abdominal EVAR. Dots 
represent a traditional protocol (relatively high dose); triangles represent a protocol with a reduced 
frequency for imaging during surveillance (relatively low dose)
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Table III. Calculated demographic and risk related parameters for patients (male and female) that 
underwent EVAR at the age of respectively 55, 65, 75 and 85 years of age.
EVAR at 55 years of age EVAR at 65 years  of age
M F Avg (M&F) M F Avg (M&F)
Tra Red Tra Red Tra Red Tra Red Tra Red Tra Red
Number of natural deaths, 
per 1000 EVAR patients 872 874 853 856 862 864 909 911 895 897 901 903
Number of radiation 
induced deaths, per 1000 
EVAR patients 12 9 13 10 12 10 8 6 8 6 8 6
Number of AAA related 
deaths, per 1000 EVAR 
patients 117 117 134 134 126 126 84 84 97 97 91 91
Life expectancy at age of 
EVAR, years 23.8 23.8 27.4 27.5 25.6 25.6 16.7 16.8 19.7 19.7 18.2 18.2
Overall reduction of life 
expectancy, days 689 682 868 860 779 771 359 353 456 450 407 402
Radiation induced 
reduction of life 
expectancy, days 37 28 43 33 40 30 20 14 21 15 21 15
EVAR induced reduction of 
life expectancy, days 653 654 825 827 739 740 339 339 435 435 387 387
EVAR at 75 years of age EVAR at 85 years of age
M F Avg (M&F) M F Avg (M&F)
Tra Red Tra Red Tra Red Tra Red Tra Red Tra Red
Number of natural deaths, 
per 1000 EVAR patients 933 934 926 927 929 930 951 951 952 953 952 952
Number of radiation 
induced deaths, per 1000 
EVAR patients 4 3 4 2 4 3 2 1 1 1 1 1
Number of AAA related 
deaths, per 1000 EVAR 
patients 63 63 71 71 67 67 47 47 47 47 47 47
Life expectancy at age of 
EVAR, years 10.5 10.5 12.2 12.2 11.3 11.4 6.1 6.1 6.1 6.1 6.1 6.1
Overall reduction of life 
expectancy, days 186 183 223 221 205 202 86 85 81 81 83 83
Radiation induced 
reduction of life 
expectancy, days 8 5 7 5 8 5 2 1 1 1 2 1
EVAR induced reduction of 
life expectancy, days 178 178 216 216 197 197 83 83 80 80 82 82
Avg = Average; Tra = traditional protocol; Red = reduced dose protocol
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Discussion
Only a few studies report on radiation exposure for patients that undergo EVAR. In one dosim-
etric study, 96 patients were included; an effective dose of 27 mSv (median value; range 16-117 
mSv) was reported for EVAR (fluoroscopy time 21 minutes); and for both preoperative and 
surveillance CT scans an effective dose of 13 mSv was reported 2. Cumulative effective dose in 
the first year following EVAR was 79 mSv. In another study a median effective dose of 8.7 mSv 
was reported for EVAR (n=24; average dose 10.5 mSv; range 2.5-28.1 mSv; fluoroscopy time 21 
min), and for computed tomography 14.3 mSv (pre-operative CT), 10.8 mSv (first postopera-
tive CT); and 5.4 mSv (surveillance CT) 6. Under these latter conditions, the cumulative effective 
dose would be 115 mSv over a 10-year period. It is well known that considerable inter-hospital 
variations occur in radiation exposure for patients in both diagnostic- and interventional 
radiology. This is well illustrated by the large difference in the above reported median effective 
dose for EVAR, respectively 27 mSv and 8.7 mSv, whereas the reported fluoroscopy time is 
about the same. Reasons for such differences in patient dose may be technical (configura-
tion and commissioning of the x-ray equipment), or operator dependent (choice for a certain 
fluoroscopy mode, proper use of collimation, positioning of the detector). The effective dose 
of 27 mSv seems to be rather high. In our calculations we used an estimated effective dose for 
fluoroscopy of 10 mSv. The patient dose of 16 mSv for computed tomography used in our cal-
culations is close to the reported value of 13 mSv 2, and substantially higher compared to the 
value of 5.4 mSv reported by Geijer et al. 6. Thus, patient dose from CT resulting from the EVAR 
surveillance regimen that was assumed for this study may be relatively high but is certainly 
well within the range of doses that occur in clinical practice. 
We did not consider additional image guided interventions in our dose calculations. The 
number and intensity of these interventions varies to a great degree and can therefore not be 
standardized. With additional procedures the cumulative dose will rise accordingly, adding to 
the risk of radiation induced mortality.
Epidemiological and experimental studies provide evidence of radiation induced cancer risk, 
albeit with uncertainties at doses of about 100 mSv or less 10. This suggests that radiation 
risks should be taken seriously, particularly for EVAR patients for whom cumulative effective 
dose during intensive surveillance protocols may exceed 100 mSv considerably. It has been 
recommended that epidemiologic studies should be performed on cohorts of patients that 
receive repeated CT scans during follow-up studies 8. Results from such epidemiologic studies 
on patient cohorts are not yet available. Therefore, methodologies for assessing the potential 
risks associated with high-dose radiological examination based on effective dose and generic 
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fatal cancer estimates are proposed as a crude estimate of the number of fatal cancers 12. 
Knowledge on radiation induced cancer risk is mainly derived from studies on radiation car-
cinogenesis at low doses in the atomic bomb survivors in Japan. Such a methodology was for 
example applied for estimating the risk of cancer from diagnostic X-ray imaging for the UK 
and 14 other countries 13. Inevitably, inaccuracies of such methodologies occur due to the 
well known uncertainties in current quantitative radiation risk estimates. A major source of 
uncertainty and a fundamental shortcoming of such approaches is that specific demographic 
characteristics of patient cohorts are neglected. Published risk estimates are commonly based 
on the assumption that radiation induced carcinogenesis in patients is equal to that in the gen-
eral population. Such an approach is inappropriate, particularly in EVAR patients, since EVAR 
procedure related risks and an increased risk of death from aneurysm, other cardiovascular 
and non-vascular causes, strongly determine life expectancy and the probability to develop 
a fatal (late) radiation induced cancer. Radiation carcinogenesis is a late effect that will be less 
prominent if additional competing mortality risks are taken into account. This study shows that 
radiation risk estimates can be calculated taking into account other relevant mortality risks. 
This was achieved by the application of life tables that integrate mortality from natural causes, 
radiation induced cancers, and EVAR and health status related mortality risks. 
The probability of long term survival of patients after EVAR, stratified according to age, was 
reported in a study by Schermerhorn et al. For the 67-74 year age interval the 48 month prob-
ability of survival after EVAR was 0.78; for the 75-84 year age interval the probability was 0.69; 
and for the ≥85 year age interval the probability was 0.52 9. For the demographic model used 
in this study the 48 month probability of survival after EVAR was 0.95 for patients undergoing 
EVAR at the age of 55; and 0.92, 0.68 and 0.56 for patients undergoing EVAR at the age of 65, 75 
an 85 years, respectively. Although comparison of the published data for the age intervals can-
not be compared straightforwardly to the age specific results of this study, we concluded that 
the demographic model compares well with the observed survival of patients that underwent 
EVAR.
The results of this study show that a methodology based on life tables and a well accepted 
model for radiation carcinogenesis can be used to calculate radiation induced deaths and an 
associated radiation induced reduction of life expectancy for patients that undergo EVAR. The 
calculations show that for patients that are prone to exposure to a high cumulative effective 
dose, the risk of radiation induced carcinogenesis still remains rather small, both in quantitative 
terms as well as compared to procedure and health status related mortality risks. For a typical 75 
year old EVAR patient, the number of radiation induced deaths per 1000 EVAR patients is 4 (3), 
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whereas the procedure and AAA related deaths is 67 (67) per 1000 EVAR patients. Correspond-
ing average radiation induced reduction of life expectancy is 8 (5) days, and procedure and AAA 
related reduction of life expectancy is 197 (197) days (figures corresponding respectively to the 
traditional and reduced dose (between brackets) protocol). It is concluded that cumulative 
radiation exposure in EVAR patients, although relatively high, should not be associated with a 
major concern with regard to radiation carcinogenesis. Still, any opportunity for optimization 
and reduction of radiation exposure of EVAR patients should of course be pursued.
The two main study limitations are inaccuracies in BEIR VII model for radiation risk assessment 
and uncertainties in patient dose assessment. Inherent inaccuracies of the BEIR VII committee’s 
preferred ERR model for estimating site-specific solid cancer mortality are the estimated errors 
for the fit parameters for the model; and the uncertainty of the most appropriate dose and 
dose-rate reduction factor (DDREF). Uncertainties in patient dose assessment originate from 
the well know phenomenon of large variations in patient dose for one and the same proce-
dure; and from the lack of reliable information on typical exposures for patients undergoing 
EVAR. However in this study we choose commonly accepted values, both with regard to the 
ERR, DDREF and organ doses. Furthermore the effect that was observed was large enough 
to reliably conclude that radiation risks associated with EVAR are modest and much smaller 
compared to AAA related risks.
Although radiation risks are of minor concern in EVAR patients, there are still good reasons 
for reconsidering current practices. First, it is a legal and ethical requirement that exposure to 
radiation is always kept as low as possible, secondly the increasing number of EVAR patients 
that now undergo intensive follow up place a growing burden on imaging capacity (equip-
ment, radiologists) and associated financial resources. Considering the increase of radiation 
associated mortality risk with the decrease of age at EVAR procedure, the urge for reduction 
of radiation exposure is especially strong for endovascular procedures in younger patients, for 
instance after traumatic vascular injury. The most promising option for dose reduction and 
health care cost saving in the EVAR population is optimization of the surveillance protocols. 
Recent practices already indicate less frequent application of x-ray imaging. Other suggested 
changes in EVAR surveillance are the use of color duplex ultrasonography 14; introduction of 
roentgen stereophotogrammetric analysis which provides (compared to CT) lower dose and 
more cost effective surveillance 15; and introduction of a reduced surveillance regimen 16. 
Therefore further efforts are still needed to achieve optimized surveillance of patients that 
underwent EVAR but it should be taken into account that optimization of surveillance should 
also take into account detection of nonaneurysmal-related findings, particularly with CT 17.
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Based on the results of this study, we conclude that radiation exposure accumulates rapidly 
for patients undergoing abdominal EVAR. However, associated radiation risks are modest and 
much smaller compared to AAA related risks.
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Part 1: Surveillance of stent-graft migration after EVAR
C
hapter 1 describes the relevance of aortic aneurysmal disease, its treat-
ment and the long term risks of endovascular aneurysm repair (EVAR). 
One of the major risks of EVAR is stent-graft migration. Migration can 
lead to repressurization of the aneurysm sac and consequent rupture of 
the aneurysm. Migration and other forms of device failure are caused by 
the repetitive strain on the stent-graft caused by the cardiac and respira-
tory cycle. These device failures can result in aneurysm related death of 
the patient despite previous EVAR.
Surveillance of EVAR patients is performed regularly to enable early detection of adverse events 
such as migration and stent fracture. CT Angiography is the current clinical gold standard to 
determine stent-graft position. However, CT has several disadvantages of which intravascu-
lar contrast requirement, cost and logistical burden are the most relevant. Furthermore, CT 
requires a significant radiation dose. 
As an alternative to CT, plain abdominal radiography (AXR) is currently used to determine 
stent-graft position. Both CT and AXR are methods in which the observer determines the posi-
tion of the stent-graft relative to a point of reference. Contrast enhanced CT enables the use of 
side branches as a point of reference. AXR images are analyzed with the vertebral end plate as 
point of reference.  The points of reference are assigned by an observer; the measurements are 
consequently sensitive to human variance. Both methods have specific disadvantages, which 
are further discussed in Chapter 1. Furthermore, the accuracy of CT and AXR to detect stent-
graft migration has not been described previously.
As a possible alternative to CT and AXR, Roentgen Stereophotogrammetric Analysis (RSA) 
could be considered as a method to detect stent-graft migration and detect possible stent 
fracture. RSA is a highly accurate technique to determine marker positions inside the body 
using calibrated, stereo plain radiography. RSA has a long and successful history in orthopedic 
surgery in surveillance of joint prosthesis micro-motion. The technical aspects of RSA are dis-
cussed in Chapter 2. In short, RSA is based on comparing the two (2-dimensional) images of a 
stereo roentgen projection to calculate a three dimensional image of the positions of markers 
in space, i.e. inside the human body. For use in endovascular surgery, RSA requires markers on 
the graft and in the aortic wall to determine the position of the stent-graft relative to a point 
of reference. These markers need to be positioned in the patient during surgery. These and 
several other technical and validation issues concerning RSA as a tool for surveillance after 
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EVAR were addressed in the first part of this thesis. Furthermore, we assessed the accuracy of 
CT and plain radiography to measure stent-graft migration. 
Validation of rSa to determine stent-graft migration 
Static model
In Chapter 3 RSA was validated as a technique to measure stent-graft migration in a static 
model. In this study, RSA was compared to CT with 3D image reconstruction. The model was 
constructed from a Plexiglas tube and a Gianturco stent cast in Plexiglas. Markers were added 
to the stent and the tube for RSA analysis. PTFE inlays in the tube were used to simulate the 
renal arteries for CT analysis. The stent was “migrated” in axial direction with a micromanipula-
tor, which was used as the standard of reference for the experiment. The initial position and the 
position after stent-graft migration were imaged with RSA and CT. CT images were acquired 
with the highest available resolution and 3D image reconstruction was performed using 
advanced post-processing software with central lumen line reconstruction. This set-up is also 
used in the current clinical stent-graft surveillance protocol at the Leiden University Medical 
Center. To correct for inter-observer variability, CT measurements were performed by 3 differ-
ent, experienced observers. 
The results showed that RSA is a feasible method to detect stent-graft migration in a static 
model, and that it was highly accurate, with a mean error of 0.002mm, SD=0.044mm, maxi-
mum error=0.10mm. This was significantly more accurate than CT which had a mean error 
of 0.14mm, SD=0.29mm, maximum error=1.0mm (p < 0.0001). No significant inter-observer 
variation was found between the CT observers (p=0.17). 
One of the questions that remained was what the influence of pulsatile motion would be on the 
accuracy of migration measurement. Theoretically, pulsatile motion of markers can produce 
errors in RSA measurement. These errors can occur due to marker motion during imaging. 
RSA in a pulsatile environment
The question of the influence of pulsatile marker motion on RSA is discussed in Chapter 4. A 
model was constructed with a fresh thoracic pig aorta fixed to a human cadaver spine. A side 
branch was attached to resemble the renal artery for CT analysis. The model was connected 
to an artificial circulation with physiological flow and pressure profiles. A stent was placed 
inside the aorta. Markers were added to the stent and aortic wall for RSA analysis, including 
a potential endovascular marker for clinical use. RSA of the stent position without pulsatile 
Sum
m
ary, future aspects and conclusions
11
159
flow was used as the standard of reference for stent-graft migration. RSA and CT imaging were 
performed of every position of the stent. 
Using standard tantalum markers, RSA had a mean error of -0.5mm, SD=0.16mm, maximum 
error= 0.7mm. Using the experimental endovascular marker, RSA had with a mean error of 
-0.4mm, SD=0.25mm, maximum error= 1.1mm. The marginally lower precision and higher 
maximum error are probably due to the fact that the endovascular marker is not spherical 
like the tantalum marker used in standard orthopedic practice. However, both RSA measure-
ments with the different aortic reference markers compared favorably to CT with 3D image 
reconstruction which had a mean error of -1.1mm, SD=1.17mm, maximum error= 2.8mm.
These results demonstrated that RSA is a feasible and accurate method to detect stent-graft 
migration in this model despite pulsatile stent-graft motion. Migration measurements using 
RSA were more accurate than CT. Furthermore, the experimental endovascular marker proved 
promising with good measurement results.
Further studies were required to test the feasibility of RSA as well as the performance of the 
endovascular marker in-vivo, before clinical introduction of the technique can be considered. 
For these reasons, an animal study was undertaken.
RSA in-vivo
In Chapter 5, we describe an experimental study with two large, 100 Kg pigs. A model of a 
stent-graft was introduced into the thoracic aorta via thoracolaparotomy. Tantalum markers 
were attached to the adventitia of the aorta as points of reference for RSA. The tantalum marker 
closest to the stent-graft model was also used as a point of reference for the CT measure-
ments. For RSA analysis, additional Nitinol endovascular clips were inserted in the aortic wall 
via endovascular technique as aortic reference markers. Stent-graft migrations were measured 
with CT and RSA. 
The standard deviation of the measurements by RSA using tantalum markers was 0.36mm. The 
standard deviation of the measurements by CT with 3D reconstruction was 0.47mm. Radiopac-
ity of the clips was insufficient to allow detection with the RSA software.
The study showed that RSA stent-graft migration measurement in vivo was feasible and very 
precise despite the physiological motion due to the cardiac and respiratory cycle and the large 
amount of soft tissue surrounding the markers. Precision of RSA was superior to CT with 3D 
image reconstruction if a well defined aortic reference marker was applied for CT analysis. It is 
likely that the precision of migration measurement with CT will decrease if a less well defined 
point of reference is used, for instance the renal or mesenteric artery, as is current practice. This 
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assumption seems to be supported by the fact that the variation of CT in the pulsatile model 
was already larger than the variation of measurement using a well defined reference marker. 
Therefore, we concluded that placement of an aortic reference marker may facilitate accurate 
stent-graft migration detection without the need for contrast enhancement. Although this 
would eliminate a significant disadvantage of CT surveillance, several other disadvantages such 
as the burden on logistics and cost, and to a lesser extent radiation burden, would remain.
As an aortic reference marker, the nitinol clip needs to be modified to increase radiopacity to 
enable RSA analysis. Enhancement of the endovascular marker with a gold or platinum ring 
could fulfill this purpose. Design testing needs to be performed before the marker can be 
introduced into practice.
Regarding aortic reference markers required for RSA
Apart from the issue of radiopacity, there are several other issues that need to be addressed 
regarding aortic reference markers. One of these issues is the question which is the appropri-
ate position of the marker relative to the graft.
In the study described in Chapter 4, we found that an increasing distance between the aortic 
and stent-graft markers due to migration caused a slight increase in the error of measurement 
in our study, which corroborates with findings as reported in the orthopedic RSA literature. 
This implies that for the most accurate RSA measurement of stent-graft migration, the aortic 
markers need to be positioned as close to the stent-graft as possible.
Safety of the nitinol endovascular clip was also studied in the animal study described in Chapter 
5. In both pigs the endovascular markers were replaced several times for evaluation purposes 
without difficulty. At post mortem investigation, the clips had (purposefully) penetrated the 
aortic wall. No adverse effects were found. It has to be remarked that this is, by nature of the 
experiment, a limited number of animals with a healthy aorta. Further studies are needed to 
evaluate the safety of a modified endovascular clip.
Another important question that remained was how many aortic reference markers are needed 
for accurate stent-graft migration detection with RSA. In orthopedic RSA multiple reference 
markers are used. As a rule, more markers will result in more accurate measurement with RSA. 
In endovascular surgery, a reference marker needs to be attached to the aortic wall. This implies 
that an extra procedure is needed during EVAR. Reducing the number of reference markers to 
only one would minimize additional risk. 
One single reference marker will enable quantification of migration in every direction, except 
rotational displacement. In contrast to axial, cranio-caudal migration or angulation of the graft 
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relative to the aortic neck, rotation of an infrarenal stent-graft around its long axis is not a 
crucial problem since this type of displacement does not affect the sealing zone and should 
therefore not lead to complications. Furthermore, axial stent-graft rotation as a single phe-
nomenon is not very likely to occur. The impact of reducing the amount of reference markers 
on the accuracy and precision of RSA migration measurement were unknown.
Accuracy of RSA using one aortic reference marker 
In Chapter 6, we described the renewed analysis of the images of the model with pulsatile 
circulation and the animal experiments. Instead of using a cluster of reference markers for RSA 
analysis, we now only used one single aortic reference marker. 
In the in-vitro model, the measurement error of RSA using multiple markers was -0.5 ± 0.16mm. 
Using only one single reference marker, the error of RSA was -0.73 ± 0.12mm. In-vivo, RSA using 
one reference marker had a pooled mean error of 0.17 ± 0.65mm as compared to standard 
RSA. 
Our data showed a very accurate detection of stent-graft migration with RSA using a single 
reference marker. Therefore, it appears that one single aortic reference marker is sufficient for 
stent-graft migration surveillance after EVAR. 
Clinical applicability of aXr for migration surveillance
Currently, plain abdominal radiography (AXR) is advocated by some to determine stent-graft 
position and detect migration. AXR has several advantages over CT. Because of these advan-
tages, AXR is an attractive and readily available alternative to CT surveillance of stent-graft 
migration. The accuracy of AXR to measure position change has been reported to be 2mm in 
an experiment by Hodgson et al. with a static model using a standard protocol for image acqui-
sition and analysis. Inter-observer variability and clinical precision have not been studied. 
In AXR, the spine is used as the point of reference to detect stentgraft migration in sequential 
examinations. Cranio-caudal stent-graft motion during the cardiac cycle has been described 
up to 3 mm in a small number of patients, making a wider range of motion likely. Further more, 
in the clinical pilot study described in Chapter 9, we found cranio-caudal stent-graft motion of 
up to 5,8mm. Because of this motion of the graft, the use of bony points of reference seems 
to be hazardous in terms of measurement accuracy. Furthermore, with increased experience 
and new generation stent-grafts, the minimum acceptable aneurysm neck length continues 
to decrease, approaching 5mm. This requires increased accuracy of our tools for migration 
surveillance.  
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In Chapter 7, we report on a study that compared migration measurement using AXR to that of 
RSA. We performed in-vitro and in-vivo studies. Stent-graft migration was simulated in a static 
model of an aorta with stent-graft. Migration was measured by five different observers in AXR 
images with image acquisition and analysis according to standardized protocols. The results 
were compared to RSA as the standard of reference. This way, accuracy and precision could be 
determined in-vitro. Next, to determine the precision of AXR in-vivo, the observers measured 
stent-graft migration in two consecutive AXR images of four patients after EVAR. 
The mean pooled error of AXR as compared to RSA was 3.0 ± 2.4 mm (range 0.01-13.1 mm, 
n=114). Of all AXR measurements, 16% had an error larger than 5mm. In-vivo, the pooled mean 
variation was 3.0 ± 4.5mm (n=76). The maximum difference between measurements in one 
patient was 33.0 mm. There was no significant inter-observer variability in the in-vitro and 
in-vivo groups.
The fact that a large portion of the measurements had an error or variation that was larger than 
5mm is worrisome, especially in view of the ever diminishing accepted aneurysm neck length 
for endografting. In-vivo, the standard deviation of 4.5mm would yield a 95% confidence 
interval of 9mm in measuring stent-graft migration. It might be safe to use AXR in patients 
with an aneurysm neck length of more than 3cm. However, this is only a very small portion of 
the patient population. 
Apart from the issue of accuracy and precision of measurement, there is the problem with the 
bony point of reference used in AXR. Changes in the vertebral column, e.g. due to osteoporosis 
or fractures, and possibly changes in neck angulation due to AAA shrinkage can influence (the 
relation to) this point of reference. 
These results showed that the accuracy and precision of plain radiography for detection of 
stent-graft migration after EVAR is insufficient for clinical use, especially when early and accu-
rate identification of minimal migration is required like in patients with short aneurysm necks.
Future aspects of rSa in endovascular surgery
RSA has several advantages over CT for its use in stent-graft migration surveillance: no neph-
rotoxic contrast requirement, ease of use for physicians and patients, low cost, low burden on 
hospital logistics, and low radiation dose. Furthermore, RSA seems to be more accurate than 
CT in measurement of stent-graft migration. This is an aspect that will be increasingly impor-
tant in the near future since there is a strong tendency towards shorter accepted aneurysm 
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There are still a lot of unanswered questions in the field of stent-graft migration that might be 
answered if accurate migration detection is routinely introduced. With more rigorous surveil-
lance, more migration seems to be found. One of the questions concerns the pattern of migra-
tion. Does migration continue to occur once it takes place? If this is the case, early detection is 
even more crucial and could reveal a high risk subgroup of patients. Alternatively, migration 
may occur at first and stabilize thereafter. Is there a graft specific pattern of migration?
Part 2: Stent-graft dynamics
The second topic of this thesis is development of a method to study 3-Dimensional stent-graft 
motion after EVAR. The cardiac and respiratory cycle, in conjunction with tissue properties, 
result in repetitive stent-graft dynamics. Knowledge of cyclic stent-graft motion after EVAR is 
limited due to the limitations of current imaging modalities. This limited knowledge results in 
unintended stent-graft construction errors and, unavoidable, insufficient pre-clinical testing. 
These forms of device failure can lead to death of the patient. Detailed knowledge of stent-
graft motion after EVAR is mandatory to further improve stent-graft durability.
Currently, dynamic studies of stent-graft motion can be performed with cinematographic 
(or cine-) CT and MRI. These methods have specific disadvantages to the patient in terms of 
intravascular contrast requirement, radiation dose (for CT) and limitation in analysis of stain-
less steel stent-grafts (MRI).  Furthermore, there are technical difficulties in ECG gated analysis. 
The images that are produced represent a temporal reconstruction of an average stent-graft 
motion over several cardiac cycles.
The main disadvantage of cine-CT and cine MRI is that reconstruction of images is limited 
to one single plane. Therefore, quantification of out-of-plane motion is impossible with the 
current techniques. This thesis describes the development, validation and clinical introduction 
of Fluoroscopic Roentgen Stereophotogrammetric Analysis, FRSA. FRSA is a combination of 
existing RSA software and technique, and new digital imaging hardware. 
In Chapter 2 we describe the technical aspects of FRSA. Contrary to RSA to detect long term 
stent-graft migration, FRSA does not require additional aortic reference markers to enable 
analysis of stent-graft dynamics. Stereo images are acquired with a Siemens digital bi-plane 
imaging system used for percutaneous cardiac intervention. The images are analyzed with a re-
programmed version of Model-based RSA software by Medis Specials BV. The re-programming 
mainly consisted of enabling the calibration of the set-up without a calibration box being pres-
ent in the image with the stent-graft, as is the case in standard RSA. The calculation of marker 
positions was unchanged.
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In contrast to cine-CT and cine-MRI, there are no limitations in terms of direction of motion, 
type of graft, length of time of image acquisition or ECG changes. 
Validation of FrSa
In Chapter 8 we describe a validation study of FRSA. The accuracy and precision of the set-up 
were validated with the use of a static and a pulsatile model of an aorta with stent-graft. After-
wards, three-dimensional stent marker motion was analyzed with a frame rate of 30 images per 
second, including three-dimensional marker position (change), diameter change and motion 
of the center of circle (center of the top end of the stent).
The results showed that the flat panel detectors did not distort the images, contrary to image 
intensifier images. The mean error of FRSA measurement of displacement was 0.003 mm (SD: 
0.019 mm; maximum error: 0.058 mm). A very high precision of position measurement was 
found in the pulsatile model (SD: 0.009-0.015 mm). During pulsatile motion, the position 
(changes) of the markers could be assessed in the x, y, and z directions, as well as the stent 
diameter change and center of circle position change.
The radiation dose of FRSA was determined in a separate experiment by our clinical physicists. 
The radiation dose is approximately 0.1 mSv for a 3 second study, which corresponds to 4 
cardiac cycles at a heart rate of 80 bpm. This compares very favorably to the 17 mSv dose of 
triple phase CT scan used for EVAR follow up.
Specifically distinguishable markers on commercially available stent-grafts, like welding points 
and positioning markers, can be used for stent-graft dynamics analysis with FRSA. Because 
there is no need for additional markers, FRSA could be introduced in a clinical pilot study.
FRSA in clinical stent-graft dynamics analysis
In Chapter 9 we describe the first results of a pilot study in two patients. Stent-graft motion was 
studied in a patient after thoracic EVAR and in one after abdominal EVAR. The motion of the 
grafts was calculated by quantification of the motion of the standard (commercially applied) 
markers used to position the stent-graft during EVAR, as well as welding points of the hooks 
to the top stent of the device. Stent-graft motion was measured during the cardiac cycle with 
respiratory arrest. In addition, stent-graft motion due to respiratory action was measured in 
the patient after abdominal EVAR. 
Three dimensional stent-graft dynamics could be quantified at 30 (stereo) frames per second 
in both patients without difficulty. The thoracic stent-graft showed a motion pattern of stent 
dilatation and a center of mass motion of the top stent in caudal-ventral-right hand side 
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direction relative to the patient, followed by an over-compensation in opposite lateral and 
cranial direction and a gradual return to the starting position with reduction of diameter of the 
graft. In other words, at the start of the systole, the graft moves toward the heart. If this motion 
is assessed in a single plain as is the case with cine-CT or cine-MRI, the initial segment of the 
aorta as viewed in the first image would be out of the reconstruction plane almost all the time. 
Only at the end of the diastole will it return to the initial position in the image reconstruction 
plane. Therefore, FRSA is much more powerful than current cinematographic imaging using 
CT and MRI as it enables quantification of the true changes of three-dimensional stent-graft 
position and configuration.
We found a significant motion of the abdominal stent-graft due to respiratory action of almost 
6mm in caudal direction. When using plain abdominal radiography to detect stent-graft migra-
tion as discussed in part 1 of this thesis, these dynamics due to respiratory action could result 
in under- or over-reporting of migration in individual cases due to the change of position of 
the stent-graft as compared to the reference point, the vertebral column. 
These studies clearly demonstrate that fluoroscopic Roentgen stereophotogrammetric analysis 
(FRSA) is a clinically feasible, non-invasive tool to quantify real time 3-D stent-graft dynamics 
after EVAR in detail. The results of this pilot are very promising in the fact that quantification of 
3D motion including rotational dynamics is now possible for the first time.
Future aspects of FRSA in endovascular surgery
The images of this non-invasive technique were of very high quality in terms of spatial and 
temporal resolution and measurement accuracy. Currently, the only limits are that specific 
markers are required to detect their position in consecutive images and that the field of view is 
limited by the detector size. As an alternative to marker detection, automated pattern recogni-
tion of the stent-graft could be used to facilitate measurements without the need for markers. 
These aspects of FRSA are subject to further evaluation at our institution. 
Further, detailed, knowledge of stent-graft motion during the cardiac cycle is required to 
better understand in-vivo behavior of stent-grafts after EVAR. New stent-grafts can be evalu-
ated, as well as existing grafts. With this knowledge, virtual mechanical modeling becomes 
possible and assessment of the failure modus of the stent-graft, such as failure due to metal 
fatigue is facilitated. Based on clinically acquired, detailed knowledge of stent-graft motion, 
forces acting on the stent-graft during the cardiac cycle can be calculated more accurately. 
Pre-clinical bench testing can be verified for adequacy. Bench testing itself will be improved 
according to in-vivo measured clinical data. One could argue that assessment of the dynamics 
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of a new stent-graft should be mandatory in the period of first clinical introduction to pos-
sibly detect unexpected motion in an early phase to determine if adequate bench testing has 
been performed and predict possible failure by fatigue modeling according to clinical motion 
data. Devastating complications and withdrawal of a graft from the market due to mechanical 
defects that arise after widespread introduction could be prevented with better bench testing 
and early detection of unexpected graft motion. 
The medical ethics committee of the LUMC approved an initial pilot study for further research 
into the specifics of motion of different grafts in the thoracic and abdominal aorta.
Addendum  
Risk of radiation exposure due to imaging in EVAR 
Medical imaging with ionizing radiation is performed during endovascular abdominal aortic 
aneurysm repair (EVAR), preoperative planning and postoperative surveillance. Cumulative 
patient dose is relatively high and causes concern about radiation induced malignancies. In 
Chapter 10, the patient dose and excessive relative risk of cancer mortality is calculated for 
typical patients aged 55 to 85, using the BEIR VII model for age-, gender- and site-specific 
solid cancer mortality. The results showed that the number of radiation induced deaths per 
1000 EVAR patients was 12, 8, 4 and 1 for patients treated at ages 55, 65, 75 and 85 years, 
respectively. The number of AAA related deaths per 1000 EVAR patients was: 126, 91, 67 and 
47, respectively. The average radiation induced reduction of life expectancy was 40, 21, 8 and 2 
days for patients treated with EVAR at 55, 65, 75 and 85 years of age respectively. Corresponding 
AAA related reduction of life expectancy was respectively 739, 387, 197 and 82 days. Therefore, 
we conclude that the impact of the considerable dose of ionizing radiation on patients after 
EVAR is small, especially when compared to the reduction of life expectancy related to vascular 
disease. 
Final Conclusions
•	 Roentgen	 stereophotogrammetric	 analysis	 is	 a	 feasible	 and	 accurate	 method	 to	 detect	
stent-graft migration in-vivo. 
•	 One	single	aortic	reference	marker	is	sufficient	for	accurate	stent-graft	migration	detection	








migration, this is especially dangerous in patients with a shorter aneurysm neck (shorter 
than 2-3cm).  
•	 Application	of	a	reference	marker	to	the	aortic	wall	will	facilitate	more	accurate	detection	of	
stent-graft migration with CT, without requiring intravascular contrast enhancement.
•	 FRSA	has	proven	to	be	a	method	with	very	high	accuracy	and	temporal	resolution	to	measure	
real time three-dimensional stent-graft dynamics in a pulsatile environment. Measurement 
of 3-D stent-graft motion has become feasible in patients after EVAR.
•	 Radiation	exposure	accumulates	rapidly	for	patients	undergoing	EVAR.	However,	associated	
radiation risks are modest and much smaller compared to AAA related risks.
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AAA abdominaal aorta aneurysma, verwijde buikslagader
EVAR endovasculaire aorta reparatie, behandeling van een aneurysma met een endoprothese
Endoprothese (eng: stent-graft) kunststof vaatprothese met een metalen (stent) geraamte 
voor bevestiging aan / in de vaatwand
Fluoroscopie filmtechniek met röntgen beelden
In-vivo in een levend wezen 
Nauwkeurigheid grootte van de meetfout ten opzicht van een gouden standaard
Precisie maat voor de afwijking in uitkomst bij een herhaalde meting
RSA röntgen stereofotogrammetrische analyse, plaatsbepaling met stereo röntgenbeelden 
Temporele resolutie het aantal metingen per tijdseenheid
Het aneurysma van de aorta is een plaatselijke toename van anderhalf maal de normale 
diameter van de hoofdlichaamsslagader. In de praktijk betekent dit dat we spreken van een 
abdominaal aorta (buikslagader) aneurysma, ofwel AAA, bij een diameter van meer dan 3-3,5 
cm. Er is een langzame toename van de diameter. Klachten in dit stadium zijn meestal afwezig 
of zeer gering. Het AAA komt in Nederland bij 2,1% van de mensen ouder dan 55 jaar voor. 
Dit percentage stijgt met toename van de leeftijd en verschillende risicofactoren. Bij mannen 
boven de 60 jaar werd in 11,4% een AAA gevonden. Over de afgelopen decennia wordt een 
toename van het vóórkomen van AAA gezien. 
Het belangrijkste risico van een aneurysma is dat het scheurt, een ruptuur. Bij een ruptuur 
is een sterfte risico beschreven tot 75-90%. Het doel van de behandeling is dan ook om het 
aneurysma uit te schakelen voordat het scheurt. Daarnaast wordt, vooralsnog experimenteel, 
onderzoek gedaan naar medicamenteuze groeiremming.
Het AAA wordt in principe behandeld als de diameter 5,5 cm of groter is. Boven 5,5 cm stijgt 
het risico op ruptuur snel. Sinds 1991 is, naast de gebruikelijke “open” operatieve behande-
ling, een nieuwe behandeling ontwikkeld: de endovasculaire aneurysmareparatie of EVAR. 
Met deze behandeling wordt het AAA uitgeschakeld via de binnenkant van de slagader. 
Dit gebeurt door een endoprothese (stent-graft) via de lies in te brengen en zodoende het 
AAA te overbruggen. Hierdoor herstelt de patiënt sneller dan na een “open” operatie via een 
buikincisie. Het belangrijkste voordeel van EVAR ten opzichte van de “open” operatie is dat het 
complicatie- en operatie-sterfterisico van EVAR lager is door het minder invasieve karakter van 
de ingreep. 
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EVAR heeft sinds de eerste introductie een stormachtige ontwikkeling doorgemaakt. De pro-
these kwaliteit en duurzaamheid zijn enorm toegenomen en EVAR is onderdeel geworden van 
de standaardbehandeling van aneurysmata. Jaarlijks worden vele duizenden patiënten over 
de wereld behandeld via EVAR. Naast het zeer aantrekkelijke korte termijn voordeel van een 
minimaal invasieve behandeling met EVAR, zijn er echter lange termijn risico’s. De lange termijn 
complicaties zijn onder andere afknikken, trombose (verstoppen) en endolekkage (druk op het 
AAA door bloeddruk of –stroom via zijtakken of langs de prothese). Daarnaast zijn migratie en 
materiaalfalen / -desintegratie belangrijke risico’s. De lange termijn aneurysma gerelateerde 
sterfte van 1-2% per jaar na EVAR is grotendeels te verklaren door deze complicaties. Om de 
complicaties in een vroeg stadium op te sporen wordt intensieve controle van patiënten na 
EVAR verricht. Dit onderzoek gebeurt met CT, echo en standaard buikoverzichts(röntgen)
foto’s. De verschillende methoden hebben specifieke nadelen en zijn kostbaar, waardoor de 
kosteneffectiviteit van EVAR wordt verminderd.
Migratie van de endoprothese is het verschuiven van de endoprothese binnen het bloedvat 
waardoor het aneurysma weer onder druk komt te staan met als gevolg opnieuw risico op rup-
tuur. Met de verdere ontwikkeling van de endoprotheses en het versterken van de fixatie aan 
de wand door bijvoorbeeld haakjes, is het risico op migratie afgenomen. Desondanks wordt 
migratie nog steeds in 1% - 66% van de patiënten gevonden, afhankelijk van de gebruikte 
opsporingsmethode en onderzoeksserie. 
Materiaalfalen kan eveneens ruptuur tot gevolg hebben. Het materiaalfalen ontstaat als gevolg 
van de continue repeterende krachten en bewegingen door de hart- en ademhalingscyclus 
en kan ontstaan ondanks de uitgebreide preklinische testen van nieuwe endoprotheses. De 
complicaties na EVAR ten gevolge van deze dynamica zijn geanalyseerd en hebben geleid tot 
verdwijnen, aanpassen of volledig vernieuwen van endoprotheses en hun testmethodes. 
Met de huidige beschikbare beeldvormende technieken is het onmogelijk om de 3 dimensi-
onale dynamica van een endoprothese in het lichaam exact te kwantificeren. Om die reden is 
ook in het verleden gebleken dat preklinische testen (achteraf ) onvoldoende bleken waardoor 
materiaalfalen kon optreden. Bewegingen als torsie en rotatie werden pas duidelijk nadat 
endoprotheses faalden en dit falen in het laboratorium werd gereconstrueerd. 
Vergaren van kennis over de krachten en bewegingen waaraan een endoprothese wordt 
blootgesteld na plaatsing zijn van groot belang om de kwaliteit en duurzaamheid van de 
behandeling en de preklinische tests te vergroten.
Dit proefschrift bestudeert nieuwe methoden om endoprothesemigratie en -dynamica op te 
sporen en te kwantificeren.
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Deel 1: Controle van endoprothese migratie na EVAR
Hoofdstuk 1 gaat verder in op aneurysmatische aandoeningen, EVAR en de lange termijn risico’s. 
Eén van die risico’s is zoals gezegd endoprothesemigratie. De klinische gouden standaard voor 
controle op endoprothesemigratie is CT-angiografie (CTA). CTA heeft als belangrijkste nadelen 
dat hiervoor contrastmiddelen worden gebruikt die schadelijk zijn voor de nieren, CTA hoge 
kosten heeft en een logistieke belasting is voor de ziekenhuisorganisatie. Daarnaast geeft CTA 
een redelijk forse stralenbelasting. Als alternatief kunnen standaard röntgen buikoverzichts-
foto’s (X-BOZ, Eng: AXR) worden gebruikt. Zowel bij CTA als X-BOZ wordt de positie van een 
endoprothese bepaald door een persoon die de afstand meet tussen de endoprothese en een 
referentiepunt. Het referentiepunt bij CTA is een zijtak van de aorta, bij X-BOZ is dit een wervel-
lichaam. Doordat een persoon deze afstand meet is er een risico op meetvariatie tussen twee 
metingen door dezelfde of verschillende personen (resp. intra- en inter-observervariatie). De 
klinische nauwkeurigheid van beide methoden is niet gevalideerd. Daarnaast zijn er specifieke 
nadelen van beide methoden die in Hoofdstuk 1 worden besproken.
Als alternatief voor CTA en X-BOZ zou Röntgen Stereofotogrammetrische Analyse (RSA) kun-
nen dienen. RSA heeft een lange en succesvolle geschiedenis binnen de orthopedie voor de 
detectie en kwantificering van microbewegingen van gewrichtsprotheses. Met behulp van 
gekalibreerde stereo röntgenfoto’s wordt de plaats van de prothese bepaald ten opzichte van 
referentiemarkers die tijdens de operatie worden ingebracht. Voor EVAR betekent dit dat tijdens 
de EVAR procedure referentiemarkers in de aortawand moeten worden geplaatst. In Hoofdstuk 
2 wordt de techniek van RSA in detail besproken. Voor het gebruik van RSA als controle op 
migratie na EVAR zijn verschillende technische- en validatievragen die beantwoord dienen te 
worden. Deze worden, samen met het onderzoek naar de nauwkeurigheid van detectie van 
migratie door CTA en X-BOZ, besproken in Deel 1 van dit proefschrift.
Validatie van rSa als methode om migratie vast te stellen
Statisch model
In Hoofdstuk 3 wordt beschreven hoe RSA is gevalideerd en de nauwkeurigheid voor de 
detectie van endoprothesemigratie is vergeleken met CT. Een plastic model werd gemaakt van 
een aorta met endoprothese. Met een micrometer kon de endoprothese worden “gemigreerd”. 
De migratie meetresultaten van CT en RSA werden met elkaar en de micrometer, de gouden 
standaard, vergeleken.
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CT analyse werd verricht met de best beschikbare resolutie en meetmethode, met 3D beeld-
reconstructie. Om te corrigeren voor inter-observervariabiliteit in de metingen werden 3 
personen gevraagd CT metingen te verrichten.
De resultaten toonden aan dat migratiemeting met RSA mogelijk was en zeer nauwkeurig in 
dit statische model. De gemiddelde fout van RSA was 0,002 mm (SD=0.044, max. fout 0.10 mm). 
Dit was significant nauwkeuriger dan CT (P<0.0001), dat een gemiddelde meetfout had van 
0.14 mm (SD=0.29 mm, max. fout 1.0 mm). Er was geen significante inter-observervariabiliteit. 
(p=0.17).
Omdat (cyclische, pulserende) beweging de nauwkeurigheid van de meting nadelig zou kun-
nen beïnvloeden, werd een volgend onderzoek verricht.
RSA in een pulsatiele omgeving
In Hoofdstuk 4 wordt een experiment beschreven met pulserende veranderingen, net als 
tijdens de hartslag. Een varkensaorta werd verbonden aan een humane wervelkolom. Een pul-
serende circulatie werd ingesteld door de aorta. In de aorta werd een model van een endopro-
these gepositioneerd, compleet met markers voor RSA analyse. Een zijtak werd geconstrueerd 
om een nierslagader na te bootsen. Aan de aortawand werden referentiemarkers geplaatst 
waaronder een potentiële endovasculaire referentiemarker voor toekomstig klinisch gebruik. 
Opnieuw werden RSA en CTA gebruikt om migratie te meten.
Dit onderzoek toonde aan dat migratiemeting met RSA mogelijk en nauwkeurig was in dit 
model, ondanks pulserende bewegingen. RSA metingen waren nauwkeuriger dan die met CT. 
De gebruikte endovasculaire marker bleek veelbelovend door goede meetresultaten.
Voordat klinische introductie mogelijk zou kunnen worden moest eerst de haalbaarheid van 
RSA en de endovasculaire marker worden getest in een levend model (in-vivo). Om die reden 
werd een dierproef verricht.
RSA in-vivo
In Hoofdstuk 5 wordt een studie met twee grote, 100 kg zware varkens beschreven. Een model 
van een endoprothese werd in de aorta gebracht. Standaard RSA markers werden op de aorta 
gefixeerd en endovasculaire referentiemarkers werden aan de binnenzijde van de aorta beves-
tigd. De standaard referentiemarker die het dichtst bij de endoprothese lag werd gebruikt als 
referentiepunt voor CT meting.
De studie toonde aan dat migratiemeting met RSA (zeer precies) mogelijk was in-vivo, ondanks 
omgevende weefsels en hart- en ademhalingsactie. De precisie van RSA was groter dan die 
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van CT. Bij CT meting werd in dit onderzoek een zeer duidelijk gedefinieerd referentiepunt 
gebruikt, in tegenstelling tot de praktijk, waarbij een (minder duidelijk gedefinieerde) zijtak 
van de aorta wordt gebruikt. Wij concludeerden dat gebruik van een externe referentiemarker 
de nauwkeurigheid van CT meting kan vergroten, zonder de noodzaak van gebruik van (scha-
delijk) contrastmiddel.
De endovasculaire marker zoals deze werd gebruikt in dit diermodel was onvoldoende zicht-
baar om te gebruiken als referentiemarker voor RSA. Om dit wel mogelijk te maken dient de 
marker te worden aangepast, bv. met een gouden of een platina ringetje. Verder onderzoek 
naar ontwerp en veiligheid dient te worden verricht.
Aorta referentiemarkers en RSA
Behalve zichtbaarheid van de marker zijn er andere belangrijke aspecten die verder moeten 
worden uitgezocht. Een daarvan is wat de beste positie is van de marker ten opzichte van 
de endoprothese. In Hoofdstuk 4 wordt beschreven dat een toenemende afstand tussen de 
referentiemarker en de endoprothese, conform resultaten in de orthopedische literatuur, 
een onnauwkeurigheid veroorzaakt. De referentie marker dient dus zo dicht mogelijk bij de 
endoprothese te worden geplaatst. In Hoofdstuk 5 wordt de diermodelstudie beschreven. 
Hier vonden we dat de endovasculaire markers zonder problemen konden worden geplaatst 
en gerepositioneerd. Bij postmortaal onderzoek van de varkens werden geen complicaties 
gevonden.
Een andere vraag is hoeveel referentie markers nodig zijn om de endoprothese positie nauw-
keurig te meten. In de orthopedie worden meerdere markers geplaatst, omdat dit tot nauw-
keuriger metingen leidt. In endovasculaire chirurgie betekent het plaatsen van een referentie 
marker een extra procedure en daardoor een (mogelijk gering) extra risico. Reduceren van het 
aantal referentiemarkers is dus wenselijk. 
Nauwkeurigheid van RSA met één referentie marker
In Hoofdstuk 6 wordt beschreven hoe de beelden van het pulserende model en de diermo-
delstudie opnieuw werden geanalyseerd met RSA waarbij één aorta referentiemarker werd 
gebruikt in plaats van het eerder gebruikte cluster van referentiemarkers.
De resultaten toonden opnieuw een zeer nauwkeurige bepaling van migratie, ondanks geringe 
afname van nauwkeurigheid door reductie van de referentie markers tot het minimum. Eén 
aorta referentiemarker lijkt dus voldoende om migratie na EVAR te controleren.
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Klinische toepasbaarheid x-boz voor migratie detectie
Standaard buikoverzichtsfoto’s (X-BOZ) worden in sommige klinieken gebruikt om endoprothe-
sepositie en eventuele -migratie te meten. X-BOZ heeft verschillende voordelen in vergelijking 
tot CT. Door deze voordelen is het een gemakkelijk en voor de hand liggend klinisch alternatief 
voor CT. De nauwkeurigheid / meetfout van X-BOZ is in een statische modelstudie beschreven 
als 2 mm. Klinische precisie en inter-observervariatie zijn niet beschreven. Bij het meten van 
endoprothesepositie met X-BOZ wordt een wervellichaam als referentie punt gebruikt. Er 
bestaat een risico dat de nauwkeurigheid van de meetmethode wordt verminderd doordat de 
aorta met de endoprothese als gevolg van de hartcyclus en ademhaling beweegt ten opzichte 
van de wervelkolom. Hierdoor kunnen niet bestaande endoprothesemigraties worden geme-
ten (vals-positieve uitslag) of opgetreden migraties worden gemist (vals-negatieve uitslag). 
Deze bewegingen kunnen oplopen tot 5,8 mm, zoals gemeten in een patiënt beschreven in 
Hoofdstuk 9. 
Door toename in ervaring van endovasculaire specialisten wordt de acceptabele minimale 
lengte van de normale aorta (de “aneurysmahals”) waaraan de endoprothese wordt bevestigd 
steeds kleiner. Op dit moment wordt in sommige gevallen een aneurysmahals van slechts 5 
mm geaccepteerd, waardoor klinisch relevante migratie al bij enkele millimeters kan optreden. 
Hierdoor is toenemende nauwkeurigheid van detectie methoden noodzakelijk.
In Hoofdstuk 7 wordt een studie beschreven waarin X-BOZ wordt vergeleken met RSA. In 
een model werden endoprothese migraties nagebootst en gemeten met RSA en X-BOZ. De 
X-BOZ metingen werden verricht door vijf personen. Hierdoor kon de meetfout van X-BOZ 
ten opzichte van RSA worden bepaald. Daarnaast werd endoprothesemigratie gemeten door 
vijf personen aan de hand van X-BOZ opnames van vier patiënten. Hierdoor kon de klinische 
precisie van X-BOZ worden bepaald. 
De gemiddelde meetfout van X-BOZ ten opzichte van RSA was 3.0 mm. 16% van de metingen 
had een fout groter dan 5 mm. Bij de klinische metingen was de variatie 3.0 ± 4.5 mm. De 
maximale meetvariatie tussen twee personen was 33 mm.
Deze resultaten zijn verontrustend omdat een dergelijke variatie en meetfout het risico op 
vals-positieve en vals-negatieve uitslagen zeer groot maakt. Om die reden concluderen wij dat 
X-BOZ onvoldoende nauwkeurig en precies is om klinische endoprothesemigratie te meten, 
met name bij patiënten met een zeer korte aneurysmahals.
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rSa in endovasculaire chirurgie: toekomstperspectief
RSA heeft verschillende voordelen in vergelijking met CTA voor endoprothesecontrole. Het 
is patiënt- en doktervriendelijk, er is geen schadelijk contrastmiddel nodig, het is weinig 
belastend voor het logistieke systeem van het ziekenhuis, goedkoop en geeft weinig stralen-
belasting. Daarnaast is RSA nauwkeuriger dan CT voor het meten van endoprothesemigratie.
Met nauwkeurige endoprothese positiemeting wordt meer migratie gevonden. Als meer 
gedetailleerde informatie beschikbaar is kunnen diverse vragen worden beantwoord, bijvoor-
beeld over migratie patronen: Blijft migratie optreden als het eenmaal begint? Stabiliseert het 
na enige tijd? Zijn er endoprothese type-specifieke patronen herkenbaar?
Deel 2: Endoprothese-dynamica
Deel 2 van dit proefschrift gaat over 3-dimensionale endoprothese beweging na EVAR. Deze 
herhaalde endoprothesebewegingen ontstaan door een interactie tussen krachten van de 
hart- en ademhalingscyclus en de aortawand. Kennis van deze bewegingen is beperkt door 
de beperkingen van de beschikbare meetmethoden. Door deze beperkte kennis ontstaan 
onbedoelde fouten in endoprotheseconstructie en preklinische testmethodes. Hierdoor kan 
een endoprothese kapot gaan en dit kan de dood van de patiënt tot gevolg hebben. Op dit 
moment zijn cine-CT en –MRI de twee klinisch beschikbare methoden van onderzoek. Deze 
hebben beide echter beperkingen en specifieke nadelen. De reconstructies van de beelden 
naar een bewegend beeld ontstaan door combinaties van verschillende opnames en zijn dus 
niet “real-time”. 
Belangrijkste nadeel is dat cine-CT en –MRI alleen kunnen meten in één plat vlak. Hierdoor 
kunnen de complexe, 3-dimensionale bewegingen van een endoprothese niet in zijn geheel 
worden bestudeerd. Het gaat hier namelijk om bewegingen buiten het in beeld gebrachte, 
platte vlak (“out-of-plane motion”). In het bijzonder is het meten van rotatiebeweging onmo-
gelijk. Deel 2 van dit proefschrift beschrijft de ontwikkeling, validatie en klinische introductie 
van Fluoroscopische Röntgen Stereofotogrammetrische Analyse (FRSA). FRSA is een combina-
tie van conventionele RSA en nieuwe digitale beeldvorming.
In Hoofdstuk 2 worden de technische aspecten van FRSA beschreven. In tegenstelling tot RSA 
voor lange termijn migratiemeting, heeft FRSA geen extra toegevoegde aorta referentiemar-
kers nodig om metingen mogelijk te maken. De beelden worden verkregen met een bi-plane 
röntgenapparaat dat gebruikt wordt in de interventie cardiologie. De RSA software werd 
opnieuw geprogrammeerd om kalibratie van de beelden mogelijk te maken. Verder werd de 
software onveranderd gebruikt.
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In tegenstelling tot cine-CT en –MRI zijn er geen beperkingen met betrekking tot bewegings-
richting, type endoprothese, duur van de opnamereeks of ECG afwijkingen.
Validatie van FRSA
In Hoofdstuk 8 wordt een validatie studie beschreven van FRSA. De nauwkeurigheid en precisie 
werden aan de hand van een model bepaald. Vervolgens werd met 30 beelden per seconde 
de 3-dimensionale positieverandering gemeten van de stent-markers, het centrum van de 
top van de stent, het zwaartepunt van de stent en de diameterverandering van de stent. De 
positieverandering van de markers kon in alle richtingen worden gemeten met een minimale 
meetfout en een zeer hoge precisie. 
De röntgenstralenbelasting van FRSA werd in een apart experiment bepaald. Voor drie secon-
den onderzoek werd een belasting gemeten van 0,1 mSv. Dit is minimaal vergeleken bij een 
CT-scan met een stralenbelasting van 17 mSv, een onderzoek dat de EVAR patiëntengroep 
diverse malen moet ondergaan voor de behandeling.
Het is voor FRSA niet nodig om extra markers op de stent aan te brengen. De markeerpunten 
die worden gebruikt voor het plaatsen van de stent tijdens de EVAR procedure, en enkele stent 
laspunten volstaan voor deze analyse. Om die reden kon de volgende stap, een patiëntenon-
derzoek, worden gezet.
FRSA in klinische endoprothese-dynamica analyse
In Hoofdstuk 9 worden de eerste resultaten beschreven van een studie van twee patiënten. 
Een patiënt werd met EVAR behandeld in de thoracale (borstkas) aorta, en een patiënt in de 
abdominale (buik) aorta. Endoprothesebeweging ten gevolge van de hartcyclus werd gemeten 
tijdens ademstilstand. Tevens werd beweging van de abdominale endoprothese ten gevolge 
van de ademhaling gemeten.
Drie-dimensionale endoprothesebeweging kon worden gemeten zonder problemen. Aan het 
begin van de systole (het samen knijpen van het hart) toonde de thoracale endoprothese een 
diameter toename en een beweging richting het hart. Dit werd gevolgd door een beweging 
in tegengestelde richting voorbij het startpunt, gevolgd door een langzame afname van de 
diameter en een terugkeer naar de uitgangspositie. Als deze beweging met een cine-CT of 
–MRI wordt gevolgd dan is het segment van aorta met endoprothese alleen tijdens het begin, 
het passeren van het startpunt en bij het weer eindigen op het startpunt kortdurend in beeld. 
De rest van de metingen worden steeds verricht aan een ander segment. Om die reden is 
FRSA een veel krachtiger instrument dan cine-CT en –MRI voor het nauwkeurig meten van 
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3D-bewegingen van endoprotheses. Daarnaast zijn de verkregen FRSA beelden “real-time”, 
zonder reconstructies aan de hand van het ECG (hartfilmpje) van de patiënt zoals bij CT en 
MRI.
Als gevolg van de ademhaling werd een beweging van de endoprothese ten opzichte van 
de wervelkolom gemeten van bijna 6 mm. Als X-BOZ wordt gebruikt voor het vaststellen van 
endoprothese migratie, zoals in deel 1 werd besproken, dan kan deze beweging van 6 mm 
t.o.v. de wervelkolom betrekkelijk eenvoudig resulteren in een vals-positieve of vals-negatieve 
uitslag aangezien de wervelkolom het referentie punt voor deze meting is.
Deze studies tonen duidelijk aan dat FRSA een klinisch toepasbare, niet-invasieve methode is 
om 3-dimensionale positie veranderingen “real-time” gedetailleerd te kwantificeren, inclusief 
rotatie bewegingen. 
FRSA in endovasculaire chirurgie: toekomstperspectief
Op dit moment is de enige beperking van de techniek dat specifieke markers nodig zijn om 
beweging te meten en dat het beeldveld beperkt is door de detectorgrootte van het fluoro-
scopieapparaat. Grotere detectoren zijn verkrijgbaar. Als alternatief voor markerdetectie kan 
geautomatiseerde patroonherkenning (van het beeldpatroon van de endoprothese) worden 
gebruikt om de metingen te verrichten. 
Meer, gedetailleerde gegevens over endoprothesebeweging tijdens hart- en adem-cyclus zijn 
nodig om het gedrag van endoprotheses in-vivo beter te begrijpen. Met deze kennis wordt het 
mogelijk om virtuele modellen te maken en materiaalfalen, zoals metaalmoeheid, te bestu-
deren. Op basis van de gemeten bewegingen kunnen de krachten die op een endoprothese 
worden uitgeoefend beter worden berekend. Gecontroleerd kan worden of de preklinische 
testopstellingen adequaat zijn gebouwd en zonodig kunnen deze worden verbeterd. Nieuwe 
endoprotheses zouden na beperkte klinische introductie mogelijk moeten worden beoordeeld 
met FRSA om onverwachte bewegingen op te sporen en om te beoordelen of de preklinische 
testen adequaat zijn verricht en mogelijk materiaalfalen te voorspellen door modellering op 
basis van klinische data. Ernstige complicaties en terugnemen van de endoprothese van de 
markt ten gevolge van materiaalfalen na wijdverbreide introductie zou voorkomen kunnen 
worden door betere testopstellingen en vroege detectie van onverwachte endoprothese 
bewegingen.
De medisch ethische toetsingscommissie van het LUMC heeft toestemming gegeven om 
verder onderzoek te verrichten naar de beweging van verschillende endoprotheses.
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Addendum 
Risico van stralen belasting tgv beeldvorming rond EVAR
Beeldvormende technieken met röntgenstralen worden gebruikt tijdens de EVAR procedure, 
de preoperatieve planning en postoperatieve controles. De totale stralenbelasting is relatief 
hoog en er bestaan zorgen over door stralen veroorzaakte kwaadaardige tumoren. In Hoofd-
stuk 10 wordt de patiëntdosis en het extra risico op sterfte aan kanker berekend voor een 
patiënt van 55, 65, 75 en 80 jaar aan de hand van rekenmodellen. 
De aanzienlijke cumulatieve stralendosis die werd opgebouwd leidde tot een gering risico 
voor de patiënten na EVAR, vooral wanneer dit risico werd vergeleken met de sterfterisico’s 
door vaatziekten in deze populatie.
Conclusies
•	 Röntgen	stereofotogrammetrische	analyse	 is	een	haalbare	en	nauwkeurige	methode	om	
endoprothesemigratie op te sporen in-vivo.
•	 Eén	 aorta	 referentiemarker	 is	 voldoende	 om	 endoprothesemigratie	 nauwkeurig	 op	 te	
sporen en moet zo dicht mogelijk bij de endoprothese worden geplaatst voor maximale 
nauwkeurigheid.
•	 Standaard	buikoverzichtsfoto’s	zijn	onvoldoende	nauwkeurig	en	precies	om	endoprothese-
migratie op te sporen. Dit is met name riskant bij patiënten met een korte aneurysmahals 
(korter dan 2 - 3 cm).
•	 Plaatsing	 van	 een	 endovasculaire	 aorta	 referentiemarker	 zal	 nauwkeuriger	 detectie	 van	
endoprothesemigratie mogelijk maken met CT, zonder gebruik van intraveneus contrast-
middel.
•	 FRSA	heeft	een	bewezen	hoge	nauwkeurigheid	en	temporele	resolutie	voor	het	real-time	
meten van drie-dimensionale endoprothese-dynamica in een pulserende omgeving. Het is 
mogelijk geworden om 3D metingen te verrichten bij patiënten na EVAR.
•	 Stralen	belasting	bij	patiënten	na	EVAR	neemt	snel	toe.	Echter,	de	hieraan	verbonden	risico’s	
zijn bescheiden en klein vergeleken bij AAA gerelateerde risico’s.









it proefschrift is het resultaat van een intensieve samenwerking 
met velen uit verschillende vakgebieden. Het is daardoor, geheel 
eigentijds, een multidisciplinair product geworden. Vanaf het 
begin bleek het een mooie uitdaging en soms ook een milde last, 
maar steeds weer een leerzame en vruchtbare ervaring. Ik heb hier 
veel plezier aan beleefd. Dank aan allen die hierin een rol hebben 
gespeeld. 
Prof. Dr. J.H. van Bockel, beste Hajo, veel dank voor de begeleiding, geboden kansen en het in 
mij gestelde vertrouwen in de afgelopen 18 jaar waarvan dit proefschrift de wetenschappelijke 
kroon van de laatste jaren is. 
Dr. E.R. Valstar, beste Edward, dank voor de samenwerking. Het is goed dat er een nieuw veld is 
ontstaan voor de toepassing van “jouw” RSA.
Hoog geachte leden van de promotie commissie, Prof. Dr. M. Malina, Prof. Dr. J.F. Hamming, 
Prof. Dr. J.H.C. Reiber, Prof. Dr. H.J.M. Verhagen, dank voor jullie bereidheid zitting te nemen in 
de commissie en voor de opbouwende kritiek.
Dr. E.H. Garling, beste Eric, veel dank voor je inspanningen bij het werk van deel 1 van dit 
proefschrift. Het was motiverend om met je van gedachten te wisselen en de haken en ogen 
te bespreken aan deze nieuwe toepassing van RSA. Dank ook dat je op de meest onmogelijke 
uren, als ik weer tijd had om me op de materie te storten, hebt meegedacht en geanalyseerd. 
Dr. B.L. Kaptein, beste Bart, zonder jouw hulp en expertise was deel 2 niet van de grond 
gekomen. Na de plaatsing van het bi-plane apparaat bij de interventie cardiologie werd de 
ontwikkeling en klinische introductie mogelijk van wat we FRSA zijn gaan noemen. Hoe jij 
onze gesprekken en brainstormsessies over kalibratie en meting (met vragen als: “maar het 
moet toch niet moeilijk zijn om…..?”) hebt vertaald naar programmatuur is mij een raadsel, 
maar de resultaten liegen er niet om! Ik hoop dat we met deze techniek veel nieuwe aspecten 
van endoprothese dynamica zullen ontdekken.
Dr. J.W. Hinnen, beste Jan-Willem, wetenschappelijk vliegwiel, het werk aan jouw en mijn 
proefschrift was een ware kruisbestuiving. Onder het genot van vele koppen koffie hebben we 
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de verschillende aspecten van beide onderzoeksgebieden doorgeakkerd. Vooral je hulp bij de 
opzet en uitvoering van de experimenten was waardevol. Hoewel je -midden in de nacht- het 
migratiemodel kapot knipte tijdens obductie van het eerste varken, waardoor de rest van de 
nacht besteed moest worden aan de reparatie voor het experiment op de volgende dag, ben 
ik er van overtuigd dat je een goed en gedreven (vaat?)chirurg zult worden.
Onmisbare hulp kreeg ik van Olivier Oudegeest, werktuigbouwkundige, Martijn Holleman, biome-
dische wetenschapper en Rozemarijn van der Vijver, toekomstig chirurg. Jullie hebben fraai werk 
verricht met de analyse van diverse onderdelen. Alle drie komen jullie uit compleet verschillende 
vakgebieden en dat maakte jullie bijdrage een extra verrijking. Veel succes met jullie carrières.
Michael Boonekamp Jr. en collega’s, jullie afdeling Fijne Mechanica van het LUMC is een ware 
schatkamer. Het was steeds weer een feest om bij jullie te komen rondkijken en samen na te 
denken hoe de modellen er uit moesten zien. “Ongeveer is ook goed” komt niet in het voca-
bulaire voor en daardoor zijn alle modellen ware huzarenstukjes geworden. Dank voor steeds 
weer korte levertijd als het gisteren af moest zijn.
Zoals gezegd is dit een multidisciplinaire inzet geweest. De afdeling Radiologie was hierbij 
een belangrijke partner. Dr. L.J.M. Kroft, beste Lucia, dank voor je radiologische insteek in 
dit onderzoek. Het was een hele toer om de dierenexperimenten uit te voeren op de CT en 
vervolgens de analyse rond te krijgen. Ook veel dank aan Edwin van der Linden, Stephan 
Frerichs en François Willemssen, voor jullie bijdrage aan de CT-data analyse. Raoul Joemai, 
jouw kennis van de techniek achter CT heeft grote indruk op me gemaakt. Dank voor je hulp 
bij de dataverwerking en de colleges “image reconstruction”. Afdeling klinische fysica, Dr. J. 
Geleijns, beste Koos, jouw kennis van de stralenbelasting is een waardevolle aanvulling voor 
dit proefschrift. Het heeft ondermeer geresulteerd in een mooi artikel dat naar ik hoop een 
belangrijk spookbeeld uit zal wissen. Dr. P.W. de Bruijn, beste Paul, eerst kwamen we elkaar 
tegen bij de afdeling Orthopedie, waar we hebben geëxperimenteerd met CT projecties, en jij 
veel te stellen hebt gehad met mijn “witjassen logica”. Later troffen wij elkaar weer in jouw rol 
als klinisch fysicus in opleiding waarbij je maat en getal wist te geven aan de stralenbelasting 
van FRSA en zo klinische introductie mede mogelijk maakte. Dank hiervoor.
Het FRSA onderdeel van dit proefschrift was er niet gekomen zonder de medewerking van 






ter beschikking stellen van jullie bi-plane apparaat, terwijl het nauwelijks 24 uur in het LUMC 
stond. Ook recent hebben we nog patiënten onderzoek gedaan en is de samenwerking erg 
plezierig en ongecompliceerd. Mede verantwoordelijk hiervoor is ook Els Nachtegaal en haar 
team van interventie medewerkers, die ons steeds met raad en daad hebben bij gestaan.
N.V. Dias, MD, PhD, dear Nuno, thank you for organizing the „Malmo-end” of the experiments. 
The data have proven to be interesting and valuable. I hope to continue the fun and exciting 
collaboration in the future.
Mijn paranimfen, Rombout Kruse en Wim Nuboer, dank voor jullie steun en vriendschap. 
Gelukkig hebben jullie alles goed gelezen en kan ik zorgeloos elke vraag doorspelen.
Lieve Marjan, dank voor je gastvrijheid, je interesse en je kwaliteits-oog.
Titia, lieve zus, de eerste 20 jaar waren wij redelijk onafscheidelijk. Ondanks het feit dat geogra-
fie en drukte belemmerend werken blijft er altijd een bijzondere band. 
Lieve Wally† en Willem, vanaf mijn eerste entree in jullie gezin heb ik mij welkom gevoeld en dat 
is altijd zo gebleven. Jullie boden mij een tweede ouderlijk thuis waarvan ik nog steeds geniet, 
ook tijdens de vrije dagen waarin ik mij heb gemeld om ongestoord te kunnen schrijven. 
Lieve ouders, jullie zijn letterlijk de scheppende voorwaarde voor dit proefschrift geweest. Een 
meer geborgen omgeving voor mijn jeugd was niet voor te stellen. Lieve Mam, dank voor je 
liefde, toewijding en steun van af het eerste begin, zij vormden de basis voor dit alles! Veel dank 
ook voor je geduld en trouw aan je vaak te bezige zoon. Lieve Pap, ondanks je steeds uitgespro-
ken advies niet in dit vak te gaan waren de dagen op de OK tijdens mijn middelbare school TE 
motiverend. Er is dan ook niets tegen bestand gebleken en het is mooi hetzelfde vak te delen.
Liefste Wally, Charlotte en Juriaan, jullie zijn de diamanten in mijn koningskroon! Wat hebben 
we toch een geluk dat juist wíj de drie leukste kinderen van de wereld hebben.
En in antwoord op jullie vraag of ik schrijver word: sorry, maar dit is echt het laatste boek…..
Lieve Wally, Grote Liefde, captain en coach van de hele thuisploeg, dank voor alles, dankzij jou 
was het een makkie!
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